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Abstract
Research in  the area o f  controlled drag release is increasingly im portant in the pharm aceutical 
industry both  from  quality  o f  life and com m ercial perspectives. One form  o f  controlled release is 
o f  active com ponents incorporated in solid polym er matrices. U nderstanding the nature and 
control o f  drug release is focal to the effective control and targeting o f  drugs. This w ill allow  the 
prediction and m odelling o f  new  delivery systems. The aim  o f  this thesis is to determ ine the 
principal m anufacturing param eters affecting the release o f  a soluble drug from  a non-sw elling 
polym er m atrix and so to understand better the dissolution m echanism . The m atrix chosen for 
study is Eudragit and the chosen drug is Diltiazem Hydrochloride. M agnetic Resonance Im aging 
(M RI) experim ents on Eudragit tablets w ith different levels o f  com pression, drug loading and 
particle size exposed to w ater w ere m ade in order to observe the ingress o f  the w ater into the 
tablets. N uclear M agnetic Resonance (NM R) spectroscopy was used to assess the am ount o f  drug 
released. Stim ulated-echo pulsed-field-gradient diffusion m easurem ents o f  drag and water 
m obility in Diltiazem Hydrochloride solutions w ere made so as to estim ate the self-diffusion 
coefficient o f  drag and w ater. A dditional X -ray C om puted M icrotom ography (//CT) and optical 
m icroscopy experim ents w ere used to characterise the tablet m icrostructure.
Experim ental evidence shows that there is a rapid  capillary uptake (< lOmins) o f  w ater into the 
initial pore space o f  a tablet ahead o f  the prim ary dissolution. This porosity  is very small, less than 
4%  for pure com pact Eudragit and even less for a drug loaded tablet. There is a slow subsequent 
dissolution characterised by a sharp diffusion front w hich separates the invaded and un-invaded 
regions. The w ater ingress proceeds linearly w ith the square root o f  tim e, t1'2. It is observed that 
w ater ingresses faster into tablets w ith  sm all drug particle size and higher drag  loading. Sw elling 
o f  the w hole tablet at interm ediate drug loadings is seen as w ater ingresses into the system. 
How ever, 110 com parable sw elling for either 100% polym er or 100% drug tablets is observed. 
There is evidence that as w ater ingresses into the tablet, air voids start to accum ulate and ripen 
w ithin the sample. Theoretical m odels are developed based on the experim ental results in term s o f  
diffusion and solubility param eters and the m easured m icrostructure. In particular, a 
dim ensionless tim e is introduced to best reflect the com petition betw een dissolution and diffusion. 
This param eter is defined as the ratio o f  the tim e required  for w ater to  diffuse across the tablet and 
the tim e for the drug to dissolve.
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Chapter 1: Introduction
Chapter 1
1 Introduction
C ontrolled release m ay be defined as a technique by w hich the active com ponents are m ade 
available to a target at a rate and duration so as to  produce a desired effect [Singh and Fan, 1986]. 
Control release is central to m any existing and foreseen technologies including agriculture, for the 
slow  release o f  pesticides and fertilisers; food, for release o f different flavours and additives; 
industrial protective coatings, for self-clean or self-repair paints; and pharm aceuticals. This last 
area is probably the m ost im portant as pharm aceutical industries try  to im prove the m ethods o f 
delivering therapeutic doses o f  m edicines that will im prove both the end user benefit for the 
quality o f  life and their ow n com m ercial advantage. The prim ary objectives o f  controlled drug 
release system s are to ensure safety, to im prove efficacy o f  drags and im prove patient 
convenience. U nderstanding the nature and control o f  drug release is central to the effective 
control and targeting drugs. H ow ever, in  m any instances developm ent o f  devices rem ains a black 
art. The central purpose o f  this thesis is to advance understanding o f  the principal factors affecting 
release from  ju s t one system: a soluble drug release from  a com pact polym er matrix. The study 
takes advantage o f  m odem  non-destructive and non-invasive im aging m ethods including 
M agnetic Resonance Im aging (M RI) and X -ray C om puted M icrotom ography (//CT) in  particular.
1.1 Controlled release systems
Controlled release system s can be constructed from  either polym er m atrices, polym er 
encapsulating drugs or pum ps. Pum ps are larger and m ore costly than polym er m atrices and 
polym er encapsulating drugs delivery systems. Externally w orn and im plantable pum ps have been 
developed and in both  cases the release rate is controlled dynam ically; the driving force is the 
pressure difference such devices are also know n as osm otic pum ps. O n the other hand, the small 
size and low  cost o f  the polym er m atrices and the polym er encapsulating drags m ake these 
system s the m ost w idely used controlled release system. The im plem entation o f  such drug 
delivery system s w as first introduced in  the 1970s, from  polym er synthesised w ith lactic and 
glycolic acid [Kashyap et al., 2004], Today, polym eric m aterials still provide the m ost im portant 
source for release system  prim arily  because o f  their ease o f  processing and the ability to readily 
control their chem ical and physical properties v ia m olecular synthesis. The basic controlled
1
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release form ulation consists o f  a polym er, either natural or synthetic, w hich is judiciously 
com bined w ith a drug or other active agent in such a way that the active agent is released from the 
m aterial in a predesigned m anner over a long period o f  time [Brannon-Peppas, 1997]. The 
advantages o f  such systems include the localised drug delivery, the tem porally uniform  dose 
delivery, in order to elim inate the potential for both under- and overdosing, the need for fewer 
adm inistrations, to reduce any side effects and the im proved drug and patient com pliance. 
Controlled release system s exist in m any forms including specially-designed tablets that can be 
taken orally, injectable m icrospheres or im plants, and transderm al patches.
Oral ingestion has long been the m ost convenient and com m only used route o f  drug delivery. For 
this reason, design and m anufacture o f  oral form ulations such as tablets and capsules is a very 
im portant aspect o f  drug delivery in the pharm aceutical industry. Systems can exists as both drug 
encapsulants and drug carriers by either protecting an active agent during its passage through the 
body until its release, or by ju s t controlling its release. These form the two broad categories o f  
polym er systems: the reservoir devices and the m atrix devices. In the form er the drug is 
surrounded by a polym er m em brane, such as capsule or m icrocapsule, w hich acts as a barrier to 
release, w hereas in the latter the drug is uniform ly distributed through the polym er netw ork 
(matrix).
p o ly m e r c o a tin g  d ru g  d isso lv ed  o r
d isp e rsed  in  p o ly m e r
d ru g
Figure 1-1: (a) Polymer reservoir system and (b) polymer matrix system
M atrix systems are perhaps the m ost com m on o f  the drug controlled release devices. This is 
probably because they are relatively easy to m anufacture, com pared to reservoir systems, and 
there is not the danger o f  an accidental high dosage that could result from  a fracture o f  the 
m em brane o f  a reservoir system. In the m atrix system  the drug dispersed throughout the polym er 
m atrix, and they are typically form ed by  the com pression o f  a polym er/drug m ixture or by 
dissolution or melting. A soluble drug may be incorporated into a w ater insoluble w axy or 
polym er m atrix (non-swelling m atrix) from  w hich it is slowly released or it can be dispersed in a 
hydrophilic polym er w hich swells, form ing a gel-like viscous layer through w hich the drug can be 
diffused. An insoluble drug may be released from a swelling soluble m atrix as its com bination 
w ith a non-sw elling polym er is not useful.
2
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1.2 Mechanisms of Controlled Drug Release
O ver the years a lot o f  effort has been m ade in order to understand the release m echanism s from 
various polym er drug delivery systems. The literature survey carried out as part o f  this work 
revealed that the underlying rate-controlling m echanism s o f  these system s are com plex and they 
fall into three fundam ental categories: diffusion, polym eric degradation and solvent-activation. As 
a consequence, a lot o f  w ork was put in experim ental research and m athem atical m odelling in 
order to predict and design new  controlled release patterns.
In the diffusion controlled system, w ater diffuses into the m em brane or m atrix so as to dissolve 
the drug, which m igrates from its initial position in the polym eric system  to the polym er’s outer 
surface and finally diffuses out o f  the polym er. It is the m ost com m on release m echanism . In a 
reservoir system, the rate determ ining step is associated w ith the diffusion o f  w ater through the 
polym er encapsulation. The release rate is constant and proportional to the initial concentration o f 
the drug. On the other hand, in a m atrix system  the rate o f  release depends upon the am ount o f  
drug present at a particular time. Therefore, it is tim e dependent [Thrash, 1995].
d ru g  d isso lv ed  o r  
d isp e rsed  in  p o ly m e r
r=0  t
Figure 1-2: Polymer matrix: Diffusion controlled system.
In the polym eric degradation system s the drug is contained w ithin a polym er m em brane or matrix. 
The polym er is designed to degrade and release drug, w hich is related to the phenom ena o f  m atrix 
erosion. The polym er degradation can be distinguished by three dissolution m echanism s: (i) w ater 
soluble polym ers are made insoluble by cross-linking them  together and w hen this is broken the 
polym er dissolves, (ii) w ater insoluble polym ers are made soluble by hydrolysis or ionisation o f  
the side groups and (iii) w ater insoluble polym ers are made soluble by backbone-chain cleavage 
to small soluble m olecules [Langer, 1993]. M any degradation system s use a com bination o f  these 
systems.
3
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d ru g  d isso lv e d  o r 
d isp e rsed  in  p o ly m e r
t=0
Figure 1-3: Polymer matrix: Degradation system.
Solvent activation system involves either the swelling o f  the polym er or osm otic effects. In the 
first case the drug is entrapped in the polym er and upon exposure to w ater (or other solvent) it 
swells allowing the release o f  the drug w hereas in the latter w ater may perm eate the drug/polym er 
system s as a result o f  osm otic pressure, causing pores to form  resulting in the release o f  the drug 
[Langer, 1990]. The m ost com m on form  o f  osm otically controlled release system  involves a semi- 
perm eable m em brane containing a small, laser-drilled hole. An osm otic agent, either the drug 
itself or a salt is contained w ithin the m em brane. W ater enters the tablet through the m em brane at 
a constant rate and drug is forced out through the hole due to the increased pressure [Thrash, 
1995].
drug dissolved or 
dispersed in polymer
(a) r=0
semipermeable 
membran
W )W— PJ
'oe
osmotic delivery 
orifice t
drug 
solution
(b)
smotic core 
*=0 containing drug
H20
enters
Figure 1-4: Solvent activation system: (a) Swelling of polymer matrix and (b) osmotically controlled 
system.
Com binations o f  all the above m echanism s are possible but having system s w ith different release 
m echanism s has the advantage that each can achieve different goals. In any case it is essential to 
understand the nature o f  these m echanism s in order to be able to construct effective drug delivery 
systems.
Diffusion is the m ost im portant m echanism  used to control drug release. It is related to the 
transport phenom ena o f  a liquid into a solid m aterial. In particular, the diffusion o f  liquid 
m olecules in polym ers has been studied for at least 40 years. In 1966, A lfrey and co-workers 
proposed two distinct diffusion behaviours o f  liquids into glassy polym ers: Fickian and Case II. In 
Fickian diffusion, sm ooth concentration profiles are observed. These vary w ith the square root o f
4
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time. This is also the case even i f  the liquid diffusion coefficient is a strong function o f  
concentration. In Case II diffusion a sharp liquid front, separating an inner glassy phase from  an 
outer sw ollen rubbery region, ingresses into the polym er linearly w ith  time. B ehind the front, the 
liquid concentration is usually uniform . B oth diffusion processes can be described by  a single 
param eter. F ickian diffusion is controlled by  the diffusion coefficient and Case II by  the constant 
velocity at w hich the boundary betw een the sw ollen polym er and the glassy phase advances 
tow ards the centre o f  the polym er. I f  it is assum ed that the m ass o f  the liquid in  polym er at tim e t 
is let", w ith  k and n constants then according to above n =  1/2 for F ickian diffusion and n =  1 for 
Case II diffusion. B etw een the tw o (1/2<«<1) lies an anom alous diffusion regim e w hich occurs 
w hen diffusion and relaxation rates are com parable [Crank, 1975].
The form  o f  drug release studied in  this thesis is that o f the active com ponent dispersed in  a solid 
polym er m atrix  system  w here the m atrix  is form ed by  the com pression o f  a  polym er/drug m ixture. 
The literature survey is m ainly bu t no t exclusively focuses on such drug delivery system.
D uring the past years a lo t o f  experim ental studies have been carried out in order to determ ine the 
release o f  the drug from  polym er m atrices. Prim arily, these experim ents rely  on m easurem ents o f 
the tem poral increase in  drug concentration in the surrounding dissolution m edium  or on 
gravim etric analysis using a range o f  standardised protocols, equipm ent and dissolution m edia. 
Studies o f  drug release from  sw elling controlled delivery system s w ere conducted using the 
U nited  States Pharm acopeia (USP) dissolution test [USP, D is s o lu tio n ^  11>, 1995] w here the 
tablet is im m ersed in a m edia bath  and the total am ount o f  the drug released into solution is 
m easured as a function o f  time. The relationship betw een the fraction o f  drug released and tim e is 
used to determ ine the diffusion process. A n exam ple w ould be the w ork o f  D ebbagh et al. 
[Debbagh et al., 1996] who used dissolution analysis and differential scanning calorim etry in 
order to investigate the effect o f  drug/polym er ratio , viscosity grades and com paction pressure on 
the drug release rate in a com bination system  o f  ethycellulose/hydroxypropylm ethylcellulose 
(HPM C)/propranolol hydrochloride. M unday and C ox [M unday and Cox, 2000] used swellable 
hydrophilic natural gums (xanthan or lcaraya gum) loaded w ith either caffeine or diclofenac 
sodium , as m odel drugs, and determ ined the degree o f  hydration as w ell as gum  and drug erosion 
by  gravim etric m eans (m ass balance). Gravim etric analysis and U SP dissolution m ethod are 
routinely used in pharm aceutical industries for studying the release o f  ding from  polym er 
systems. D issolution testing has been  used in  conjunction w ith other analytical techniques for 
exam ple h igh perform ance liquid chrom atography (HPLC) [Sung et. al., 1996] and U ltraviolet 
(UV) spectroscopy [Cox et al., 1999] to determ ine the release rate o f  the drug. H ow ever, the 
m ethods traditionally applied to follow  liquid transport in polym ers provide only lim ited 
inform ation. There is still an overall lack o f  understanding about the release m echanism s as 
dissolution tests cannot probe the drug presen t w ithin the swollen m atrix  and do not provide
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inform ation on the relative im portance o f  the tw o m echanism  o f  drug release, w hich include the 
diffusion through the sw ollen polym er and the release o f  drug at the edges o f  the tablet through 
erosion. In addition, as the drug and solvent concentration profiles are no t available from  these 
experim ents it is no t possible to test the results w ith  theoretical m odels. A  lack o f  understanding 
o f  these m echanism s leads to difficulties in predicting form ulations and drug delivery designs.
M ore detailed inform ation on the sw elling and erosion o f  a release system  has been obtained in 
the past by  m easuring dim ensional changes and m ore recently it has been m onitored optically 
[Sujja-areevath et al. , 1998], including spatially resolved Rayleigh light scattering [Gao and 
M eury, 1996]. A dler et al. [Adler et al., 1999] used fluorescent m icrospheres as non-diffusing 
m arkers to follow  localised deform ation w ith in  hydrating hydrophilic m atrix  tablets. They used 
confocal scanning m icroscopy to study the differential swelling. Ion-beam  analysis has also been 
used  to study the m olecular diffusion into various drug release polym ers [Jenneson et al., 1998]. 
H ow ever, these techniques are generally indirect as they require doping or contrasting agents and 
are often invasive or destructive.
D rug delivery design has becom e im perative but is constrained by  a restricted understanding o f 
the m echanism s o f  dissolution. W ith such understanding w ould com e the ability to confidently 
m odel the behaviour o f  current and new  delivery systems. A lthough there has been m uch work, 
designing polym er m atrix controlled release system s rem ains som ething o f  a b lack  art. The 
pharm aceutical industry in particular is keen to see research earned  out turned into predictive 
capability. There is an urgent need  to apply advanced experim ental techniques capable o f  
obtaining spatially resolved inform ation to probe the dissolution phenom enon and drug release at 
a m olecular level.
Several spectroscopic and im aging m ethods are currently available to determ ine drug distribution 
in a polym er m atrix non-invasively, including Fourier T ransform  infrared (FT-IR) spectroscopy 
[K azarian and Chan, 2003] and Ram an spectroscopy [Vergote et al., 2002], However, in some 
cases the polym er m atrix  can only be studied in  the form  o f  a thin film. A nother restriction 
involving the R am an spectroscopy is the sam ple heating due to  the absorption o f  the laser 
radiation, w hich m ight lead to polym orphic changes. Even though these techniques provide non- 
invasive analysis, the tw o m ethods that have the ability to provide internal im ages o f  the m aterials 
under study and visualise the sam ple in  3D over a tim e course are X -ray C om puted Tom ography 
(CT) [Sinlca et a l ,  2004] and M agnetic R esonance Im aging (M RI) [M elia et al., 1998]. X -ray CT 
is an im aging technique, w hich has recently  advanced in  the area o f  drug developm ent as it can 
also provide cross-sectional im ages in different planes through the sample. However, it is 
som etim es lim ited by long im age acquisition tim es and in situ experim ental conditions. O f  all 
these m ethods, M R I is today central to m easurem ents o f  drug distribution in polym er systems. It 
is a  pow erful im aging technique that provides internal im ages o f  m aterials on a m icroscopic and
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m acroscopic scale. A lthough it has been  used extensively for m edical im aging it has rapidly 
gained in  interest and used successfully in different fields o f  research for m apping o f  liquids in 
solid objects. This is really  im portant in  studying controlled release system s as the liquid transport 
in one o f  the key role m echanism s.
1.3 Magnetic Resonance Imaging and X-ray Computed Tomography in 
Controlled Drug Release
M agnetic Resonance Im aging (M RI) is a pow erful technique that offers non-invasive and non­
destructive tim e-resolved spatial m apping o f  w ater transport in porous m aterials. Im age contrast is 
based on com position, m olecular m obility  and local m icrostructure. It is versatile, as a w ide range 
o f  N M R  m odalities can b e accessed, and 2D and 3D im aging can be undertaken. M RI has becom e 
an increasingly popular probe o f  diffusion in polym er as it avoids experim ental lim itations o f  the 
aforem entioned techniques. It has been used by  num erous groups to study liquid ingress into 
polym ers. Rothw ell et ah [Rothwell et al., 1984] used the technique to study the absorption o f  
w ater in glass-reinforced epoxy resin  com posites, and w ere able to obtain im ages o f  the w ater 
distribution w here the w ater uptake w as only 1% by weight. B lackband and M ansfield 
[B lackband and M ansfield, 1986] studied the diffusion o f  w ater into solid b locks o f  nylon 6,6 and 
were able to determ ine the diffusion coefficient and its concentration dependence in a non ­
destructive m anner by  N M R  im aging. The transport was F ickian in nature. W eisenberger and 
K oenig [W eisenberger and K oenig, 1990] have used M R I to investigate diffusion and desorption 
o f  m ethanol in partially  sw ollen poly(m ethyl m ethacrylate) (PM M A) rods, observing Case II 
diffusion. N M R  im aging also allows the study o f  the m obility o f  polym er chains as dem onstrated 
by  the w ork o f  Tabalc and Corti [Tabak and Corti, 1990] on PM M A  and polystyrene bars exposed 
to vapours o f  deuterated chloroform  and carbontetracloride. K norgen et al. [Knorgen et al., 2000] 
used M R I technique to study the diffusion o f  organic solvents in polym eric m aterials like natural 
rubber, nematic-lilce netw orks, and hydrogels and observed the changing o f  the m aterials during 
the swelling processes. Fyfe et al. [Fyfe et a l ,  1993] have studied the absorption and desorption 
o f  w ater in nylon 6,6. H yde et al. [Hyde et al., 1995] studied the diffusion o f  decalin in ultra-high 
m olecular w eight poly(ethylene), and observed high degrees o f  swelling, and Fickian diffusion. 
The above review  illustrates the range o f  liquid-polym er system s that M R I has been applied to, 
and the capability the technique provides for studying a w ide range o f  transport kinetics and 
swelling behaviour. It proves that M R I is a central technique for spatial resolved exam ination o f  
diffusion processes in  polym er netw orks in real-tim e conditions. These features m ake M R I ideal 
for studying both  the penetration o f  polym eric controlled drug release m atrices by water, and the
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subsequent release o f  drug as the technique has enorm ous potential to elucidate im portant 
m echanism s that m ight contribute to understanding the drug release process.
In the last few  years, M R I has started playing an increasingly im portant ro le in  the pharm aceutical 
industry. D ue to its non-invasive nature it represents a fundam ental tool for interpreting key 
processes involved in the controlled drug release m echanism s and it has an evolving role as an 
investigative procedure to assist product developm ent. A part from  being  a non-destructive 
m ethod- hence it does no t require slicing o f  the sam ple w hich could induce changes to w ater 
distribution, it is possible to conduct experim ents in situ, depending on the system  under study. It 
can offer a chem ical-selective analysis such that specific com ponents in the system  can be 
selectively im aged. It can be spatially selective to a certain region o f  the sam ple and it can give 
the relative concentration as a  function o f  spatial location, thus the technique is no t lim ited by  the 
sam ple geom etry. The m ethod is far from  being a routine application as the behaviour o f  each 
system  is dependent on the m aterial, the m atrix  or the solvent and can be observed by different 
N M R  param eters (e.g. T i, T 2), w hich have to be chosen very carefully for the different purposes.
M R I has been  used to study internal m echanism s underlying in vitro drug release behaviour in 
dosage forms and to m onitor events w ithin pharm aceutical processes. H ydration underpins the 
system  o f  m any solid pharm aceutical dosage form s, and m ost studies have utilised M R I to 
observe and m easure the internal events unfolding as a consequence o f  solvent penetration. 
Penetration o f  aqueous fluids into such system s (dosage form s) often results in drug dissolution, 
and the release rate o f  the drug is usually determ ined by the kinetics o f  w ater penetration and the 
polym er-w ater interaction. Contrary to other m ethods, for the investigation o f  the diffusion 
process o f  solvents into polym er m atrices M RI, provides inform ation relating to the nature o f  the 
diffusion process in a polym er m atrix  on a spatial resolved level. It interprets the ingress o f 
solvent into polym ers by  m apping non-invasively the liquid concentration in the polym er as a 
function o f  time.
M R I has successfully been used as an investigative m ethod by different research groups in order 
to m onitor drug release. B ow tell et a l  [Bowtell et a l ,  1994] m onitored the form ulation o f  the gel 
layer in hydrating H PM C tablets and H PM C tablets containing insoluble calcium  phosphate 
particles or diclofenac. Rajabi-Siahboom i et a l  [Rajabi-Siahboom i et a l ,  1996] characterised the 
w ater m obility in the gel layer o f  H PM C  tablets and m easured the spatial distribution o f  self- 
diffusion coefficient and T 2 relaxation across the gel layer by  M RI. K ojim a et a l  [Kojima et al.,
1998] looked at the differences betw een swelling o f  m icronised low -substituted 
hydroxypropylcellulose (HPC) tablets and swelling o f  HPC and H PM C  tablets. They 
dem onstrated that M RI w as sensitive enough to distinguish betw een gel layer form ed and the core 
o f  the tablet. Fyfe and Blazelc-W elsh [Fyfe and Blazek-W elsh, 2000] studied the release o f  
fluorinated drugs trifluprom azine-H C l and 5-fluorouracil from  H PM C tablets using M RI. B y
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applying JH  and 19F im aging techniques they m anaged to determ ine (i) w ater and drug 
concentration profiles and (ii) diffusion coefficients that m ay be used in predicting m echanism s o f  
drug release from  other swelling m atrix system s. Fahie et al. [Fahie et al., 1998] dem onstrated 
how  M R I technique can be used to help in  the developm ent o f  new  m atrices w here the internal 
structure w as designed such as to provide predictable drug release. M ilroy et al., [M ilroy et al., 
2003] used M R I and scanning m icrobeam  nuclear reaction analysis to m onitor the w ater ingress 
into the polyglycolide disks during degradation.
The literature survey earned  out as part o f  this w ork revealed that X -ray CT is good in 
characterising the density distribution in dry pow der compacts. Sinka et al., [Sinka et al., 2004] 
m easured the m aterial density distribution in pharm aceutical tablets non-invasively by  X -ray CT. 
The tablets were m anufactured using m icrocrystalline cellulose. Y oon et al. [Yoon et al., 2004] 
reported the first use o f  in situ R am an spectroscopy and m icrofocus X -ray C T to probe and assess 
the diffusion behaviour o f  C 0 2 in  PM M A  m atrices. Ozeld et al., [Ozeki et al., 2003] used X -ray 
C T to com pare the physical properties, com pression characteristics, and internal structures o f  
tablets containing a-lactose m onohydrate, cornstarch, hydroxypropylcellulose as high polym er 
binders, and ascorbic acid as a m odel core m edicine. The technique can successfully be used to 
im age the m icrostructure o f  a sam ple and detect any irregularities in the internal structure that can 
be liked to the m anufacturing procedures. In this thesis X -ray CT has been used as a 
com plem entary technique to follow  the ingress o f  w ater into the system  in real-tim e and gain 
inform ation about the dissolution process in a m icroscopic scale.
1.4 Theoretical models
D iffusion, swelling and erosion are the m ost im portant rate-controlling m echanism  o f  com m ercial 
available controlled release systems. The behaviour o f  pharm aceutical system s containing a drug 
and a polym er can be analysed by  a m athem atical m odel w hich can predict the drug release, the 
sw elling and dissolution o f  the system. The problem  o f  tablet dissolution is one o f  the great 
im portance in pharm aceutical science, as dissolution is the lim iting step o f  the release o f  drag into 
the system. In the developm ent o f  controlled release systems, especially in oral applications, it is 
necessary that the in vitro release and the in vivo delivery are com patible. Therefore, a 
m athem atical and physical analysis o f  m atrix  dissolution becom es an im portant pharm aceutical 
research subject [Harland et al., 1988a].
M odelling o f  controlled release o f  drugs from  polym eric devices has been a subject o f  
considerable research in the past years. The dissolution o f polym er in  a solvent involves two 
transport processes, the solvent penetration and the chain disentanglem ent. W hen the rate lim iting
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step is diffusion then the solvent diffusion during dissolution process obeys Fickian second law  o f  
diffusion w here the solvent ingress proceeds as a square root o f  time, t]/2.
dc _ d2c 
dt dx2
1-1
w here D  is the diffusion coefficient, c is the concentration o f  the drug w ith in  the m atrix  as a 
function o f  position, x, and t is the time. M ost o f  the m odels that have been developed today are 
based on solutions o f  the Fickian diffusion equation. I f  the D  is a function o f  concentration then
dc
¥ dx
■D
r d A
yd X ;
1-2
There are m any instances w here the rate controlling step is due to m atrix swelling or m atrix 
erosion. In these cases a zero order release is achieved w hich m eans that the solvent advances 
linearly w ith  tim e, t‘ (Case II diffusion), into the polym er matrix.
N um erous studies have been reported  in the literature investigating the release m echanism s from  
various polym eric drug delivery system s. V arious m echanistic m odels including w ater diffusion 
into a polym er m atrix, swelling, polym er dissolution, drug diffusion in sw ollen polym er and drug 
dissolution have been established by  different research groups principal am ongst these are Singh 
and Fan [Singh and Fan, 1986], H arland et al. [Harland et al. 1988a], N arasim han [Narasim han 
and Peppas, 1996 and N arasim han, 2001], Peppas et al. [Peppas et al., 1994] and B razel and 
Peppas [Brazel and Peppas, 2000].
A  m odel that predicts polym er dissolution in  the absence o f  em bedded drug is that o f  N arasim han 
et al. [Narasim han et al., 1999]. T hey applied M R I to study the dissolution o f  swollen, 
noncrystalline poly(vinyl alcohol) in water. They suggested that polym er dissolution m odels can 
be developed by  (i) using phenom enological m odels and Fickian equations, (ii) using external 
m ass transfer as the controlling resistance to dissolution, (iii) using stress relaxation and (iv) 
analysis using anom alous transport m odels for solvent transport and scaling law s for actual 
polym er dissolution [N arasim han et al., 1999]. Their m odel is based on anom alous transport and 
scaling laws. A n one dim ensional w ater diffusion is followed by  chain disentanglem ent in 
am orphous, uncrosslinked, and linear polym ers. The equation for the swollen polym er is 
determ ined to be
1-3
1-4
dux d
\ d  au‘ l
di . Da Vi u, 9ct„
dt dx 12 a dx _ dx jRT(1- u, ) ( l -2 * o ,)  dx
gg*. g ,  | E do,
dt rj/E ( l - t / j ) 2 dt
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w here Vj is the volum e fraction o f  solvent in the swollen polym er, D n  is the solvent-polym er 
m utual diffusion coefficient, V} is the m olar volum e o f  the solvent, R is the gas constant, T is the 
tem perature, % is the solvent-polym er interaction param eter <7XV is the xx com ponent o f  the 
viscoelastic stress tensor o f  the polym er, rj is the viscosity o f  the polym er, and E  is the tensile 
m odulus o f  the polym er.
The coupled m odel equation for diffusion boundary w ith constant thickness, 8 is expressed as
dS  d u 0du2 _ d 
dt dx
n  r f
dx dt dx
1-5
w here v2 is the polym er volum e fraction, S  is the position o f  the rubbery-solvent interface, and Dp 
is the polym er self-diffusion coefficient in  the diffusion boundary. In  this m odel the polym er 
dissolution involves the determ ination o f  m any param eters. The m odel also neglects the pore 
space w ithin the polym er m atrix. This m odel is typical o f  m any in  the polym er dissolution 
literature.
One m odel that predicts the drug release from  sw ellable polym er system s is that o f  Siepm ann et 
al. [Siepm ann et al., 1999a]. T heir m athem atical m odel describes drug release from  dissolving 
H PM C  m atrices by  considering cylindrical devices and accounting for both radial and as well as 
axial transport. The w ater and drug diffusion are based on F ick ’s second law. D iffusion 
coefficients o f w ater and drug are taken to  be concentration dependent follow ing a generised free 
volum e theory
d e t  _ d
dt dr
D.
dr
, r f  dct ( 8
r dr dx
A
3c*_
dz
1-6
w here ck and Dk are the concentration and diffusion coefficient o f  the diffusing species 
(k =  l:w ater; k  =  2: drug), respectively, r  is the radial coordinate, z  the axial coordinate and t the 
tim e. A ccording to the free volum e theory  o f  diffusion, exponential dependence o f  the 
diffusivities o f  w ater and drug D } and D 2, w as considered.
A = £ > i » e x p - A
\ \
1 - and D 2 =  D 2eq exp
'leq J)
- A
A
l - 1-7
'\eq )  J
w here J3t and were dim ensionless constants, characterising the concentration dependence. Also, 
cleq w as the concentration o f  w ater, D leq and D 2eq the respective diffusion coefficients o f  w ater and 
drug in  equilibrium  sw ollen o f  the system. The diffusion coefficient o f  w ater and drug were 
determ ined by fitting a sim plified theoiy  (neglecting polym er dissolution) to adequate 
experim ental data [Siepm ann et al., 1999a]. The dissolution o f  polym er w as based on the 
reptation theory [Narasim han and Peppas, 1996]. A  critical polym er concentration is considered
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below  w hich disentanglem ent processes begin  to dom inate, resulting in  convection-controlled 
transport o f  chains. A  dissolution constant, kdiss, is defined to describe the velocity o f  dissolution 
per un it area and can be controlled by  either the rate o f  disentanglem ent or by  diffusion through a 
boundary layer, adjacent to the H PM C -w ater interface. A  m ass balance for the polym er chains is 
w ritten as
M , = M 0 - k dissA,t 1-8
w here Mt w as the m ass o f  the d iy  m atrix  at time t, M0 was the m ass o f  the d iy  m atrix at t =  0, and 
A, was the surface area o f  the system  at tim e t. This m odel predicts the release kinetic o f  a drug 
from  soluble polym er matrix. H ow ever, it neglects the initial pore space o f  the m atrix  and it does 
no t account the effect o f  the com ponent particle size on dissolution. It is confusing due to m any 
param eters used to describe the m echanism  even i f  one dim ensional diffusion is considered.
A nother m odel relevant to this study is that reported by  H arland et a l  [Harland et a l ,  1988b]. 
This is because it introduces a dim ensionless param eter to classify different dissolution regim e 
lim its. They developed a new  m odel to account for the kinetics o f  drug release from  porous, non- 
sw ellable polym eric particles in  the case w here both  drug dissolution and diffusion m echanism s 
control the overall release process. They considered a spherical particle m ade from  non-sw ellable 
polym eric m aterial and a w ater-soluble solid drug dispersed in  the polym er. The spherical system  
is p laced in contact w ith w ater and the w ater soluble drug starts to dissolve and diffused through 
the pores o f  the polym er out o f  the system. The m odel incorporates a linear first order dissolution 
term  in the Fickian diffusion equation. The equation describing the drug dissolution and diffusion 
is the follow ing generalised differential equation
D
dt
(  d c 2 dc
2 ---------
y d r  r  dr
+ k(scs- c ) 1-9
w here c is the concentration o f  the drug, r  is the radial position in the sphere, D  is the drug 
diffusion coefficient, s  is the system  void fraction, cs is the drug saturation concentration in the 
system, k w as the first order dissolution constant (in units o f  s"1) and t is the release time. They 
defined a dissolution/diffusion dim ensionless num ber, D t,
dissolu tion  , _ kR1
------------------ num ber, D i    1-10
diffusion D
w here R is the initial radius o f  the spherical particle. N ote that the param eter k, w hich is the 
dissolution rate (in units o f  s"1) is defined differently to the param eter k used later in this w ork (see 
page 15 in this chapter and C hapter 6, Sections 6.2 and 6.3.1). In H arland’s w ork the 
dim ensionless num ber, D {, indicates the relative im portance o f the m echanism  in  the overall 
release and it is possible to identify regions o f  linear time dependence o f  the drug released.
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H ow ever, the m odel cannot predict the tim e w hen the dispersed drug is fully dissolved. The 
diffusion coefficient D  is referred  to the drug diffusivity in  w ater, w hich is assum ed to be 
independent o f  drug concentration as seen in equation 1-9. N o supporting experim ental data is 
shown.
Finally, D roin et a l  [Droin et a l ,  1985] studied the drug release in  synthetic gastric liquid using 
sheets m ade from  Eudragit RS as the polym er binder, and sodium  salicylate as the drug. A  double 
transfer has been observed w hen exposed to liquid. The liquid invaded the m atrix, dissolved the 
drug w hich then diffused out o f  the system. B oth  these transfer m echanism s obeyed Fickian 
diffusion, w ith a constant diffusivity for the drug and a concentration dependent diffusivity for the 
liquid. The polym er m atrix  sw elled because o f  higher rate o f  transfer for the liquid, bu t w ithout 
affecting the stability and solidity o f  the sam ple m atrix. The m atter transfer w as m odelled based 
on num erically explicit m ethod w ith finite differences. The m odel was able to take into account 
different laws for diffusivity and am ounts o f  m aterials transferred at equilibrium , and it could be 
used for various sizes and shapes o f  the controlled release system  [Droin et a l ,  1985]. In this 
m odel the m atrix is considered as a th in  plane sheet, it neglects the initial pore space o f  the m atrix 
and the effect o f  the com ponent particle size on dissolution.
1.5 Scope of the Thesis
The process o f  dissolution and drug release from  solid dispersions o f  dings in polym ers is related 
to diffusion o f  w ater into the polym er/drug m atrix followed by  phenom ena such as polym er 
swelling, polym er dissolution, diffusion o f  drug, and drug dissolution. These phenom ena largely 
control the drug release process, bu t the overall process m ay be very com plex and m any factors 
affect the release m echanism . Interaction betw een polym er, drag and solvent are considered to be 
prim ary factors for the release control. Furtherm ore, the rate o f  d rag  release from  a polym er 
m atrix  is dependent upon various other form ulation variables, such as type o f  polym er, drug, 
polym er grade, polym er/drug ratio, particle size o f  drug and polym er, drug solubility, porosity  and 
com paction pressure. A ll these can influence drug release rate to greater or lesser extent.
The aim  o f  this study is to determ ine the principal m anufacturing param eters affecting the release 
o f  a soluble drug from  a non-sw elling polym er m atrix and so to understand better the dissolution 
m echanism . The m atrix chosen for study is Eudragit. It is a copolym er o f  acrylic and m ethacrylic 
acid ester w ith  low  content o f  quaternary am m onium  groups. The chosen drag is Diltiazem  
Hydrochloride (.HCl), w hich is highly soluble in water. B oth m aterials are w idely used in  research 
o f  controlled release systems. This m ethacrylic resin  appears particularly attractive due to its high 
chem ical stability, good com pactability properties and there are a large variety  o f  products 
available on the m arket w ith  different physicochem ical characteristics. E udragit is com m only
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used in  the preparation o f  m atrix  tablets for oral sustained release, in tablet coatings and in 
m icroencapulation o f  drugs [Azarmi et al., 2002]. Diltiazem HCl is w idely used in  treatm ent o f  
arrhythm ia and hypertension [K ristm undsdottir et al., 1996]. De Filippis et al. [De Filippis et al., 
1995] studied the effect o f  Eudragit on the dissolution behaviour o f  different drugs using solid 
dispersions prepared by  drying a m ixed solution o f  polym er and drug. K ristm undsdottir et al. 
[K ristm undsdottir et al., 1996] used dissolution tests to study the release o f  Diltiazem HCl from  
Eudragit particles prepared by  spray-drying.
The sam ple used in this thesis is in the form  o f  the tablet prepared by  direct com pression o f  the 
pow dered polym er and drug com bination. The physical characterisation and preparation o f  the 
tablets are discussed in C hapter 3. The tablet is exposed to w ater and the drug release is m onitored 
using a com bination o f  techniques such as N uclear M agnetic Resonance (NM R), M RI, X -ray 
//CT, optical m icroscopy and U V  spectroscopy. A m ongst these the forem ost m ethod in this thesis 
is M RI. F or this reason C hapter 2 is dedicated to explaining the fundam ental principals o f  M RI 
and the theory behind the m easurem ents carried out in this thesis. It also includes a b rie f 
description o f  the com plem entary m ethods used, X -ray //C T  and U V  spectroscopy. The different 
instrum entation o f  each im aging m ethod together w ith experim ental procedures, sample 
preparation for each experim ent and data processing are detailed in C hapter 3.
Spectroscopic characterisation o f  the raw  m aterials is conducted, w hich contributes to the 
interpretation o f  spatially resolved M R  data. These experim ents are presented in C hapter 4 and 
involve the determ ination o f  'H  N M R  Ti and T 2 relaxation tim es o f  w ater swollen, equilibrated 
E udragit pow ders at tw o different N M R  frequencies, 20M Hz and 400M Hz. For both  frequencies 
the Ti and T 2 m easurem ents show  single com ponent relaxation for T] w hereas T 2 shows a double 
com ponent relaxation attributed to w ater and polym er respectively. CY CLCRO P I3C-edited 
spectroscopy is applied on concentrated Diltiazem HCl solution. This m ethod has the ability to 
select a specific 13CH3 group in the m olecule w hile suppressing all proton resonances, w hich do 
not arise from  the desired m olecular groups. The objective o f  this m ethod is to m ap drug 
concentrations in  partially  sw ollen system  in  im aging studies. The principle o f  this technique is 
described in Chapter 3. Three different CH 3 groups in the drug m olecule are assigned. Based on 
these groups the self-diffusion coefficient o f  drug and w ater are estim ated by  conducted 
stim ulated-echo pulsed-fleld-gradient diffusion m easurem ents o f  drug and w ater m obility in 
Diltiazem HCl solutions.
In tbe follow ing chapter, Chapter 5, the release o f  Diltiazem HCl from  Eudragit tablets when 
exposed to w ater and the evolving m icro-structure o f  the system  during dissolution is investigated 
using non-destructive im aging techniques. The effect o f  drug release is studied in  respect to 
different m anufacturing param eters including different d ing loading, levels o f  com paction,
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particle size, m atrix  type and dissolution environm ents so as to enable the understanding o f  the 
dissolution m echanism  o f  the sam ple m atrix. M R I is used to follow  the w ater ingress, the m atrix  
sw elling and dissolution. The am ount o f  the drug release is obtained from  N M R  and U V  
spectroscopy. X -ray //C T  and optical m icroscopy are used to gain inform ation about the overall 
porosity  o f  the system.
In Chapter 5 it will be shown that w hen the m atrix  is exposed to w ater there is rapid capillary 
uptake (< lOmins) o f  w ater into the initial pore space o f  a tablet ahead o f  the prim ary dissolution. 
This porosity  is very small, less than 4%  for pure com pact Eudragit and even less for drug loaded 
tablet. The w ater then ingresses at a m uch slow er rate w ith dissolution characterised by  a sharp 
diffusion front w hich separates the invaded and un-invaded regions. The w ater ingress proceeds 
linearly w ith  the square roo t o f  tim e, t1/2. The rate o f  w ater ingress is affected by  the drug load and 
the drug particle size. As w ater continues to ingress into the system  there is a swelling o f  the 
tablet at interm ediate and h igh drug loadings. H ow ever, it w ill be  shown that this is no t prim arily 
due to the m aterials as there is no com parable swelling for either 100% Eudragit or 100% 
Diltiazem HCl tablets. A n im portant observation m ade in this thesis, w hich affects the release o f  
the drug, is the accum ulation and ripening o f  air voids w ithin the sam ple m atrix  as w ater ingresses 
into the tablet. This phenom enon was bo th  observed by M RI and X -ray //CT. The h igh spatial 
resolution o f  the X -ray //C T  system  allow ed the air-void size distribution to be quantified as it 
changes over time.
In Chapter 6 a sim ple m odel is proposed suggesting that the ripening o f  the air-voids occurs via a 
com bining process o f  air voids, w hich possibly involve little m otion or som e local diffusion. A lso, 
a  sim ple m athem atical m odel o f  the dissolution m echanism  o f  the m atrix is presented in the same 
chapter. The experim ental results are m odelled in term s o f  diffusion and solubility param eters and 
the m easured m icrostructure. In particular, a dim ensionless time, z, is defined as the ratio o f  the 
tim escale o f  diffusion and the tim escale o f  dissolution
w here L is the tablet thickness (cm), r0 is the drug particle size (cm), k is the dissolution constant 
(cm /s) and D w is the w ater diffusion coefficient (cm2/s). This param eter com pares the tim e taken 
for w ater to  diffuse across the tablet w ith  that for a drug particle to dissolve. It is found that for z»  
1, diffusion is the dom inant m echanism  leading to a sharp diffusion front w hich progresses as a 
square root o f  time, tm . For z «  1 dissolution dom inates and sm ooth w ater profiles are predicted. 
This param eter helps describe the effect o f  particle size on dissolution m echanism .
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The dim ensionless param eter defined by  H arland et a l , [Harland et a l ,  1988b] in equation 1-10 
(Di = kR2/D ) uses different definition o f  k. H e defines k to have units o f  s '1 w hereas here k has 
units o f  cm/s. How ever, it im plicitly only includes a single length scale R, w hich is equivalent to 
the tablet size L defined in equation 1-11. It does not include the size o f  the drug particle r, w hich 
in this analysis w ould require the typical dim ension o f  a pore w ithin the m icrostructure and, due 
to the different definition o f  k, also the total internal surface area o f  porous m icrostructure. 
Therefore, H arland cannot discuss the tim e for dissolution as effectively as in the current work.
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Chapter 2
2 Basic Principles of Imaging
In this thesis the release o f  the soluble drug from  a non-sw elling polym er m atrix was studied 
using different im aging techniques. E ach contributed to the collection o f  data used to understand 
the dissolution m echanism  o f  the sam ple m atrix. The m ost im portant w as M agnetic Resonance 
Im aging (M RI). It was com plem ented by  X -ray Com puted Tom ography (CT) to study the 
m icrostructure o f  the system, U ltraviolet (UV) spectroscopy to determ ine the am ount o f  the drug 
released from  the system  and optical m icroscopy to  exam ine the surface and particle size o f  the 
m atrix. This chapter is a sum m ary o f  general M R I theory explained w ith a judicious m ix o f  
classical and quantum  physics. The basic principles o f  X -ray CT and U V  spectroscopy are also 
briefly  described.
2.1 Historical Background of Magnetic Resonance Imaging
M agnetic Resonance Im aging (M RI) is a  pow erful im aging technique that is an extension o f  the 
phenom ena o f  N uclear M agnetic Resonance (NM R), a spectroscopic m ethod related to the study 
o f  m olecular structure and dynam ics. In 1937 Isidor Rabi [Rabi et a l , 1938] discovered the N M R  
phenom enon during an ion beam  experim ent. H e w as awarded by  the N obel Prize for Physics in 
1944 for his invention o f  the atom ic and m olecular beam  m agnetic resonance m ethod o f  
observing spectra. It was no t until 1946 w here two different groups, one led  by  Purcell [Purcell et 
a l , 1946] at H arvard U niversity and the other by B loch [Bloch et a l , 1946] at Stanford 
U niversity, who independently succeeded in dem onstrating the phenom ena o f  N M R  in liquids and 
solids for the first time. They w ere aw arded the N obel Prize for Physics in  1952. Since then, 
nuclear m agnetic resonance has becom e a routine tool for physicists and chem ists to probe 
m olecular structure. It has been  w idely used for the analysis o f  sm all samples, show ing that 
different m aterials resonate at different m agnetic strengths.
In 1971 R aym ond D am adian [Dam adian, 1971] reported differences in nuclear m agnetic 
relaxation tim es (Tj and T 2) o f  norm al and cancerous tissues, thus m otivating scientists to 
consider m agnetic resonance as a potential diagnostic technique. In 1973 Lauterbur [Lauterbur, 
1973] and M ansfield and G rannell [M ansfield and Grannell, 1973] independently proposed 
m ethods o f  im aging, based on the shift in  resonant frequency that results from  a change in  the
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m agnetic field im posed on the object. This was the beginning o f  M RI. A fter that, developm ent 
has been rem arkably rapid, from  the first dem onstration o f  M RI o f  the w hole body in 1977 
[Dam adian et a l ,  1977], the beginning o f  clinical trials o f  the first M R  im aging prototypes in 
1980 until the achievem ent o f  the spin-warp im aging technique [Edelstein et al., 1980] and real 
tim e im aging m ethods such as echo-planar im aging (EPI) [M ansfield, 1977], now  com m only 
know n as Fourier im aging, w hich form  the basis o f  alm ost all m odem  M RI. N ow adays M R I has 
becom e an essential tool in m edicine and it is routinely used in hospitals for diagnostic purposes 
and in 2003, Lauterbur and M ansfield were aw arded the N obel Prize in  M edicine for their 
pioneering work. D ue to the increasing progression o f  the technique, M R I has m anaged to find 
vast applications in other areas including m aterial science. The sensitivity o f  N M R  for m olecular 
diffusion processes was m arked in H ahn’s [Hahn, 1950] publication on spin echoes in 1950. He 
reported that self-diffusion influenced the spin-echo amplitudes. In 1954 C arr and Purcell [Carr 
and Purcell, 1954] introduced m ultiple echo pulse sequences to alternatively m inim ise diffusion 
attenuation effects in  sam ples w ith m obile com ponents or to m easure self-diffusion coefficients in 
liquids by  applying a constant m agnetic field gradient. The pulsed field gradient technique 
developed by  Stejskal and Tanner [Stejskal and Tanner, 1965] in 1965 dem onstrated a novel w ay 
for determ ining diffusion coefficients and form s the basis o f  today’s diffusion w eighted im aging 
m ethods, w hich is w idely used in  the study o f  m aterials. The basic principles o f  diffusion M R I 
were introduced in 1985 by Taylor and B ushell [Taylor and Bushell, 1985]. They com bined N M R  
im aging principles w ith  those introduced earlier to encode m olecular diffusion effects in the N M R  
signal by  using b ipolar m agnetic field  gradient pulses [Stejskal and Tanner, 1965]. Throughout 
the years various techniques have been considered for studying m aterials including Stray Field 
M agnetic Resonance Im aging (STRAFI) introduced by  Sam oilenko et al. in  1987 [Sam oilenko et 
al., 1987] being am ongst the m ost prom inent. Consequently, M R I is clearly a young, bu t grow ing 
science. Over the years the technique has evolved into a complex, interdisciplinary science, w hich 
has seen m ajor breakthroughs and innovation until present research.
2.2 The Fundamental Physics of MRI
M R I is a developm ent o f  N M R  and is a logical extension o f  the basic principles o f  m agnetic 
resonance. There are essentially two approached in explaining the fundam entals o f  M RI; the 
quantum  physics and the classical.
2.2.1 The Quantum Physics Approach
M agnetic resonance is a phenom enon that has its origin in the m agnetic properties o f  atom ic 
particles such as electrons, protons, neutrons, w hich form  building blocks o f  atom s and m olecules.
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A ccording to quantum  theoiy  an atom ic nucleus w ith either an odd num ber o f  protons or neutrons 
or both possess a property called intrinsic angular* m om entum  or “spin ” o f  m agnitude
| j | = Vl(I + l)» 2-1
w here I is the nuclear spin quantum  num ber and ti is equal to the P lank’s constant (h=6.6262 x 
10'34Js) divided by  2%. W hen a nucleus contains an even num ber o f  protons and neutrons, the 
individual spins o f  these particles pair o ff and cancel out and the nucleus is left w ith  zero spin, I = 
0. In a nucleus containing odd num ber o f  protons or neutrons, pairing is incom plete and the 
nucleus has a net spin o f  I =1/2 or greater. All such nuclei undergo N M R  bu t the hydrogen atom, 
consisting o f  a single proton (I =1/2), is regarded as the m ost suitable to use for M R I due to its 
h igh  N M R  sensitivity and natural abundance and also because o f  the high concentration o f  w ater 
in the hum an body.
A  nucleus can be considered as a  charged sphere spinning about its ow n axis. A ccording to the 
law s o f  electrom agnetism  a spinning sphere o f  charge generates a m agnetic dipole m om ent, ju, 
w hich is proportional to the spin angular m om entum
ju = 2-2
w here y  is the gyrom agnetic ratio rad/s/T  and is a characteristic constant for each m agnetic 
nucleus. For the hydrogen proton y =  42.56M H z/T. Each hydrogen proton is spinning, creating a 
m agnetic field and acts very m uch like a tiny bar m agnet (dipole).
In the absence o f  an external m agnetic field, the m agnetic m om ents o f  the hydrogen nuclei in a 
m acroscopic sam ple are random ly oriented and are considered to have a ne t m agnetisation o f  
zero. W hen placed in an external m agnetic field, B 0, applied along the z-axis the m agnetic 
m om ents o f  the hydrogen nuclei are trying to align w ith  this field. The energy o f  the m agnetic 
m om ent, ju, in  the external m agnetic field is given by
E =  - \x • B 0 =  yJz B0 2-3
w here B 0 is (traditionally) taken as defining the z-direction. The z com ponent o f  the angular 
m om entum  (Jz) can have mfh values w here mi is the m agnetic quantum  num ber w hich can take 
the values nii = -I, -(I-1),....,(/-1), I. This creates (2/+1) energy levels know n as Zeem an levels. So, 
the hydrogen proton w ith spin, I  - 1/2 it has two Zeem an energy levels w ith  mj =  ±1/2. Q uantum  
theory states the proton can adopt only one o f  the tw o possible orientations relative to the 
direction o f  the m agnetic field. The p referred  orientation has the m agnetic m om ent aligned 
parallel (spin m = +1/2) to the field. The other has it aligned anti-parallel to the applied field (spin 
m =  -1/2) [W estbrook and K aunt, 1998]. The energy o f  low  and high energy states is 
E+./= - y  h B 0 / 2 and E„./, =  +  y  h B 0 / 2, respectively. For norm al field strengths this difference in
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energy is sm all and at room  tem perature the preference for the low er level is veiy  small: about 
one pu t on 106.
Energy
B=0
Bn
1 = 1/2
B=Bn
mr = - 1/2
= + 1/2
AE
depends 
on field 
strength
Figure 2-1: The Zeeman energy levels of hydrogen proton in a magnetic field B0. The 
lower energy state with m=+l/2 where magnetic moment parallel to B0 and 
higher energy state with m=-l/2 and magnetic moment anti-parallel to B0.
The levels are separated in energy by  AE =  y/z B 0. This is the energy required to induce a 
transition from  the low er to the h igher energy state. The energy separation o f  the states depends 
linearly on the strength o f  applied m agnetic field B 0.
The transition o f  the nucleus betw een the two energy levels is accom panied by  absorption o f  a 
photon. The energy o f  this photon m ust exactly m atch the energy difference betw een the two 
states. The energy, E, o f  a photon is related  to its frequency, co, by P lank's constant, %
AE = yh  B 0 = h cd
(O0 =  yB0 2-4
w here <o0 is the Larm or resonance frequency in  rad/s and B 0 is the external m agnetic field in Tesla 
(T). The physical origin o f  m agnetic resonance is the observation o f  the transitions (spin slips) 
induced betw een the energy levels.
The spins in therm al equilibrium  are distributed am ong the two states according to the Boltzm ann 
distribution, w hich is the ratio o f  spins in the h igher energy level, n \ to the num ber o f  spins in the 
low er level, n+, given by
: e - A E / k BT  _ e ~yT>B0/ k n T 2-5
w here kB is the B oltzm ann’s constant and T  is the absolute tem perature. For the nuclei at room  
tem perature and norm al laboratory field  strength there is a sm all excess in the num ber o f  spins in
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the low er energy level w ith respect to the higher level. It is the population difference that gives 
rise to a net m agnetisation (m agnetic m om ent per un it volum e) M , that can be detected by N M R. 
The net m agnetisation o f  the sam ple is the difference o f  the tw o distributions m ultiplied by  the 
m agnetic m om ent
As the total num ber o f  spins o f  n— n +  n it can been  shown that
A t room  tem perature, y h B 0« k BT  and the exponential term s m ay be approxim ated by 
1- ytiB J k BT. So from  equations 2-6 and 2-7
The significance o f  this relation is that the m agnetisation depends prim arily  on the applied 
m agnetic field B 0, the tem perature T  o f  the system, and the distribution o f  the spins through the 
volum e. The rem aining param eters are intrinsic constants.
W hile quantum  physics com pletely describes particle dynamics in a m agnetic field, it  is 
cum bersom e to describe a large collection o f  particles. The classical physics perspective is 
considered to  exam ine the effect o f  m agnetic fields on the bu lk  m agnetisation o f  m any atom ic 
nuclei.
2.2.2 The Classical Physics Approach
A n alternative approach to explaining m agnetic resonance is to consider the classical m otion o f  a 
m agnetic m om ent in a uniform  m agnetic field, B 0, under the conditions o f  constant total energy. 
The m agnetic m om ent experiences a torque due to the m agnetic field, w hich tends to align it 
perpendicular to the applied field
M  = (n+ - n ) p 2-6
2-8
T  = p  x B 0 2-9
The law  o f  conservation o f  angular m om entum  states:
2-10
So for nucleus the only contribution to the angular ] 
com bining equations 2-9 and 2-10
dJ dp
m om entum  com es from  its spin. H ence,
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So the torque exerted produces a change in angular m om entum  perpendicular to both B0 and p 
and thus perpendicular to the angular m om entum  J . The result corresponds to a rotation o f  the 
direction o f  p  in a cone-shape fashion about the z-axis o f the B0. Such a m ovem ent, w hich is 
analogous to the m otion o f  a gyroscope, is referred to as precession and in such instances it is 
known as Larm or precession [Harris, 1986].
Figure 2-2: Precession of magnetic moment about B0
The precessional frequency is given by [Banwell and M cCash, 1994]
m agentic m om ent _ pB 0
COo —  - x B 0 = >  cOq —  2-12
angular momentum  J
Replacing p from equation 2-2 then
co0= y B 0 2-13
This equation is called the Larm or equation and the frequency o f  precession, co0, is know n as 
Larm or frequency. The angular frequency o f  the precession is identical to the Larm or frequency 
derived in the quantum  m echanical description above equation 2-4. The Larm or equation is 
im portant because it is the frequency at w hich the nucleus will absorb energy. The absorption o f  
that energy at that specific frequency is referred to as resonance and it will cause the proton to 
alter its alignment.
This describes the m otion o f  a single m agnetic dipole under the influence o f  the static m agnetic 
field. I f  there are a large num ber o f  dipoles, that is a collection o f  spins, in the sample it is 
possible to define a net m agnetic m om ent or m agnetisation, M  (as in equation 2-6), for the 
sample, w hich is the resultant o f  the nuclear m agnetic m oments
M  =  ] T p ,  2-14
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A s the m agnetic field is applied along the z-axis it is convenient to  determ ine the conventional 
coordinate system  used in N M R. The z axis is know n as the longitudinal direction and the x y -  
p lane perpendicular to the m agnetic field is the transverse plane. So in the presence o f  the static 
m agnetic field the z-com ponent o f  each m agnetic dipole w ill add to give a detectable net 
m agnetisation, M z. A t therm al equilibrium  this is non-zero because there is a slight difference in 
the population o f  spins pointing one w ay versus spins point another (given by  the Boltzm ann 
distribution). The net m agnetisation along z is: M z = M 0, w hereas there is no bulk  m agnetisation 
at therm al equilibrium  for M x and M y: M x = M y =  0.
Figure 2-3 Thermal equilibrium of spin distribution results in a net magnetisation along the z-axis.
A s the net m agnetisation is in  a m agnetic field B 0, it w ill experience a torque and sim ilar to the 
equation 2-11 o f  m otion for M  can be w ritten
d M
—  = / M x B ,  2-15
In M R  im aging, the energy that is transferred is radio frequency w aves (RF) and like all 
electrom agnetic radiation, it has electric and m agnetic com ponents. W hen the m agnetic 
com ponents o f  a RF pulse are applied perpendicular to an external m agnetic field w ith  a 
frequency equal to the Larm or frequency, this causes the net m agnetisation to tilt aw ay from  the 
external m agnetic field, B 0. This energy input has two effects on the protons. Firstly, the 
individual nuclei absorb energy that forces them  to change from  the low  energy state to the high 
energy state, a process know n as excitation. This results in the decrease o f  the longitudinal (z- 
axis) m agnetisation due to the reduction in difference in population betw een the spins in  the two 
states. C lassically, this serves to reorient the direction o f  the net m agnetisation. Secondly, the RF 
pulse induces all the protons into a coherent precession around the static field B 0 (z-axis) w ith a 
frequency equal to the Larm or frequency, resulting in  the increase o f  the transverse (xy-plane) 
m agnetisation.
I f  the R F pulse is applied in  the form  o f  a tim e varying field B b applied perpendicularly to B 0 and 
oscillating at co0 then  the equation o f  the field B i acting on the sam ple is derived by  considering
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only the circularly polarised com ponent o f  B x rotating in the same direction as the precessing 
m agnetisation in the xy-plane [Callaghan, 1993]. The com ponent that rotates in the opposite 
direction to the nuclear precession is ignored provided that B i « B 0. The B field acting on the 
sam ple is
B totai(0 = B jcos (D0t i - 5 /s in  co0t j +B0 k 2-16
w here i, j and k are unit vectors along the x, y  and z axes, respectively. Thus, during the pulse 
from  equation 2-15 o f  m otion the m agnetisation o f  each x, y  and z com ponent can be expressed as
^ Y = = r [M y B 0 +  M ZBX s in  a>Qt\
d M  r 1
-8, cos m f  - M XB 0 ] 2-17
" f  * = y [ -  M XBX s in  -  M yB x cos a y ]
I f  a  starting condition (for t=  0) M(0)=Mok is defined, then the solutions for M  are
M x = M 0 s in  coxt  s in  a f t
M y = M 0sma>xt c o s a f  2-18
M z = M 0cosa>xt
w here coj = yB,. This im plies that by  applying a rotating m agnetic field o f  frequency co0, the net 
m agnetisation sim ultaneously precesses about the m agnetic field B0 at an angular frequency co0 
and about the B i field at a frequency ©i. This results in a spiral m otion o f  the net m agnetisation 
down and around the z axis as show n in  Figure 2-4(a).
In order to sim plify descriptions it is convenient to picture the excitation process in  a fram e o f  
reference, (x ’y ’z ’ plane), w hich rotates about the z-axis at frequency co0 (or in m ore general case 
at co). Initially, the equilibrium  m agnetic m om ent, M, is aligned parallel to the applied m agnetic 
field, B0 (laboratory frame). The m agnetisation is m oved away from  the equilibrium  by  a sm aller 
m agnetic field B x, w hich is applied as an RF pulse. In this frame, know n as ro tating fram e, B0 is 
zero w hen co =  co0 (resonance), B x is stationary along, for example, the x ’-axis and this tim e the 
m agnetisation precesses around B x instead o f  B0, at a frequency equal to cox = y  B x. A fter the 
pulse the m agnetisation precesses around B0 in  the transverse plane at the Larm or frequency, co0. 
How ever, w hen co + co0 (off-resonance) then the situation becom es m ore com plicated and in  the 
rotating fram e there is a residual field that takes the value (B0 -  co/y) along the z direction 
[Callaghan, 1993]. Therefore, the m agnetisation precesses, in the rotating fram e, about this 
residual field and B}.
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Figure 2-4: (a) Spiral motion of net magnetisation in a laboratory frame under the effect of 
both B! and B0 when co = « 0 (b) magnetisation in the rotating frame precesses about 
B, at 0! where Bi is stationary (c) magnetisation flips into transverse plane (d) 
magnetisation precesses about B0 at co0 in the laboratory frame.
In an N M R  experim ent the B] field is applied as a short RF pulse. I f  the duration o f  the pulse is tp 
(a few ps long) then the m agnetisation will rotate by an angle 6 = yB,tp. The RF pulse used to 
describe the energy needed to rotate the m agnetisation from the longitudinal plane (z-axis) into 
the transverse plane (xy-plane) is referred to as 90° pulse while the pulse that inverts the 
m agnetisation is know n as 180° pulse. The direction o f  the pulse is also specified.
Follow ing excitation, as the m agnetisation rotates in the xy-plane o f  the laboratory frame about 
the z-axis it will induce a current in a coil o f  wire placed around the sam ple w ith its sym m etry 
axis perpendicular to B0. This signal from the coil is the N M R signal. The signal appears to die 
away w ith time and the plot o f  the signal intensity against time is referred to as Free Induction 
Decay (FED). The Fourier Transform  o f  the N M R  signal, recorded in the time dom ain, will 
produce the absorption line in the frequency dom ain. The coil that detects the N M R signal is the 
same one used for the excitation. A  sim ple diagram  o f  the detection o f  the N M R  signal by a 
radiofrequency receiver is shown in Figure 2-5.
am p lif ie r  m a g n e t y / re c e iv e r
Figure 2-5: Diagram for the detection of the NMR signal.
In general, a time signal s(t), can be converted into a frequency spectrum  S(co) by the following 
integration w hich defines the Fourier transform.
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£ ( /y )=  P  s(t)ex p (-ico t)d t
J-00
2-19
The integration assum es s(t) as a continuous function over all o f  time. N ote that the result o f  this 
integration is a com plex function o f  frequency and that it will have real and im aginary 
coefficients.
Figure 2-6: FID and its Fourier transform for (a) resonance signal and (b) off-resonance signal.
The figures are drawn w ith reference to the dem odulated signal, i.e. for the rotating reference 
frame.
2 .2 .2 .1  R e la x a t io n  T h e o ry
Since the application o f  a resonant RP pulse disturbs the spin system, there m ust subsequently be 
a process, known as relaxation, o f  com ing back to equilibrium. There are two m ain relaxation 
processes associated w ith M agnetic Resonance (M R). The first involves the exchange o f  energy 
betw een the spin system  and its surroundings. Such a process is called spin-lattice relaxation. It is 
the rate at w hich equilibrium  is restored and it is characterised by the spin-lattice or longitudinal 
relaxation time, T i. It is the rate at w hich nuclear spins align w ith the direction o f  the magnetic 
field and hence achieve therm al equilibrium  with their surroundings. It defines the possible 
repetition rate o f  experim ents. The spins how ever do not only exchange energy w ith the 
surrounding lattice, but also am ong them selves. This is the second process called spin-spin 
relaxation and is characterised by the spin-spin or transverse relaxation time, T 2. It is the rate at 
w hich coherently precessing nuclei dephase relative to each other after excitation and hence 
achieve therm al equilibrium  am ongst them selves. It is always a faster, or equally fast process than 
spin-lattice relaxation. The detection o f  these processes forms the basis o f  the M RI signal.
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Figure 2-7: (a) Spin-spin and (b) spin-lattice relaxation in the rotating fram e after 90° pulse.
A fter a 90° pulse, the spins w ill tend to return to their equilibrium  distribution, in w hich there is 
no transverse m agnetisation, M x and M y, and the longitudinal m agnetisation, M z, is at its 
m axim um  value and oriented in the direction o f  the static m agnetic field.
N uclear spin relaxation arises from  the static and dynam ic interaction o f  nuclear spins am ongst 
them selves and w ith  their surroundings. The relaxation rates depend critically on the m agnitude o f  
the interactions and also on the rate o f  their fluctuation. In this w ay bo th  %  and T2 relaxation 
tim es are very sensitive to m olecular environm ent and m otion. B oth  Ti and T 2 relaxation tim es are 
veiy  sensitive to local m olecular m otion. To a first approxim ation, Ti depends on the am ount o f  
m olecular m otion at the M R  experim ental frequency w hich is usually  in the 10M Hz -  1GHz 
range. It varies significantly w ith  M R  frequency and depends on the correlation time o f  m olecular 
m otion, xc. T 2 depends on low  frequency m olecular m otion typically in the kH z range. A  careful 
study o f  the frequency dependence o f  the relaxation tim es can reveal considerable detail about 
m olecular m otion o f  a w ide frequency range. The theoretical link  betw een relaxation and m otion 
w as first m ade by Bloem bergen, Pound and Purcell [Bloem bergen et a l ,  1946], after w hom  the 
m odel is com m only nam ed the BPP theory. A ccording to this theory, T x is long (typically l-10s) 
for both  very m obile liquids and very rig id  solids w hereas it is a m inim um  (typically ms) for an 
interm ediate state w ith m olecular m otion characterised by  interm ediate correlation time, xc, o f  the 
order o f  the inverse M R  frequency, ©o’1. Indeed it is a m inim um  w hen the average rate o f  
m olecular m otion (x f1) m atches the N M R  frequency ©0, i.e. ©0xc =  1. T 2 is sensitive to the am ount 
o f  m otion at low  frequency w hich increases as xc increases. H ence, T 2 is usually very short in 
solids (jus) so that T i>T 2 w hereas for liquids T 2 ~  Ti and is o f  the order o f  seconds. The schem atic 
dependence o f  both  T i and T 2 on xc according to BPP theoiy  is shown in  F igure 2-8.
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Figure 2-8: The dependence of Ti and T2 on the correlation time x c. For short t c 
(co0t c« 1 ) ,  Tj and T2 are equal. The fluctuations of the spins are averaged 
to zero known as extreme motional narrowing. At g>0t c«1 Tx passes 
through a minimum. For long rc (co0t c>1), characteristic form less mobile 
samples a rigid lattice limit is reached and T2 attains a constant value.
2.2.2.2 Bloch equations
The m aster equations that govern the spin relaxation are the w ell-know n B loch equations [Bloch, 
1946]. The B loch equations provide a phenom enological description o f  the dynam ics o f  nuclear 
spins. T hey sum m arise the interaction o f  nuclear spins w ith the external m agnetic field (Bi) and 
its local environm ent (B0). I f  at tim e t, follow ing an RF pulse, the m agnetisation has com ponents 
M x, M y and M z, then the rate o f  change o f  the m agnetisation com bined w ith the Larm or 
precession (equation 2-15 and 2-17) in the laboratory fram e is described by:
d M , 
dt 
dM y 
dt 
dM z 
dt
■=rWy Bq + M ZBX sin coQt ] -  
-=y[M zBx cos eo0t - M XB0]~ M >
IT 2-20
-~y\^M xBxsmcod - M yBy cos a>0t ] - M z ~ M C 
T,
In the ro tating fram e these equations w ould be m odified as:
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2-21
In the laboratory fram e, the longitudinal m agnetisation returns tow ard the equilibrium  value, M 0, 
w ith a tim e constant Ti and the transverse m agnetisation decays tow ard zero w ith a tim e constant 
T 2. Therefore, T 2 defines the M R  signal lifetim e.
2.2.2.3 Spin-lattice relaxation time Ti
The spin-lattice relaxation tim e T i can be determ ined by two distinct m ethods, the inversion 
recoveiy  and the saturation recovery m ethod [Haacke, 1999].
The inversion recovery experim ent, also know n as 180°-90° m ethod, consists o f  a com bination o f 
tw o R F pulses. The first pulse, a 180° pulse inverts the longitudinal m agnetisation, that is all the 
protons that were responsible for the ne t m agnetic m om ent pointing upw ards (+z axis), now  point 
dow nw ards ( -z  axis). In the absence o f  any further perturbation, the longitudinal m agnetisation 
slow ly reverts back  up to its equilibrium  direction. How ever, in  order to acquire a signal a second 
pulse, 90° is applied after a tim e x. This pulse flips the longitudinal m agnetisation existing at the 
tim e it is applied, into the transverse plane (xy-plane) w here it rotates about the z-axis resulting in 
a FID  signal, w hich can be m easured. The am plitude o f  the signal is proportional to the m agnitude 
o f  the z m agnetisation. The signal am plitude depends on the time betw een the 180° and the 90° 
pulse, w hich is know n as inversion tim e, z  (pulse gap). Therefore, in  order to m easure Ti it is 
necessary to vary z  and repeat the m easurem ent. M easurem ents are repeated at a repetition delay 
(RD) interval long com pared to T i. Clearly, the optim um  RD (approxim ately 5TQ is chosen by  
experience and trial experim ent. A  sim ple schem atic representation o f  an inversion recovery 
sequence is presented in Figure 2-9 (see nex t page).
For short r, the longitudinal m agnetisation im m ediately after the 90° inspection pulse (t=0) is 
equal to the negative o f  the equilibrium  value
The recovery back  to +M 0 is exponential and described by  the B loch equation the solution o f  
w hich is
M s (o) =  - M 0 2-22
2-23
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The inversion recovery sequence is w ritten as
[Pi8otP90-FID]
180° 90° 180° 90°
RF Pulse
I i  I  I
0 /  Ti
ii
(a) ( b ) ' (c) (d)
0 / time RD
RD
(a) (b) (c) (d)
Figure 2-9: The Inversion Recovery Sequence for measuring T ls is the combination of two RF pulses 
applied in a num ber of repeated sequences for different % values, each m easurement 
separated by a delay RD.
The alternative process for m easuring the T x relaxation time is the saturation recovery (SR) 
sequence. It a quicker m ethod and consists o f  a chain o f  90° pulses at relative short repetition 
tim es. B efore the initial pulse is applied the longitudinal m agnetisation, M z, is at its m axim um  
value, Mo. The first pulse disturbs the equilibrium  and rotates the longitudinal m agnetisation onto 
the xy-plane, perpendicular to the m ain  m agnetic field. A t this point the M z is zero w hereas the 
transverse m agnetisation, M xy, is at a  m axim um  value. Because M z equals zero, the nuclear spins 
are said to be saturated. For a long repetition tim e (5T X) the saturated spins w ould fully recover 
resulting in FID s o f  equal am plitudes each tim e [Bushong, 1996]. The M z m agnetisation recovers 
w ith the T x relaxation tim e according to the form ula derived from  the B loch equations
M z(z)=M02-24
The saturation recovery sequence is w ritten as
[(P9otP90)„-FID]
2.2.2.4 Spin-spin relaxation time T2
The spin-spin relaxation, T 2, can be m easured by  using “Spin-Echo” sequences. A s m entioned 
earlier the application o f  a 90° pulse generates the precessing coherent transverse m agnetisation,
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M xy. A s explained previously, due to m agnetic field inhom ogeneities and inter-nuclear interaction 
individual spins precess at different frequencies so that they gradually lose their phase relationship 
by  fanning out (dephase). Therefore, the M xy, hence the signal, reduces until eventually the spins 
are uniform  distributed in the transverse plain and the signal disappears. The FID decays 
exponentially and the tim e constant that determ ines the rate o f  decay is T 2, derived from  the B loch 
equations.
M x,y = M 0e~rlT' 2-25
However, by  application o f  a 180° pulse the dephasing spins are inverted so that phase coherence 
is again established for a short tim e and a spin-echo signal is obtained. A  schem atic o f  echo 
form ation is shown in  Figure 2-10.
Figure 2-10: Spin-echo sequence.
It is necessary to separate relaxation due to  inhom ogeneity o f  the m agnetic field, w hich is 
equipm ent specific (in the case o f  an inhom ogeneous m agnet or applied field  gradient) or sample 
specific (in the case o f  an inhom ogeneous sam ple like a porous m edium ) and that due to 
m olecular m otion w hich is again sam ple specific and is due to nuclear interaction. F or rapidly 
relaxing com ponents due to strong m olecular interaction it is sufficient to excite the sam ple w ith a 
single pulse and to m onitor the subsequent FID decay. For slow er relaxing com ponents a CPM G 
[Callaghan, 1993] sequence is used. In this sequence 180° pulses are regularly  applied to refocus 
dephasing due to m agnet inhom ogeneity bu t no t m olecular interactions. The true decay is thus 
seen in  the peak  am plitudes o f  a train o f  echo signals.
In the CPM G sequence a 90° pulse is applied follow ed by  a train o f  180° pulses each separated by 
2t . This w ill obtain m any spin-echoes and T2 can be m easured by  tracing the decay o f  the echo 
sizes. In this case there is a 90° phase shift in the rotating fram e o f  reference betw een the initial
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90° pulse and the subsequent 180° pulse to reduce phase errors w hich are accum ulated during the 
180° pulse train.
The CPM G  sequence can be w ritten as
[P90t (P18ox echoT)n]
Tw o factors contribute to the decay o f  transverse m agnetisation, (i) m olecular interactions (said to 
lead to a pure T2 m olecular effect) (ii) variations in B 0 (said to lead to an inhomogeneous T2 effect 
The com bination o f  these tw o factors is w hat actually results in the decay o f  transverse 
m agnetisation. The com bined tim e constant is called T 2 star and is given the symbol T2*. The 
relationship betw een the T 2 from  m olecular processes and that from  inhom ogeneities in  the 
m agnetic field is as follows.
1 1 1
—  =  —  +   2-26
T T  Tx 2 2 2i'nhomo
2.3 Magnetic field gradients
In an N M R  experim ent, a m easurem ent o f  the frequency o f precession o f  the m agnetisation gives 
inform ation on the field experienced by  that group o f  spins. In an M R I experim ent spatial 
inform ation about the spins in  the sam ple can be obtained by the use o f  m agnetic field gradients. 
A  spatially varying m agnetic field  m akes the frequency o f  the N M R  signal depend upon position. 
The m agnetic field gradients refer to an  additional m agnetic field applied using specially designed 
coils. They are usually applied as a  series o f  pulses during an im aging study. The principle field 
direction rem ains along the sam e direction as the external m agnetic field, B0, but it varies in 
strength in any one o f  the direction is applied, x, y  and z. The field from  a m agnetic field gradient 
is no t uniform  throughout the sample. A ctually, the strength o f  the field varies linearly w ith 
distance. Therefore, the am plitude o f  the signal at a particular frequency indicates the num ber o f
protons at a particular position. M agnetic field gradients can be applied in any direction
dB  dB  d B z
G v =  —  , G  =  — - , G  =  —  w h e re  B ft =  B , 2-27
x dx y dy  dz ° z
w here G x, G y and G z are the linear applied gradients along the x, y, or z directions. So in the 
presence o f  a m agnetic field gradient, the local applied m agnetic field  is given by:
B 0(r )  = B 0 + G • r 2-28
w here B0 is the applied field from  the m agnet and G  is the applied gradient along a position  r . 
G iven that the m agnetic field  varies linearly  along r ,  the Larm or frequency now  depends on the 
position o f  the spins w ithin the sample:
fl>0( r )  =  r ( 5 0 +  G - r )  2-29
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This sim ple linear relation betw een the precession frequency co and the nuclear spin coordinates, 
r, is o f  fundam ental im portance for the understanding o f  the im aging principle. A ccording to  the 
Larm or equation the m agnetic field gradient causes identical nuclei to precess at slightly varied 
frequencies. A  spatially variant m agnetic field w ill lead to a spatially variant distribution o f  
resonant frequencies.
M ansfield and Grannell (1973) introduced the concept o f  reciprocal space, called k-space. k- 
space does no t correspond to the image. It is w here the M R  signal is stored and is an array o f 
num bers w hose Fourier transform  is the M R  image, k  is know n as the w ave num ber w hich refers 
to the num ber o f  a com plete w ave cycles that exist in  one m eter o f  linear space (units cycles m '1).
k is defined as the Fourier conjugate to the nuclear spin coordinate r and for a constant m agnetic 
field gradient is
k = —  r G t  2-30
2 n
w here t is the tim e for w hich the gradient is applied.
The N M R  signal acquired in  the tim e dom ain in  the presence o f  im aging gradients in all 
directions m ay be w ritten as
S (k ) =  J J f p ( i j  e x p ( z 2 ; r k - r)d r  2-31
w here p(f)  is the spatial distribution o f  spin density w ithin the sam ple and the integral is over all 
sam ple volum e, neglecting any relaxation decay. Perform ing inverse Fourier transform  in  all three 
directions o f  this sam pled k-space data gives a description o f  the spatial distribution (or im age) o f  
spin density o f  the space scanned by  r
p ( f )  =  J J J £ (k )  exp(-z 2 ^ -k - r)<2k 2-32
In other words, b'(k) is m easured in  the tim e dom ain w hile its Fourier transform  yields p(r) in  the 
frequency domain. In this sense, it is valid  to say that there is a correspondence betw een the real 
space and frequency, and betw een the reciprocal space and time [Callaghan, 1995]. So acquisition 
in the tim e dom ain, the signal is usually  visualised as sam pling k-space.
D epending on their function, the gradients are know n as (i) slice select gradient, (ii) frequency 
encoding gradient and (iii) phasing encode gradient. The slice selection gradient is used to acquire 
an M R  im age from  a particular location in the sample and w ith  a  particular thickness. The 
frequency and phase encode gradients are used to encode spatial inform ation w ithin the slice. A  
typical exam ple o f  tw o-dim ensional k-space im aging sequence is shown in  Figure 2-11. The 
structure is com m on to m any schem es for N M R  im aging o f  an object slice.
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Figure 2-11: Pulse sequence diagram  of a two-dimensional spin-echo imaging 
experiment. The echo occurs at time 2t known as echo time, TE. The 
slice gradient Gs, the phase encode gradient GP and the frequency 
encode gradient GR are shown.
• Slice selection
Slice selection is a technique to isolate a single plane in  the object being im aged, by  only exciting 
the spins in that plane. To do this a shaped RF pulse (selective pulse), w hich only affects a lim ited 
part o f  the N M R  spectrum, is applied, in the presence o f  a linear m agnetic field gradient, Gs, 
along the direction w hich the slice is to be selected. This results in the excitation o f  only those 
spins whose Larm or frequency, w hich is dictated by  their position, is the sam e as the frequency o f  
the applied R F pulse. The thickness o f  the slice is determ ined by the m agnetic field strength 
across the sam ple and the length o f  the R F pulse. The Fourier transform  o f  the RF pulse 
determ ines the profile o f  the excited slice. In Figure 2-11 the slice select gradient is applied at the 
same tim e as the initial R F pulse. The negative gradient is used for the same duration as the pulse 
to re-phase the spins o f  the excited slice at the start o f  the subsequent encoding. F or a transverse 
image, G s is applied in  the z-direction: Gs =  Gz.
« Phase encoding
A fter the slice selection, a phase encoding gradient, GP, is applied along for exam ple the y- 
direction (GP=G y) for a fixed period o f  tim e and before the m ain acquisition tim e o f  the FID. The 
phase encoding gradient does no t change the frequency o f  the acquired signal because it is no t on 
during signal acquisition. H ow ever, it m odulates the initial phase o f  the detected signal. By
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repeating the experim ent a num ber o f  tim es w ith different gradient am plitudes, it is possible to 
generate data that m ay be Fourier transform ed to determ ine signal position [Keevil, 2001].
•  F req u en cy  encoding
The frequency encode gradient is applied linear and in a direction perpendicular to the slice select 
gradient, conventionally is applied along the x-direction, Gx. It is turned on during N M R  signal 
acquisition and for this reason it is also know n as readout gradient GR (GR=G X). As the readout 
gradient tends to dephase the coherences before the echo is formed, an extra gradient pulse is 
applied before the 180° pulse in order to com pensate the first h a lf  o f  the read  gradient as shown in 
Figure 2-11. A fter the application o f  the readout the resonance frequency o f  the spins responsible 
for the signal becom es a linear function o f  their position along the gradient direction. The Fourier 
transform  o f  the acquired signal determ ines the am ount o f  signal at each frequency and thus at 
each position. I f  only the read-out gradient is applied, a one-dim ensional im age, usually  term ed as 
profile, is obtained. In Figure 2-11 the com pensate gradient has a positive m agnitude because o f  
the presence o f  the 180° pulse.
2.3.1 Image contrast
The contrast in an M R  im age is strongly dependent upon the w ay the im age is acquired. By 
adding R F or gradient pulses, and by  careful choice o f  tim ings, it is possible to  highlight different 
com ponents in  the object being imaged.
The spin density throughout an object is directly related to the im age contrast as i f  there are no 
spins present in a region it is no t possible to get an N M R  signal at all. In m edical M RI, im aging is 
associated w ith the hydrogen nuclei in the m obile w ater and the im age contrast com es m ost often 
from  the degree o f  w ater m obility. In fact, as the w ater becom es less m obile, so the im aging 
becom es m ore difficult. For instance solid tissues (bones) give alm ost no signal because the w ater 
is relative im m obilised and thus appear dark by  contrast w ith soft tissues. A n alternative im aging 
technique can be used such as X -ray CT for these purposes. H ow ever, as there is a  sm all 
difference in  proton spin density betw een m ost soft tissues in  the body due to sim ilar w ater 
content, other suitable contrast m echanism s m ust be employed. These are generally based on the 
variation in the values o f  Ti and T 2 for different tissues.
The relaxation tim es Ti and T2 are very im portant in  im aging, as they have the greatest effect in 
determ ining contrast. W hen describing the effect o f  the tw o relaxation tim es on im age contrast, it 
is im portant to distinguish betw een relaxation tim e m aps, and relaxation tim e w eighted images. In 
the form er the pixel intensities in  the im age have a direct correspondence to the value o f  the 
relaxation time, w hilst in  the latter the im age is a  proton density im age w hich has been weighted 
by the action o f  the relaxation. The T 2 relaxation contrast is indeed a natural consequence o f  the
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spin-echo im aging sequence. O nly nuclei w ith a T2 o f  the order of, or greater than the echo tim e 
contribute to the echo and so to im age intensity. Shorter T 2 com ponents decay away before the 
echo is form ed and so they do no t appear in  the image.
M agnetic resonance im ages suffer from  a num ber o f  artefacts. A n im age artefact is any feature 
w hich appears in an im age w hich is riot present in the original im aged object. The quality o f  the 
im age can also be affected by  various param eters such as m agnetic field inhom ogeneity and 
m otion o f  spins during experim ent.
2.4 Diffusion
D iffusion is the process through w hich sm all m olecules are transported from  one part o f  a  system  
to another as a result o f  random  m olecular m otions o f  the individual m olecules. On average the 
m olecules are transfeired by  diffusion from  the region o f  higher to that o f  a low er concentration 
o f  the system. This process w as recognised by  F ick  in 1855, w ho put diffusion on quantitative 
basis by  adopting the same equation as that derived a few  decades ago by  Fourier (1822) for heat 
conduction [Crank, 1975], The m athem atical theory o f  diffusion for an  isotropic substance is 
related  to the rate o f  transfer o f  diffusing substance through unit area o f  a section that is 
proportional to the gradient o f  concentration m easured norm al to this section
F  =  - D —  2-33
dx
w here F  is the rate o f  transfer o f  the diffusing substance per unit area o f  section, c is the 
concentration o f  the diffusing substance at position x, dc/dx is the concentration gradient and D  is 
the diffusion coefficient. I f  the F  and the concentration are expressed w ith the same unit o f  
quantity then the diffusivity is independent o f  this unit and has dim ensions o f  (length)2(tim e)'1 or 
cm2/s. Equation 2-33 is applicable to the diffusion in the steady state, that is w hen the 
concentration does no t vary w ith time. On the other hand, F ick’s second law  describes the 
nonsteady state transport process, w here the concentration w ithin the diffusing volum e changes 
w ith  respect to time.
dt
f  o2 hd c
dx~
2-34
This is the case where D  is independent o f  concentration. In one-dim ensional diffusion the 
concentration gradient is found only in  one direction along for exam ple the x-axis. In systems 
w here D  depends on the concentration o f  the diffusing substance then equation 2-34 becom es
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dt dx
r d A
ySX;
2-35
w here concentration profiles can be m easured w ith MRI.
2.4.1 NMR Diffusion
As m entioned, diffusion is a transport property o f  m olecules. Translational diffusion across a 
nonzero concentration gradient is one such case; i f  the concentration gradient is zero (i.e., 
hom ogeneous w ith respect to concentration), then the translational diffusion process is referred to 
as self-diffusion. The study o f  diffusion reduces ultim ately to the study o f  m olecular m otions— or 
dynam ics— and can therefore provide valuable physical information.
In 1965 Stejskal and Tanner [Stejskal and Tanner, 1965] dem onstrated that pulsed magnetic field 
gradients could be used in N M R  to probe the displacem ent o f  protons in a sample. A standard 
pulsed gradient spin-echo (PGSE) and a stim ulated echo pulsed field gradient sequence, is shown 
in Figure 2-12.
90° 180
m  t i t
0 ^ _____________________x
A
90° 90°
■ !■ !
< ----------------------------------
A
Figure 2-12: (a) Pulse gradient spin-echo sequence, (b) Stimulated echo pulsed field 
gradient sequence.
The PG SE sequence consists o f  a spin-echo sequence w ith two m agnetic field gradients on each 
side o f  the 180° RF pulse. The first gradient im poses a phase shift on the nuclear spins in a 
sample, w hich depends upon position according to
90°
1M echo
time
echo______
- x time
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</>=yg-r1d
w here g is the gradient strength, i j  is the position o f  the spin and S is the duration o f  the pulse. 
This phase shift is reversed by the 180° R F pulse. I f  the spins do not m ove during the diffusion 
tim e, A, the second PFG  pulse exactly reverses the effect o f  the first and the N M R  signal has 
intensity equal to that in the absence o f  the PFG  pulse pair. Flowever, i f  the spins do m ove to a 
different spatial position, r2, then  the second PFG  pulse is unable to exactly reverse the effect o f  
the first and the spins have a residual phase shift o f  y<5g-(ri-r2), w here the negative sign arises 
from  the refocusing effect o f  the 180°, a t the echo form ation tim e 2 t. A veraged over all o f  the 
nuclei results in an attenuation o f  the echo signal w hich is depend on the diffusion coefficient, D, 
the diffusion time, A, and the duration and strength o f  the gradient. So, this sequence uses the 
difference in the position dependant phase shifts on the precession o f  the resonant nuclei in  the 
sam ple to m easure their m ovem ent during the diffusion time, A. The phase shift increases 
according to how  far spins in the sam ple have m oved during the diffusion tim e. As the gradient 
pulses are stepped up in strength, causing the phase shift im parted by  the gradient pulses to 
increase, for each spin and hence attenuation o f cum ulative signal for all o f  them , the 
m agnetisation decays according to:
S (g)/S (o) =exP["Y 2 S 2 S 2 D { A - 5/3)] 2-36
w here D  is the diffusion coefficient, and S is the signal intensity. This indicates that the signal w ill 
also decay as the diffusion tim e is increased. The self-diffusion coefficient, D, can be obtained 
from  the sem ilogarithm ic p lots o f  S  versus y2g2S2(A-d/3).
In the case w here D  is sm all and T 2« T i  an alternative o f  this m ethod can be used w ith  three- 
pulsed stim ulated echo variant as show n in  Figure 2-12(b) [Tanner, 1970]. Tw o 90° R F pulses are 
used instead o f  a single 180° R F pulse to prevent spin-spin relaxation o f  the sam ple m agnetisation 
during the diffusion time; the second 90° R F pulse stores the m agnetisation along the longitudinal 
axis. The stored m agnetisation is recalled  at later tim e by a third 90° R F pulse and rephrased in a 
stim ulated echo (echo generated by  sequence o f  three 90° R F pulses). This still allows the 
possibility o f  spin-lattice relaxation during the indicated gap, t  betw een the 90° RF pulses w ith Ti 
is generally slow er than T 2 [Callaghan, 1995].
V ery sm all diffusion coefficients require either very strong gradients or long diffusion times. The 
use o f  high-gradient system  is related  w ith  the technique o f  Stray Field M agnetic Resonance 
Im aging (STRAFI). Stray Field M agnetic R esonance Im aging (STRAFI) exploits the very large 
m agnetic field gradient in the order o f  60T/m  available in the fringe or stray field o f  a 
superconducting m agnet. A  fringe-field diffusion m easurem ent o f  sm all diffusion coefficients has 
seen m uch developm ent in  recent years and the strong peripheral gradient has m ade possible the
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study o f  diffusion coefficients as small as 10 " c m 2 s 1 in a variety o f  polym er m elts and solutions 
[K im m ich et al., 1991].
2.5 X-ray Computed Tomography
In 1973 H ounsfield [Hounsfield, 1973] first developed the com puterised axial tom ography, w hich 
is now adays is referred to as com puted tom ography or CT. H ounsfield's scanner consisted o f  a 
finely collim ated source defining a pencil beam  o f  X-rays, w hich is then m easured by a well 
collim ated detector. M R also owes a debt to com puted tom ography (CT) as it was initially 
developed on the back o f  CT. W hen Lauterbur [Lauterbur, 1973] first dem onstrated magnetic 
resonance im aging in 1973 he used a back projection technique to reconstruct the images sim ilar 
to that originally used in CT. The im pact that CT had in the m edical com m unity is not to be 
disregarded as it stim ulated interest both o f  clinicians and m anufacturers to the potential im pact o f  
the M RI technique. It had already dem onstrated the advantage o f  tom ographic sections through 
the head or body o f  a patient allow ing diagnosis o f  disease processes in a non-invasive way.
X -ray CT is a technique that uses x-rays to produce images o f  thin slices. It is a non-destructive, 
non-invasive im aging technique, w hich provides cross-sectional im ages in different planes 
through a com ponent. In this thesis a third-generation cone-beam  X -ray CT scanner was used, 
illustrated in Figure 2-13. An X -ray source and an X -ray detector are placed at opposite sides o f  a 
sam ple w hich sits on a precision m echanical turntable. The X-ray detector is used to m easure the 
intensities o f  the X -ray beam  transm itted through the sample, as the sample is rotated in the cone- 
beam.
sample table
Figure 2-13: Schematic diagram of the third-generation cone-beam X-ray CT system
The X -ray cross-sectional im ages are generated by processing the transm itted intensities. A 
m athem atical algorithm  is then used to generate (or reconstruct) the CT images from the 
m easured transm itted intensities. A  3D CT data can be obtained from a single rotation o f  the 
com ponent and cone beam  reconstruction algorithm s are then needed to com pute the 3D CT 
dataset. The reconstruction o f  the X -ray CT im ages is discussed later in C hapter 3. In both CT and
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M RI, physical characteristics o f  a volum e elem ent or "voxel" o f  the sam ple are translated by  the 
com puter into a two dim ensional im age com posed o f  picture elem ents or "pixels". The pixel 
intensity in  CT reflects the electron density o f  the m aterial w hereas in M RI, as already seen, the 
signal intensity reflects the density o f  m obile hydrogen nuclei m odified by the chem ical 
environm ent, that is, by  the m agnetic relaxation times, T x and T2, and b y  m otion. Therefore, X -ray 
C T is a suitable choice for skeletal im aging or solid m aterials that have low  proton spin density.
The resultant CT im ages are true cross-sectional images, and show  the geom etry o f  the 
com ponent in the plane o f  the cross-section. I f  an X -ray source w ith a very sm all size (m icrofocus 
source) is used, then the spatial resolution achievable can be very h igh (circa. 10/zm for m m  sized 
com ponents) [Burch et al., 2004]. A t any instant o f  tim e during the scan, the beam  o f  x-rays is 
attenuated by  the sample: different parts o f  the beam  are attenuated by  varying am ounts, 
depending on the types and am ounts o f  the m aterials the x-rays pass through. M aterials w hich 
attenuate the x-rays m ore strongly appear lighter (whiter) in the im age and others w hich are less 
attenuating appear darker (blacker). The CT im age values know n as grey-levels give inform ation 
on the m aterial x-ray attenuation at each point in the image. The C T grey levels can be converted 
to values w hich are directly proportional to the local m aterial density.
A part from  the clinical use o f  X -ray CT the technique has found a vast application in studying 
m aterials. In this thesis X -ray CT has been used to study the m icrostructure o f  the system  as it 
provided spatial resolution o f  10//m.
2.6 Ultraviolet (UV) Spectroscopy
U V -V is spectroscopy probes the electronic transitions o f  m olecules as they absorb light in the UV 
and visible regions o f  the electrom agnetic spectrum  (UV = 200-400nm , V isible =  400-800nm ). 
A ny species w ith an extended system  o f  alternating double and single bonds w ill absorb U V  light, 
and anything w ith colour absorbs visible light, m aking U V -V is spectroscopy applicable to a wide 
range o f  samples. For organic com pounds in solution the visible region is o f  less im portance as 
m ost o f  the organic com pounds are colourless. U V  spectra used for determ ination o f  structures are 
com m only obtained in  solution.
A  basic U V  spectrophotom eter consists o f  an energy source, a sam ple cell, a dispersing device 
(prism  or grating) and a detector.
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Radiation
source
Sample Dispersing 
device or 
prism
Slit Detector
Figure 2-14: Simple schematic diagram of a UV spectrophotometer.
The drive o f  the dispersing device is synchronised w ith the x-axis o f  the recorded so that the latter 
indicated the w avelength o f  radiation reaching the detector via the slit. The prism  will bend the 
light in different degrees according to the wavelength. The signal from  the detector is transm itted 
to the y-axis o f  the recorder indicating the am ount o f  radiation absorbed by the sample at any 
particular wavelength. M ost instrum ents use double-beam  where the absorption o f  a reference 
cell, containing only solvent for exam ple if  the sam ple is dissolved in w ater it will contain only 
w ater, is subtracted from the absorption o f  the sam ple cell. The energy source, the m aterials from 
w hich the dispersing device and the detector are m anufactured m ust be appropriate for the range 
o f  w avelength scanned and as transparent as possible to radiation.
The absorbance o f  a solution increases as attenuation o f  the beam  increases. A bsorbance is 
directly proportional to the length o f  the sam ple cell, b, and the concentration, c, o f  the absorbing 
species. Beer's Law  states that A = ebc, w here e is a constant o f  proportionality, called the 
absorbtivity. D ifferent m olecules absorb radiation o f  different wavelengths. An absorption 
spectrum  will show a num ber o f  absorption bands corresponding to structural groups w ithin the 
m olecule.
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Chapter 3
3 Materials and Methods
fri this chapter the m aterials and experim ental m ethods used in this study are presented. The 
chapter is organised in tw o sections. The first is associated w ith the physical and chem ical 
characterisation o f  the m aterials under study. The second is focused on describing the 
experim ental m ethods used to obtain the inform ation on the dissolution o f  the sam ple m atrix. The 
m ethods included the spectroscopic characterisation o f  the m aterials and the im aging studies o f  
drug release from  the solid polym er m atrix.
3.1 Materials
The solid m atrix chosen in this study w as Eudragit RSPO and the chosen active drug was 
Diltiazem Hydrochloride (HCl). B oth the polym er and drug w ere supplied by  N app 
Pharm aceuticals R esearch L td  m anufactured by D egussa R ohm  Pharm a Polym ers, Germany.
Eudragit RSPO  is a copolym er o f  acrylic and m ethacrylic acid ester. It is a solid substance in  the 
form  o f  w hite powder. It is insoluble in  aqueous m edia, as taken from  m anufacturers data sheet, 
bu t it is perm eable, plasticised and has pH -independent release profile. The perm eability in  w ater 
is due to the presence o f  quaternary am m onium  groups in its structure, w hich are present as salts 
[Haznedar and D ortunc, 2004]. Omari et a l  [Omari et a l ,  2004] and O th and M oes [O th and 
M oes, 1989] suggested that Eudragit RS w as capable o f  swelling in digestive fluid independently 
o f  pH. In th is thesis 100% Eudragit tablets were exposed to w ater and experim ental evidenced 
show ed virtually no swelling o f  the tablet.
Eudragit RSPO  is com m only used in film  coating o f  tablets, granules and other sm all particles 
and also in  m atrix form ulation. It is a h igh m olecular w eight polym er, M W : 150 000, and tablets 
consisting o f  Eudragit as b inder exhibit som e advantages as hardness, palatability, strength and 
stability [Droin et a l ,  1985]. The chem ical structure o f  the polym er is show n in  Figure 3-1.
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Figure 3-1: Chemical structure of Eudragit RSPO (redrawn from manufacturer data sheet).
T he active drug, Diltiazem HCl is a calcium  ion influx inhibitor, slow  channel blocker or calcium  
antagonist w idely used in the treatm ent o f  angina pectoris, cardiac arrhythm ia and hypertension 
[K ristm undsdottir et ah, 1996]. It is a solid substance in the form  o f  a white to off-white 
crystalline pow der w ith b itter taste. It is soluble in m ethanol, chloroform  and w ater and it is 
odourless. It has a m olecular w eight o f  450.98 [The Japanese Pharm acopoeia, 2001]. The 
chem ical structure o f  the active drug is in  Figure 3-2.
CH3
Figure 3-2: Chemical structure of Diltiazem Hydrochloride -(2A,3»S)-5-[2-
(Dimethylamino)ethyl]-2,3,4,5-tetrahydro-2-(4-methoxyphenyl)-4- 
oxo-1,5-benzothiazepin-3-yl acetate monohydrochloride (redrawn 
from [Glaser and Sklarz, 1989]).
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3.2 Methods
3.2.1 Magnetic resonance spectroscopy and imaging studies
In this study m agnetic resonance spectroscopy and im aging experim ents w ere carried out using a 
400M H z spectrom eter and a 9.4T superconducting magnet. The m agnet was equipped w ith room  
tem perature shims for im proving the heterogeneity o f  m agnet and x,y,z gradient sets w ith strength 
up to 80G/cm  for spatial localisation o f  signals in im aging and diffusion experim ents. The shim 
and gradient coils started to heat up as current passed through and in order to avoid the 
overheating o f  the coils a cooling system  com prising o f  a water pum p was used. The sam ple was 
placed in a N M R  sample probe, w hich contained a built-in radiofrequency (RF) coil that was as 
close around the sample as possible. The RF coil has two purposes: (i) to transm it RF pulse into 
the sample so as to excite the nuclear spins and (ii) to detect the m agnetic fields created by the 
precessing m agnetisation. The sam ple was placed into the N M R probe so that the area o f  interest 
was w ithin the coil. A  com puter was used to send the signal to initiate the pulse sequence and to 
receive and process the data that the instrum ent acquired. A detail description o f  the apparatus set 
up and principles can be found in [Leach, 1992]. A  simple schem atic diagram  o f  a M RI system  is 
shown in Figure 3-3.
Figure 3-3: Block diagram of the MRI system used for the imaging experiments.
The M RI equipm ent at the U niversity o f  Surrey (Figure 3-4) consists o f  a 400 'H  M Hz 
Chem agnetics Infinity Spectrom eter (Varian Solid State Office, UK) coupled to a M agnex 9.4T 
(89m m  diam eter bore) superconducting m agnet (M agnex Scientific, Oxon, UK). The
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radiofrequency was am plified by a H igher V oltage Pow er Supply from C reative Electronics (Los 
A ngeles, California) for the proton, 'H , spectrum  and Chem agnetics Pow er Supply for the carbon, 
13C. The im aging gradients and M atrix Shim  Set were supplied by Resonance Research 
Instrum ents, USA. A double tuned 1j,C -‘H  probehead (IBM T, Frauenhofer Institute, Germ any) 
was used for the CY CLCRO P experim ent (see Section 3.2.2.2) and a ‘H m icroscopy probe from 
the same m anufacturer was used for 'H  im aging and spectroscopy experim ents.
Figure 3-4: *H MRI microscopy (9.4T) facility at the University of Surrey.
The m agnetic resonance spectroscopy and im aging experim ents were controlled from Spinsight 
version 4.1 (Chem agnetics N M R products, O tsuka electronics, USA), w hich is a data acquisition 
and processing software. The acquired data w ere saved in the form o f  A SCII files, single raw  
data, and processed using code w ritten in IDL version 5.5 (Research Systems Inc., Colorado, 
USA ) w ith incorporated standard processing for the Fourier Transform ation. Details on 
acquisition param eters for each experim ent are discussed in the following sections.
'H  N M R  Tj and T 2 relaxom etry m easurem ents were also acquired using a bench-top 20 ’H M Hz 
M aran perm anent m agnet (0.5T) spectrom eter from Resonance Instrum ents. The resulting data 
w ere plotted in xM gr version 4.1.2 graphing program  where the Tj and T2 relaxation tim es were 
calculated.
All the graphs presented in this thesis were plotted in M icrosoft Office Excel 2003.
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3.2.2 NMR Characterisation of Raw Materials
All the experim ents described in  the follow ing sections w ere conducted at least tw o tim es apart 
from  the Ti and T 2 m easurem ents o f  the equilibrated Eudragit tablets in Section 3.2.2.1. Results 
are discussed in C hapter 4.
3.2.2.1 Ti and T2 characterisation of equilibrated Eudragit samples
Experim ents w ere carried out to optim ise experim ental procedures and characterise the m aterials 
under study. The N M R  Tj and T 2 relaxation tim es o f  w ater swollen, spatially and tem porally 
equilibrated Eudragit sam ples at tw o different N M R  frequencies, 20M H z and 400M H z were 
determ ined.
Sam ples o f  know n concentrations w ere prepared each containing 3.00gr o f  Eudragit variously 
sw ollen by  m illi-Q  w ater ranging in am ount from  0.0m l to 0.9ml. The sam ples w ere m ade up in 
N M R  tubes. The exact am ount o f  w ater was first put in the tubes follow ed by the w eighed 
pow der. The tubes were carefully sealed by  w rapping the N M R  cups w ith  paraffin  film  to prevent 
w ater evaporation and the w eight o f  each one was recorded. The sam ples w ere shaken thoroughly 
and left to equilibrate. Com plete spatial equilibration took approxim ately six w eeks during w hich 
the sam ples were held vertically  in an oven at up to 60°C. Throughout this period m easurem ents 
o f  Tj and T2 were m ade to optim ise the experim ental param eters and to check on the equilibration 
by  recording the changes in the m easured values. From  tim e to tim e sam ples w ere re-w eighed so 
as to check for any loss o f  water. The “definitive” m easurem ents w ere m ade after seven w eeks at 
w hich point Ti and T2 results w ere no t evolving noticeably further. A ll the m easurem ents w ere 
conducted at room  tem perature. The resulting w ater m ass fraction for each equilibrated Eudragit 
sam ple is listed in Table 3-1.
Table 3-1: Mass fraction of w ater for each equilibrated E udragit sample.
S am ple  
(m l H 20  /  3 .0g r E u d ra g it)
M ass frac tio n  o f H 20
0.0 0.00
0.1 0.03
0.2 0.06
0.3 0.09
0.4 0.12
0.5 0.14
0.6 0.17
0.7 0.18
0.8 0.21
0.9 0.23
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The low frequency m easurem ents w ere recorded using a bench-top ’H 20M H z perm anent magnet, 
whereas the high frequency m easurem ents were carried out at ’H 400M H z using a Chem agnetics 
Infinity spectrom eter w ith vertical bore super conducting magnet, both described in Section 3.2.1. 
For both N M R frequencies, the Tj was m easured using the inversion recovery m ethod, w hereas 
the T 2 was determ ined from  the 90°-Free Induction Decay (FID) pulse sequence and the CPM G 
sequence. A  schem atic diagram  o f  the pulse sequences used and the data param eters are 
sum m arised in Figure 3-5 and Table 3-2.
Longitudinal relaxation, T,
i . Inversion Recovery sequence
RF Pulse
180°
_ l
90°
FID
time
IP 180 X P90 — FID]
(b) Transverse relaxation time, T,
IF90 -  FID]
RF Pulse
CPMG
90° 180° 180° 180° 180°
2t 4t 6t 8t
IP90T(P 180'CechO 1
Figure 3-5: (a) Inversion recovery pulse sequence for measuring T x and (b) 90°-Free 
Induction Decay (FID) pulse sequence and the CPMG sequence for 
measuring T2 both at 20MHz and 400MHz.
time
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Table 3-2: Summary of data used to measure T! and T2 at 20MHz and 400MHz.
Parameter Method Sequence P90 (//$) x (pulse gap) RD*(s)Averages
NMR Frequency 20MHz
T i
re laxation time
Inversion
recovery [Piso x P90 -  F ID ]
3.7
3.6 (0.9m l H 20 )  
3.8 (0.2m l H 20 )
3.7
0 .02s < 2s
0.05s < 3s 
(0.7,0.8,0.9m l H 20 )
3 16
FID [P90-FID] 3.6 (0.9m l H 20 ) - 10 16
t 2
relaxation
time
C P M G [P90 X (Piso T echo x)n]
3.8 (0.2m l H 20 )
3.7
3.6 (0.9m l H 20 )
3.8 (0.2m l H 20 )
64 ps 
128//S 
256/zs
10 16
NMR Frequency 400MHz
T i
re laxation time
Inversion
recovery [P180x P 90- F I D ] 11
0 .02s
<
10.240s
10 4
t 2 FID [P90 -  F ID ] 2 - 6 32
relaxation
time C P M G [P90 x (P 180 x echo x)n] 10 750/zs 10 16
*RD=repetition delay
3.2.2.2 13C- H CYCLCROP spectroscopy of Diltiazem HCl concentrated solution
Experiments were conducted on concentrated Diltiazem HCl solution in order to selectively 
obtain MR signals from specific --CH3 groups in the molecule and their corresponding protons and 
importantly to suppress the water signal. For this purpose cyclic J  cross polarisation 
(CYCLCROP) technique was applied which allowed the indirect detection of 13C nuclei coupled 
to XH nuclei with the high NMR sensitivity of protons and therefore considerably better signal-to- 
noise compared to direct 13C NMR. The experiments were carried out using CYCLCROP 13C- 
edited spectroscopy on a 9.4T superconducting magnet (Section 3.2.1).
The principle of the CYCLCROP [Heidenreich et al., 1998] editing sequence involved the 
selection a single resonance from a specific location of a molecule while suppressing all other 
resonances from the sample. The sequence consisted of two successive polarisation processes 
where the magnetisation was transferred within the selected group from the ’H to the J  coupled 
13C nucleus (JH—»13C) and backward to the XH nuclei (13C—4H). The transfer began by applying a 
radiofrequency (RF) pulse (90°) followed by a spin lock pulse (SL) on the primary side (!H 
nuclei) and a contact pulse (CP) applied on the secondary side (13C nucleus). At the intermediate 
stage of the polarisation transfer cycle a combination of radiofrequency and gradient pulses 
were applied so as to saturate all the uncoupled protons [Kunze et a l, 1993], [McDonald et al,
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1999]. The desired magnetisation was fully transferred and stored to the 13C nuclei. The outcome 
of the CYCLCROP editing sequence was a FID signal in time domain.
Polarisation took place when SL & CP were matched according to the Hartmann/Harm condition 
[Kunze and Kummich, 1994]
7CE\,eff,C ~ YHE\,eff,H -^1
where yc and yH were the gyromagnetic ratios of 13C and 'H respectively and Beff>H and Beff,c were 
the magnetic fields effective in the doubly rotating frame. A schematic representation of the 
CYCLCROP editing sequence is shown in Figure 3-6.
1H—>13C Saturation 13C—>!H
-<  ►-< >•
Figure 3-6: The CYCLCROP editing sequence.
In order to obtain a strong signal for the drug a highly concentrated solution was required. The 
solution was prepared by gradually dissolving Diltiazem HCl powder in milli-Q water (in house). 
Initially, 2ml of milli-Q water were put in an NMR tube and small amounts of the drug were 
added progressively, mixed and dissolved until the solution became saturated. The final 
concentration of the drug solution was 29% (w/v), containing O.Sgr powder in 2ml of water. 
Above this concentration the drag could not dissolve in solution. The jH and 13C spectra of the 
29% (w/v) Diltiazem HCl solution were recorded at a set frequency of 400MHz and 100MHz 
respectively, with a 90° pulse of Tips for both spectra, (for pulse sequence see Figure 3 -5(b) the 
90°-(FID) sequence) in order to select a specific -CH3 group in the molecule and conduct the 
CYCLCROP editing sequence. Due to 13C natural abundance it was necessary to centre the proton
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and carbon channels at the respective frequencies yielding a better signal-to-noise. The 
CYCLCROP spectrum was obtained with typical parameters of: contact time of 4.5ms; 90° pulse 
of 21 ps (x=contact time + 90° pulse, see Figure 3-6); gradient time of 3ms; and saturation time of 
about 38ms. The NMR measurements usually required between 15 and 60mins for a typical rfl 
analysis and a few hours for the 13C. For a complete CYCLCROP editing sequence the time 
required was dependent on the parameters set. All measurements were conducted at room 
temperature.
3.2.2.3 Self-Diffusion measurements of drug and water mobility in Diltiazem HCl 
solutions
Drug solutions of various concentrations were prepared in order to determine the self-diffusion 
coefficient of the actual drug, Diltiazem HCl, and water using the spectroscopically resolved 
stimulated-echo pulsed-field-gradient method (Chapter 2, Section 2.4.1).
90° 90° 90°
♦ J U  ■ - ■  ♦ - u
1 ;  1 1
1 r I1  ; echo
«----------------------------------------- x ----------------------------------------- ►
Figure 3-7: Stimulated-eclio pulsed-field-gradient sequence.
The pulse sequence is similar with that discussed in Chapter 2, Figure 2-12. They only differ in an 
extra gradient pulse that was put before the staid of the actual pulse sequence as shown in Figure 
3-7. The extra pulse served no purpose other than to “warm-up” the amplifiers and compensate 
against “pulse droop”. In these experiments the drug was dissolved in a 2ml solution containing 
95% D20  / 5% H20 . Deuterated water (D20 ) [Sigma-Aldrich Chemicals] was used in order to 
reduce the dominant water signal intensity to levels typical of the drag. The samples studied are 
listed in Table 3-3.
Table 3-3: Test drug solutions: Drug was dissolved in a 2ml mixture of 95%D20  / 5% HzO.
% Drug concentration
(w/v)
Drug weight 
(gr)
5 0.1
13 0.3
20 0.5
26 0.7
29 0.8
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Typical parameters in standard notation for the diffusion stimulated-echo PFG experiments were: 
gradient pulse length, 8 = Sms; pulse gap, x = 10ms; repetition delay = 8s; and the number of 
averages n = 128. The diffusion data were obtained using an array of field gradient strengths 
varied between 2 and 80G/cm in steps of lG/cm and at diffusion times, (gradient pulse 
separation), A, of 30 and 120ms. The resulting spectra were obtained from the FT of the recorded 
signal. All measurements were carried out at room temperature.
3.2.3 Imaging studies o f drug release from a solid polymer matrix
All the experiments described in the rest sections were conducted at least two times. Results are 
discussed in Chapter 5.
3.2.3.1 Magnetic resonance imaging studies of drug release from a solid matrix 
under static dissolution conditions
MRI experiments on water exposed samples were conducted to follow the water ingress, the 
sample swelling and dissolution, and the drug release in order to understand the dissolution 
mechanism of the sample. The sample matrix was prepared by mixing the two components. The 
mixture was compressed in an instrumented single-punch tablet machine (IP Technical Services, 
UK) equipped with 9mm flat-faced punches in order to obtain tablets weighing 240 ± 2mg, 
3.0 ± 0.2mm in height and compressed at 2tons (0.303GPa). The tablets were placed into 9mm 
external diameter NMR tubes exposing both of its surfaces to lightly copper sulphate (CuS04) 
[Fisher Scientific] doped water (3.7xlO'4M). The purpose of CuS04 in the water was to reduce the 
nuclear spin-lattice relaxation time of pure water, which normally is in the order of some seconds 
to a few hundred milli-seconds. This led to an improved signal averaging capability as the shorter 
relaxation time allowed higher number of repetitions. The above experimental set up 
corresponded to a static dissolution experiment and a schematic diagram of the sample in the 
magnet is shown in Figure 3-8, where the tablet was supported by a teflon sleeve, which is ]H 
MRI invisible. In the rest of the thesis the copper sulphate (CuS04) doped water is referred to just 
water for convenient purposes. This applies only for the static dissolution experiments.
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Figure 3-8: MRI experimental set up for the static dissolution experiment. The 
dissolution cell was placed into a MR microscopy probe.
The ’H MRI 2D images of a vertical slice were acquired on the 400 'H MHz superconducting 
magnet (9.4T) (see Section 3.2.1). A standard spin-echo imaging sequence (Chapter 2, Section
2.3) was used with echo time of 4ms, repetition delay of 4s and number of averages 2. The NMR 
signal was sampled 512 times during the acquisition period and the phase-encoded gradients were 
stepped in 64 repeats. A sine-bell apodisation was applied both in read direction and phase 
direction. In the phase it corresponded to both the static magnetic field direction and to the 
vertical direction in the tablet and in the second it corresponded to the horizontal direction. The 
slice was at the centre of the tablet with thickness of 1 mm. The image quality is defined by its 
resolution. The pixel resolution is given by field-of-view (FOV) divided by the number of data 
points acquired. The FOV determines the size of the region scanned according to
FOVread =
1
Ak and FOV .
1
phase
read Akphase
where Akread = yGreadAt and Akphase = yGphaseA r  where t is the time of gradient applied in
the read-direction and r is the time of gradient applied in the phase-direction. The resultant 
magnitude Fourier transformed image field-of-view (FOV) was 15 x24mm2. The actual image 
resolution (after apodisation) was a few pixels. The in-plane pixel resolution was calculated from
Pixel sizeread = FOVread / scan matrixread
P ix e l s izephase = F O V phaSe / scan m atrixphase
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Hence the image pixel size was 29x375//m2. The total time required to obtain an image varied 
from 4 to 34mins depending on the number of averages accumulated and the phase-encoded 
gradient steps.
The MRI experiments were performed as a function of manufacturing parameters including drug 
loading, compaction level, different particle size components for both polymer and drag and more 
which are fully described in the following sections. All experimental data were obtained for 
tablets primary compressed at 2tons, and exposed to water under static dissolution conditions. The 
’H MRI images were acquired at room temperature with similar pulse sequence and parameters 
set described above.
3.2.3.2 Water ingress into polymer, drug and polymer incorporating drug tablets
MRI experiments on water exposed Eudragit tablets incorporating different drug loadings were 
carried out in order to observe the effect of drag load to water diffusion and dissolution of the 
sample matrix. The drag loaded Eudragit tablets were prepared as described above containing a 
wide range of drug concentrations ranging from 5% up to 85%.
Similar, MRI experiments on 100% Eudragit and 100% Diltiazem HCl compressed tablets 
(prepared as in Section 3.2.3.1) were conducted to observe the effect of water on the tablets. For 
the 100% Eudragit tablets the images of samples prepared at two different compression levels, 0.1 
and 3tons (0.015 and 0.455GPa) were also obtained. Moreover, Ti weighted images of those were 
acquired from a saturation recoveiy sequence. The primary use of the saturation recoveiy 
sequence was to measure Ti relaxation time. As already discussed in Chapter 2 Section 2.2.2.3, 
saturation recoveiy sequence consisted of multiple 90° RF pulses at relatively short repetition 
times (delay). The RF pulse tilted the magnetisation of the spin system into the xy-plane 
perpendicular to the main magnetic field and the spin system was saturated. Applying a T5 
saturation delay time, t, on a standard saturation recovery sequence it was possible to obtain a T x 
weighted image. A simple diagram of the sequence is shown in Figure 3-9.
90°90o90o90o90o90°
delay
IMAGE
Saturation
Figure 3-9: Diagram of pulse sequence used to acquire a Tx weighted image.
Typical parameters include P90 of 85ps, echo time of 10ms, repetition delay of 1000ms and 
number of averages 4. The NMR signal was sampled 128 times during the acquisition period, the 
phase-encoded gradients were stepped in 16 repeats and the slice thickness was 1mm. The %
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weighted image was obtained for an array of saturation delay times ranging from 50ms to 
4000ms.
3.2.3.3 Water ingress into drug loaded Eudragit tablets with different particle size 
components
Tablets with different particle size components for both polymer and drug were examined in order 
to observe the effect of particle size on dissolution. The ‘H MRI images of the tablets were 
acquired with similar parameters as before for samples listed in Table 3-4.
Table 3-4: Drug loaded Eudragit tablets having different particle size fractions for both 
polymer and drug.
% Drug concentration
(w/w)
Polymer particle size 
(am)
Drug particle size 
(wm)
45 <45 100-180
45 100-180 <45
45 100-180 45-100
25 45-100 45-100
3.2.3.4 Water ingress into drug loaded Eudragit tablets incorporating a third 
component in the sample matrix
A third highly soluble component was incorporated into the sample matrix in an attempt to 
achieve faster dissolution of the drug. The third component used was Sucrose [Sigma-Aldrich 
Chemicals] due to its high solubility (lgr in 0.5ml water), its ready availability in various particle 
sizes from large granular to fine powder and the fact that it has been used in pharmaceutical 
formulations as a channel former in matrix systems. The three component tablet had similar 
structure as the one described for the two component system. The AH MRI 2D images were 
recorded with analogous parameter sets as done before. The amount of sucrose into the tablet 
varied from 5%, to 30% and the ratio of polymer/drug was always kept 55/45, It is noted that 
sucrose was ground to a dry fine powder prior to mixing with the other components.
3.2.3.5 Water ingress into drug loaded Eudragit tablets exposed to water using 
Eudragit RLPO as polymer
MRI experiments were conducted on drug loaded Eudragit samples using Eudragit RLPO as 
polymer rather than Eudragit RSPO. The structure of Eudragit RSPO and RLPO differ only in the 
extent of the quaternary ammonium substitutions, with RSPO containing much less than RLPO. 
The ammonium groups are present as salts and are believed to make the polymer more permeable. 
So, water can permeate more freely into Eudragit RLPO than RSPO, due to the relative 
hydrophilicity of the RLPO polymer, and their permeability to water is unaffected by pH [Azarmi
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et al., 2002]. The tablets were prepared according to method in Section 3.2.3.1 and images were 
acquired with parameter sets mentioned in the same section.
3.2.4 Magnetic resonance imaging studies o f drug release from solid polymer 
matrix exposed to different dissolution environment
The effect on the dissolution mechanism was observed by changing the surrounding environment 
to which the tablet was exposed to. Different experimental conditions were investigated details of 
which are described in the following sections.
3.2.4.1 Magnetic resonance imaging studies of drug release from a solid polymer 
matrix under dynamic dissolution conditions
In these experiments the H MRI 2D images of the samples were recorded while tap water was 
continuously flowing over the tablet surface. This assessed the feasibility to observe the effect of 
water flow, over the surface of the tablet, on dissolution and to determine the concentration of 
drug released. The experimental set up of such system is shown in Figure 3-10.
Figure 3-10: Diagram of the dynamic dissolution cell.
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In the dynamic dissolution experiments the samples were made up of a layer of 55% (w/w) drug 
loaded Eudragit tablet above a 100% Eudragit layer as shown in Figure 3-10. The lower Eudragit 
layer was to provide structural integrity as experiments proceeded. Tap water was passed through 
a capillary tube, over the surface of the drug loaded Eudragit tablet and diffused into the system 
so as to dissolve the drug. The drug was released from the polymer and collected with the water 
that came out of the system, as shown in Figure 3-10. Analysis of that water gave the opportunity 
to gain information, such as the rate at which the drug was diffused out of the tablet and the 
amount of the drug present in the water, from a different perspective and correlate the results with 
those obtained from static measurements. The amount of drug in the water sample collected at 
different time points from the dynamic dissolution experiments was estimated using UV 
spectroscopy, which is discussed in Section 3.2.6. Moreover, dynamic experiments were carried 
out using different water flow rates in order to examine any change in the release rate and also 
any effect in the images. The 'H MRI 2D images of the samples were recorded using a similar 
acquisition method as in static dissolution experiments except the repetition delay was changed to 
10s due to tap water).
3.2.4.2 Magnetic resonance imaging studies on drug loaded Eudragit tablets 
exposed to phosphate buffer pH 7.4
MRI 2D images were recorded for samples exposed to phosphate buffer solution pH 7.4, under 
static dissolution in order to observe any different behaviour in the system (swelling). The 
phosphate buffer was prepared as follows; 1.38grams of disodium hydrogen phosphate [Sigma- 
Aldrich Chemicals], 0.19grams potassium dihydrogen phosphate [Fisher Scientific Chemicals], 
0.20grams of sodium azide [Fisher Scientific Chemicals] and S.Ograms of sodium chloride (NaCl) 
[Sigma-Aldrich Chemicals] were dissolved in lltr of milli-Q water and the final pH of the buffer 
was adjusted to 7.4 using concentrated hydrochloride (HCl) (typically 2M) [A.S. Clough, private 
communication. Similar preparation method was found in www.thelabrat.com/protocols/3.shtml. 
viewed on 01/09/05]. The *H MRI 2D images were acquired with similar parameter (repetition 
delay of 8s) as before.
Drug loaded Eudragit tablets were also exposed to aqueous sodium chloride solution (NaCl) of 
0.2M and 2M concentrations and similar MRI experiments were conducted.
3.2.4.3 Magnetic resonance imaging studies on polymer tablets exposed to 
concentrated drug solution
MRI experiments on 100% Eudragit tablets exposed to concentrated drug solution were carried 
out in order to observe any swelling effect of the solid matrix due to the presence of dissolved 
drag. The concentration of the drug solution was 29% (w/v), which was the maximum
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concentration of drug in solution as discussed in Section 3.2.2.2. The experiments were conducted 
under static dissolution conditions with similar imaging parameters as in Section 3.2.3.1.
3.2.5 X-ray Computed M icrotomography (//CT)
High spatial resolution (10//m) imaging experiments were conducted using a bench-top third- 
generation cone-beam X-ray /C T scanner. A detail description of the apparatus set up and 
principles can be found in [Jenneson et al., 2004]. In this system an X-ray source and an X-ray 
detector were at opposite sides of the sample which was placed on a precision mechanical sample 
table. The X-ray detector measured the intensities of the X-ray beam transmitted through the 
sample, as the sample rotated in the cone-beam. The X-ray cross-sectional images were generated 
by processing the transmitted intensities. The resulting CT image values known as grey-levels 
gave information on the microstructure of the sample in the plane of the cross-section. The third- 
generation cone-beam X-ray //CT system at the University of Surrey is shown in the Figure 3-11.
X-ray source Mechanical Sample holder X-ray detector
sample tablet
Figure 3-11: Third-generation cone-beam X-ray CT system at the University of Surrey.
The X-ray detector was a Hamamatsu C7942 flat-panel CMOS (complementary metal oxide 
semiconductor) array and the X-ray source a Hamamatsu L6731-01 microfocus x-ray tube with a 
focal spot size of 5//m, X-ray energy of 55kVp and a filament current of 0.1mA. The distance 
between the source and the sample was 50mm whereas the distance of the sample and the X-ray 
detector was 450mm. The mechanical sample table was a computer controlled rotational stepper 
motor with a resolution of 0.01°. The sample was rotated through 360° producing a series of 2D
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projected images of 512x512 pixels. The X-ray projections contained superimposed images of the 
entire sample, which were recovered into a three-dimensional data set by COBRA version 4.9.5 
(Exxim Computing Corporation, Pleasanton, USA) reconstruction program using the filtered 
back-projection algorithm known as the Feldkamp technique [Feldkamp et al., 1984]. For each 
sample 900 projections were recorded giving a total acquisition time of approximately 8hrs. The 
reconstructed X-ray //CT image was essentially a set of consistent grey-scale values with 10//m 
pixel spatial resolution.
3.2.5.1 X-ray //CT of water ingress into drug loaded Eudragit tablets
High resolution X-ray //CT experiments on drug loaded Eudragit tablets were conducted in order 
to gain information on the microstructure of the sample. In order to achieve 10//m spatial 
resolution the size of the sample was reduced and as a consequence the drug loading was reduced 
to prevent the rapid dissolution of the drug when exposed to water. Therefore, a new sample die 
was purchased that produced 3mm diameter tablets. The sample was placed in a specially 
designed cell as shown in Figure 3-12 made from teflon.
4 mm
Figure 3-12: Schematic diagram of the sample cell placed on the third-generation 
cone-beam X-ray CT system.
All experiments were conducted on 25% (w/w) drug loaded tablets prepared according to method 
in Section 3.2.3.1. The tablet weight was 32 ± 4mg with 3mm in diameter, 3.5 ± 0.5mm in 
thickness and compressed at O.ltons (0.137GPa) (greater pressure could damage the sample die). 
The images were recorded using a third-generation cone-beam X-ray //CT scanner as discussed in 
Section 3.2.5 and the wet samples were exposed to distilled water. The system was calibrated with 
the three components: drug and polymer compressed tablets and water in order to produce 
histograms, which provided information on the component fractions in the sample. The X-ray 
//CT experiments on drug loaded Eudragit tablets were acquired under static and dynamic 
dissolution conditions. In all experiments and dissolution conditions, the image of the completely 
dry tablet was initially acquired prior to exposing it to water.
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In the static dissolution condition two sets of experiments were obtained. In the first one, the 
scans of the wet tablet were taken after it was left to soak in water for 2 days. In the second set the 
tablet was initially exposed to water for 60mins. Then the surrounding water was taken out and 
scans of the sample were acquired to observe the effect of the drying process to the morphology 
of the sample.
In the dynamic dissolution experiments the images of the wet tablet were acquired with water 
going in the tablet in real-time. The water above the tablet was refreshed every 50mins in order to 
avoid drug saturation.
The set up and acquisition parameters for both dissolution conditions were the same as discussed 
in Section 3.2.5. However, in the static experiments for each sample 900 projections (20 frames 
summed for each projection) were recorded giving a total acquisition time of approximately 8hrs, 
whereas in the dynamic experiments for each sample 450 projections (2 frames summed for each 
projection) were recorded giving a total acquisition time of approximately 47mins. The resulting 
images had 10/zm pixel spatial resolution.
3.2.6 Determination o f drug content in solution using spectroscopic 
techniques
The amount of the drug released from the sample matrix over time was estimated using UV 
spectroscopy and !H NMR spectroscopy. The UV experiments were conducted on a Perldn-Elmer 
Lambda 9 UV/VIS/NIR spectrophotometer and the 'H NMR on a 400MHz spectrometer as shown 
in Section 3.2.1.
Siepmann et al. [Siepmann et al., 1999b] investigated Diltiazem HCl and theophylline in ethyl 
cellulose and Eudragit® RS 100 films containing various plasticizers. They detected Diltiazem 
HCl using UV spectroscopy at wavelength, X — 236nm. Standard solutions of known drug 
concentration were prepared and their UV absorbance was measured between 200-400nm. The 
UV absorbance of the water samples collected from the MRI dynamic dissolution experiments 
(see Section 3.2.4.1) were again recorded between 200-400nm and compared with the standard 
solutions in order to estimate the percentage of drug in solution over the period of time. UV 
results were correlated with NMR spectroscopy experiments. A static dissolution experiment was 
set up by exposing the top surface of 55% (w/w) drug loaded Eudragit tablets to water. The 
sample was placed in the magnet so as only the water above the surface was within the MRI coil. 
The ’H NMR spectrum (for pulse sequence see Figure 3-5(b), with 90° pulse of 11 /zv) of the 
solution was recorded periodically (over five days) in order to determine amount of drug released 
over that period.
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3 . 2 . 7  O p t i c a l  m i c r o s c o p y
Optical microscopy experiments were used to characterise the tablet microstructure using a Zeiss 
axiolab-A microscope. The optical micrographs obtained under reflected and transmitted 
illumination and the distances were calibrated using a graticule,
3.2.7.1 Observation of sample matrix under an optical microscope
Drug loaded Eudragit and 100% polymer tablets, and just polymer and drag powders, were 
examined under an optical microscope at different magnifications under reflected and transmitted 
illumination. The drug loaded and polymer tablets were both observed dry and after they were 
immersed in water for lbrs and llhrs, respectively, in order to observe any changes in their 
surface.
3.2.7.2 Dissolution of a single drug particle in water
A single drug particle was placed under an optical microscope. The particle was exposed to water 
and the time required for the particle to fully dissolve was recorded. The particle size against the 
time required for the single particle to dissolve was plotted and the gradient of line was used to 
estimate the dissolution constant of the drug. This information was used for modelling the 
dissolution mechanism.
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Chapter 4
4 NMR Characterisation of Raw Materials
In this chapter, experiments to optimise experimental procedures and characterise the materials 
under study are presented. The results were subsequently used to aid the inteipretation of spatially 
resolved MR data. The XH NMR Ti and T2 relaxation times of water swollen, spatially and 
temporally equilibrated Eudragit samples at two different NMR frequencies, 20MHz and 400MHz 
were determined. For both frequencies Ti data was best fit by a single component exponential 
recovery whereas T2 required a double exponential decay fit with a short and long component 
corresponding to polymer and water respectively. CYCLCROP 13C-edited spectroscopy was 
applied on a concentrated Diltiazem HCl solution (29%w/v) in order to select a specific 13CH3 
group in the molecule while suppressing all proton resonances, which did not arise from the 
desired molecular groups. This experiment assessed the feasibility of mapping drug 
concentrations in partially swollen system in imaging studies. Finally, the self-diffusion 
coefficient of the drug and water in various solutions of drug as a function of concentration were 
determined using the spectroscopically resolved stimulated-echo pulsed-field-gradient method. 
This information was subsequently used for modelling the drug egress.
4 . 1  T i  a n d  T 2  c h a r a c t e r i s a t i o n  o f  e q u i l i b r a t e d  E u d r a g i t  s a m p l e s
The *H NMR Ti and T2 relaxation times of water swollen, spatially and temporally equilibrated 
Eudragit samples at two different NMR frequencies, 20MHz and 400MHz were determined. 
Experimental data showed that the spatial equilibration of samples took six weeks during which it 
was observed that the weight of each sample did not change significantly. For both frequencies, 
the T; was measured using the inversion recovery method, whereas the T2 was determined by 
recording the FID and CPMG of each sample.
4 . 1 . 1  T x a n d  T 2 d e t e r m i n a t i o n  a t  2 0 M H z
4.1.1.1 Ti longitudinal relaxation time at 20MHz
Figure 4-1 shows an exemplar data set of a L  recovery curve for an equilibrated sample of 
swollen Eudragit prepared according to the method in Chapter 3, Section 3.2.2.1 and measured at
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20MHz using the parameters listed in Table 3-2 of Chapter 3. The set shown is for a concentration 
of 3.0gr Eudragit and 0.1ml H2Q.
T i measure o f 0.1ml H 20  &  3.0gr Eudrag it at 2 0 M H z  
Single component exponential fit
+ ♦  #  *—#— ©■ #  #  • -----
© Experimental data 
—  Exponential fit
1000 
Time (ms)
1500 2000
Figure 4-1: Ti measure of 0.1ml H20  & 3.0gr Eudragit at 20MHz. Single component 
exponential fit.
The data has been fitted with a single exponential recovery curve (black solid line) and a constant 
offset to account for the relative poor inversion achieved in the experiment, according to the 
formula
M ( P = M 0( l - 2 e x p ( —r f  + C ^ ,  4-1
The important fit parameter is Ti and is shown as a function of concentration in Figure 4-3.
Figure 4-2 shows the same data set fitted to a double exponential recovery according to the 
equation 4-2.
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Figure 4-2: Ti measure of 0.1ml H20  & 3.0gr Eudragit at 20MHz. Double 
component exponential fit.
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M (r )= M l  (1 -  2 « p ( ~ ) )  + M \  (1 -  2 e x p ( -^ »  + Coffsa 4-2
11
The analysis showed that the data was well fitted by a single component exponential recovery and 
that there was insufficient experimental evidence to justify the two component fitting with the two 
relaxation constants Txa and T]b. This can be seen in Figure 4-2, which is almost identical to the 
single component fit. Therefore, the spin-lattice relaxation, Tx, was taken to be a single 
component relaxation process for the whole range of the equilibrated samples.
Figure 4-3 shows the Ti (±3ms) (estimation of error is shown later) values obtained according to 
equation 4-1 plotted against the water mass fraction of the equilibrated Eudragit sample (see 
Chapter 3, Table 3-1 for water mass fraction values).
T x o f  equ ilibrated Eudrag it samples vs. H 20  mass
400 
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^  250
s~  200 
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0 0.03 0.06 0.09 0.12 0.15 0.18 0.21 0.24
H 20  M a s s  Fraction
fraction at 2 0 M H z
F ig u re  4-3: T x o f  e q u ilib ra te d  E u d ra g it  sam ples vs. H 20  M a ss  F ra c t io n  at 2 0 M H z .
It is observed that the Tx of the samples increases as the water mass fraction increases.
4.1.1.2 T2 transverse relaxation time at 20MHz
The T2 transverse relaxation time was determined by recording the FID and CPMG of each 
sample. Figure 4-4 shows an exemplar of the FID data obtained at 20MHz for an equilibrated 
sample of 3.0gr Eudragit and 0.1ml H20  concentration. The associated experimental method and 
parameter sets can be found in Chapter 3, Section 3.2.2.1 and Table 3-2 respectively.
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F ID  o f 0.1ml H 20  &  3.0gr Eudrag it at 2 0 M H z
Time (um)
F ig u re  4-4: F ID  o f  0 .1m l H 20  &  3 .0g r E u d ra g it  a t 2 0 M H z .
The analysis showed evidence of two components in the samples, a short and a long component. 
The FID signal of the sample showed an initial sharp decay corresponding to the short component 
(polymer) followed by a slower decay corresponding to the fast component (water). As the signal 
did not go to zero the T2 of the long component was better determined by CPMG as shown in 
Figure 4-5 (for parameter set see Chapter 3 Table 3-2).
F ig u re  4-5: C M P G  m easure  o f  0 .1m l H 20  &  3 .0g r E u d ra g it  a t 2 0 M H z . (x=64/s, 
n um be r o f  echoes=64 and po in ts  pe r echo=4).
The combination of the FID and CPMG results led to the estimation of the T2 transverse 
relaxation time for the Eudragit equilibrated samples. The front end of the FID’s were fitted to 
Gaussian decay for the short component together with a constant offset to account the long 
component better measured by CPMG and any baseline offset according to the formula
T2
M * /y  = M 0 S  exP(-=r) + M 0L + Coffset «
z 2 S
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where T2s is an indicative time constant or inverse rate for the short component. The Gaussian 
decay of the FID is usually assumed to arise from inhomogeneous distribution static inter-nuclear 
dipolar interactions. The CPMG data sets were fitted to a single exponential decay and constant 
offset.
=  M ol e x p (— -L-) + coffse, 4-4
12 L
Table 4-1 summarises the T2 results obtained from the combination of the FID and CPMG 
analysis. The experimental errors are also included the estimation of which is discussed later.
T ab le  4-1: T 2 doub le  exponen tia l re co ve ry  f it  fo r  the equ ilib ra ted  E u d ra g it  sam ples a t 2 0 M H z .
Sam p le  
m l H 2O/3.0gr 
E u d ra g it
M qs 
(%  m agn itude)
T 2s 
(T 2 o f  sh o rt 
com ponent)(±2 ps)
M ol
(% m agn itude)
t2L
(T 2 o f  lo ng  com ponent 
fro m  C P M G )  (±4ms)
0.0 94 20 6 0.7
0.1 91 22 9 4
0.2 87 22 13 10
0.3 90 21 10 12
0.4 82 21 18 20
0.5 83 21 17 19
0.6 77 21 23 27
0.7 77 21 23 34
0.8 78 19 22 43
0.9 76 20 24 50
The constant offset was generally found to be relatively small and was ignored. Accordingly the 
percentage intensities shown in Table 4-1 were derived from
% Intensity{short) = —  x 100 and % Intensity(hng) = — — x 100.
M o s  + M ol X I os  Y  M ol
The above data showed that the T2 of the polymer (T2S, short component) remained roughly 
constant over the whole range of concentrations. On the other hand, the T2 of water (T2L, long 
component) was consistent with the increasing water mass fraction of the sample, which was also 
seen for its amplitude. Figure 4-6 shows plots of the amplitude of T2 long component and T2 
relaxation times of short and long component in the sample to the water mass fraction from data 
in Table 4-1.
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F ig u re  4-6: (a) T 2 o f  sh o rt com ponent (b) T 2 o f long  com ponent and  (c) Percentage 
am p litu de  o f  T 2 lo ng  com ponent in  eq u ilib ra te d  E u d ra g it  sam ples at 
2 0 M H z .
Repeat measurements of Tj and T2 relaxation times for the equilibrated Eudragit sample of 3.0gr 
Eudragit and 0.9ml H20  concentration were recorded to check the reproducibility of the results
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and to obtain an estimate of the of random experimental error. Table 4-2 shows the values of these 
repeat experiments.
T ab le  4-2: R epea t m easurem ents o f T x and T 2 fo r  the e q u ilib ra te d  sam p le  o f  3 .0gr E u d ra g it  
and 0 .9m l H 20  concen tra tion . T he  percentage m agn itudes o f  the T 2s a n d T 2L are 
shown.
S am p le  m easured  T x (ms) T 2S(//s) T 2L(ms)
five  tim es s ing le  com ponent f it  sh o rt com ponent long  com ponent fro m  C P M G
1 376 77% @  19 23% @ 5 4
2 377 76% @ 2 0  24% @  54
3 374 76% @  20 24% @  53
4 375 76% @ 2 0  24% @  53
________ 5_________________ 376______________ 76% @  20________________ 24% @  53__________
The results confirmed that the measurements were reproducible to within better than 5%. The data 
were in good agreement with the order of the Tx and T2 values obtained from the original 
measurement as shown in Table 4-1 for the T2 of the sample and Figure 4-1 for the Tx value 
(372ms). This suggested that the random experimental error was small for all relaxation times as 
already noted in the primary results (Table 4-1 and Tx values).
The spatial homogeneity of the equilibrated samples with higher mass fraction of water was 
examined by determining the relaxation times of the samples at different height in the magnet. 
The NMR tubes of the samples were placed in the magnet at about 1cm to 2cm higher level than 
the original position. The results are summarised in Table 4-3.
T ab le  4-3: T x and  T 2 m easurem ents o f  e q u ilib ra te d  E u d ra g it  sam ples re co rded  at d iffe ren t sam p le  
he igh t in  the m agnet. T h e  percen tage m agnitudes o f  the T 2S a n d T 2L a re  shown.
Sam p le  
m l H 20  / 
3 .0g r E u d ra g it
T i
s ing le  com ponent f it  
(±3 ms)
T 2S (short 
com ponent) (±2//s)
T 2L (long  com ponent 
f ro m  C P M G )  (±4ms)
0.7 250 80% @  20 20% @  35
0.8 320 79% @  21 21% @ 4 0
0.9 330 79% @  21 21% @  45
The data obtained showed faster T! and T2 relaxation times compared to initial measurements of 
the samples (see Table 4-1 for T2 and Figure 4-3 for Tx results) and especially for the Tj times. 
These results suggested that either the samples were not well mixed or that were dryer as it moved 
upwards. There was more water at the bottom that at the top of the tube.
4.1.1.3 Ti and T2 determination at 400MHz
The data obtained from the Tx and T2 measurements of the water swollen, spatially and temporally 
equilibrated Eudragit samples at 400MHz were interpreted similar to results at 20MHz. For the 
Th the data was fitted by a single component exponential recovery according to equation 4-1.
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Figure 4-7 shows the resulting graph of the determined % (±3ms) values with the water mass 
fraction of the samples (Chapter 3, Table 3-1).
T i o f  equ ilib rated Eudrag it samples vs. H 20  mass 
fraction at 4 0 0 M H z
1400 
1200 
1000 
' I '  800 
600 
400 
200 
0
0 0.03 0.06 0.09 0.12 0.15 0.18 0.21 0.24
H 20  M a ss  Fraction
F ig u re  4-7: T i  o f e q u ilib ra te d  E u d ra g it  sam p les vs. H 20  mass fra c t io n  a t 4 0 0 M H z .
The Ti values of the samples did not increase substantially with water mass fraction in the same 
way as is seen for the 20MHz measurements in Figure 4-3. Here the T x value of the dry polymer 
powder gave a high value. There was an initial decrease in the % value between the dry and the 
sample with 0.1ml water. Thereafter it began to increase slowly until it became almost constant 
for samples with higher amounts of water.
It is very unclear what is happening. One hypothesis is that the Ti of the dry polymer and the 
water used in preparing the samples is very similar, circa Is, so that they cannot be easily 
distinguished. However, the Ti of the polymer with a very small amount of water is somewhat 
less, say 800ms. Therefore, the measurement reveals a weighted average of polymer with a small 
water fraction (likely <1%) and the bulk water between the grains. However, it is stressed that this 
is no more that a hypothesis. As will be seen in later chapters the situation is further complicates 
by the fact that a different Ti is measured in imaging studies of pressed tablets exposed to water. 
It is observed that the Ti relaxation times for both water and polymer were highly frequency 
dependent as the values obtained at 20 and 400MHZ were quite different.
The T2 of the equilibrated samples was obtained from the combination of the FED and CPMG data 
analysis based on the equations 4-3 and 4-4 as shown at 20MHz. Table 4-4 summarises the results 
of the two component exponential decay fits with the percentage magnitudes and the associate 
plots are shown in Figure 4-8.
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T ab le  4-4: T 2 doub le  exponen tia l re co ve ry  f it  fo r  the eq u ilib ra te d  E u d ra g it  sam ples a t 4 0 0 M H z .
Sam p le  
m l H 20  / 3 .0gr 
E u d ra g it
M 0s
(% m agn itude)
T 2s 
(T 2 o f  sh o rt 
com ponent) (±2//s)
M ol 
(%  m agn itude)
t 2L
(T 2 o f lo ng  com ponent f ro m  
C P M G )  (±4ms)
0.0 88 19 12 12
0.1 88 19 12 8
0.2 82 20 18 8
0.3 81 21 19 9
0.4 70 21 30 17
0.5 70 21 30 20
0.6 58 21 42 26
0.7 57 22 43 26
0.8 43 24 57 35
0.9 41 23 59 32
Data for the T2s relaxation times of the samples compared well with the values obtained at 
20MHz as seen in Table 4-1. The T2L were difference especially for the high concentration 
samples and the correlation of water and component amplitudes did not follow a linear trend as in 
Figure 4-6(c).
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T 2 o f  long component in equ ilibrated Eudrag it samples 
at 4 0 0 M H z
H 20  M a s s  Fraction
e
■csa
a,
£
<
0s
% Amplitude o f T 2 long component in equilibrated 
Eudrag it samples at 4 0 0 M H z
H 20  M a ss  Fraction
F ig u re  4-8: (a) T 2 o f  sh o rt com ponent (b) T 2 o f  lo ng  com ponent and  (c) Pe rcen tage  
am p litu de  o f T 2 lo ng  com ponent in  e q u ilib ra te d  E u d ra g it  sam ples at 
4 0 0 M H z .
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4 . 2  C Y C L C R O P  s p e c t r o s c o p y  o f  D i l t i a z e m  H C l  c o n c e n t r a t e d
s o l u t i o n
Cyclic /  cross polarisation (CYCLCROP) pulse sequence (Chapter 3 Section 3.2.2.2) was used to 
indirectly detect a 13C nuclei coupled to ]H nuclei in a drug solution and so determine the amount 
of drug in solution.
In order to select a specific methyl group (-CH3) in the drug molecule the JH and 13C spectra of a 
29% (w/v) Diltiazem HCl solution, prepared according to the method in Chapter 3, Section 
3.2.2.2, were first recorded at set frequency of 400MHz and 100MHz respectively. The parameter 
sets are mentioned in the same section. The and 13C spectra allowed the peak labelling of the 
proton and carbon spectra lines corresponding to specific proton and carbon atoms in the 
molecule. Ananthanarayanan et al [Ananthanarayanan et a l , 1993] demonstrated the complete 
assignment of the proton resonances in the ’H-NMR spectrum of the drug and the chemical 
structure of Diltiazem showing the numbering of protons and carbons in the molecule as 
represented in Figure 4-9.
9
F ig u re  4-9: C h e m ica l s tru c tu re  o f  Diltiazem show ing  (a) the n um b e r in g  o f  p ro ton s in  
the m o lecu le  and  (b) the n um be rin g  o f  ca rbons in  the m o lecu le  (C op ied  
f ro m  [A n an th an a ra yanan  et al., 1993]).
In addition, Glaser and Sklarz [Glaser and Sldarz, 1989] assigned both the ’H and 13C NMR 
spectral parameters o f Diltiazem HCl dissolved in Deuterated Dimethyl Sulfoxide ((CD3)2SO). 
Therefore, it was possible to assign three distinct methyl groups in the drug molecule that gave the 
best resonance. These were C(18)-H3(9), C(23)-H3(16) and C(20)-H3(10) and the lH and 13C 
spectra showing the labelling of the specific pair of proton and carbon atoms is shown in Figure
4-10.
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10000 15000
Hz
*H spectrum of 29% w/v Diltiazem HCl solution
Hz
F ig u re  4-10: (a) I3C  spectrum  and  (b) !H  sp ec trum  o f  29%  (w/v) Diltiazem HCl so lu tion .
Figure 4-10(b) is an enlarged area of the ’H spectrum of the drug obtained showing the resonances 
of the protons under study. However, comparing the full spectrum with that obtained by 
Ananthanarayanan et al. [Ananthanarayanan et al., 1993] it was observed that not all the peaks in 
the molecules were resolved. This suggested that some peaks were possibly covered by the broad 
base of the water resonance line and broadening was due to the concentrated nature of the 
solution.
The CYCLCROP spectrum of the concentrated drug solution was obtained for the three methyl 
groups in the molecule for a range of carbon frequencies in each case using parameters listed in 
Chapter 3 Section 3.2.2.2. The proton and the carbon frequencies were centred at the respective 
frequencies of the methyl group. Saturation pulses were set at the water frequency to suppress the 
water signal. Figure 4-11 shows an exemplar of the intensity data obtained from the CYCLCROP 
spectrum of the C(20)-H3(10) methyl group at selected carbon frequencies.
CYCLCRO P  spectrum of C(20)-H3(10) 
Intensity plots obtained at different carbon frequencies
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4iinnSJ
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F ig u re  4-11: C Y C L C R O P  spec trum  o f  C (20 )-H 3(10). In tens ity  p lo ts  ob ta ined  at 
th ree  d iffe re n t ca rb on  frequencies.
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The spectra of the CYCLCROP editing sequence showed a single peak corresponding to the 
selected methyl groups in the molecule and the complete suppression of the H20 resonance line.
Experimental data revealed that the signal-to-noise of the 13C spectrum (Figure 4-10(a)), which 
took approximately 4hrs to acquire, was quite poor. On the other hand, CYCLCROP spectrum 
had faster acquisition time, less than 2hrs and it gave almost 10 times better signal-to-noise. In 
practice, the full acquisition time of the carbon spectrum corresponded to almost three complete 
CYCLCROP sequences. So by adding the three CYCLCROP spectra obtained in Figure 4-11, the 
resulting spectrum demonstrated the better signal-to-noise ratio of CYCLCROP compared to the 
normal 13C spectrum per unit acquisition time. The improvement was by a factor of the order of 
10. This is represented in Figure 4-12.
F ig u re  4-12: T o ta l in te n s ity  o f  th ree  C Y C L C R O P  sequences C (20 )-H 3(10).
In order to validate the experiment and demonstrate the absence of any residual signal, which did 
not correspond to the selected methyl group, the 13C contact pulse was turned off. The sequence 
was re-run and Figure 4-13 is the intensity plots obtained from three CYCLCROP sequences 
(similar to Figure 4-12) when the I3C contact pulse was turned off.
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Intensity o f three C Y C L C R O P  sequences obtained for 
C(20)-H3(10) when 13C  contact pulse was turned off.
F ig u re  4-13: In tens ity  o f th ree C Y C L C R O P  sequences ob ta ined  fo r  C (20 )-H 3(10) 
w hen  the 13C  contact pu lse  w as tu rn ed  off.
The above plots showed clearly that no signal was acquired, as the magnetisation transfer did not 
take place. This data confirmed that the experiment was completed successfully as the signal in 
the spectrum of the concentrated drug was due to the cyclic polarisation transfer editing process.
Example spectra of the CYCLCROP editing sequence for the concentrated drug solution showing 
stacked plots of the intensity of another methyl group C(23)-H3(16), obtained for an array of 13C 
frequencies, together with the spectra obtained when the 13C contact pulse was switched off are 
presented in Figure 4-14. Note that the H20  peak was strongly suppressed. The small peaks 
observed were probably due to H20  residues but they did not interfere with the resulting signal.
C Y C LC R O P  spectrum of C(23)-H3(16) 100.600745Hz
100.600740Hz
100.600735Hz
100.600730Hz
100.600725Hz
100.600720Hz
- I -  ii. - ltnA.■ >.i . i i . i ■ i . iIj
U Jufi/J/ MUiajjUiii ilk \
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F ig u re  4-14: E x a m p le  C Y C L C R O P  spectra  o f  C (23 )-H 3(16) ob ta ined  fo r  an a r ra y  o f 
13C  frequencies. T he  spectra  show  the I3C  con tact pu lse  a lte rn a te ly  on 
and  off.
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4 . 3  S e l f - D i f f u s i o n  m e a s u r e m e n t s  o f  d r u g  a n d  w a t e r  m o b i l i t y  i n  
D i l t i a z e m  H C l  s o l u t i o n s
The self-diffusion coefficient of the drag and water from various solutions of drug as a function of 
concentration was determined using the spectroscopically resolved stimulated-echo pulsed-field- 
gradient method. Figure 4-15 shows exemplar spectra of a test solution with 26% (w/v) drag 
concentration prepared according to the method in Chapter 3 Section 3.2.2.3 and acquired using 
parameters listed in the same section. The spectra shown are for two different gradient strengths 
g=2 and 22G/cm. Based on the proton spectrum of the drug from Figure 4-10(b) the'proton peaks, 
corresponding to specific methyl groups in the drug molecule, were assigned on the spectra. For 
the rest of the analysis these proton peaks are referred to as drag peaks.
F ig u re  4-15: E xa m p le  spectra  o f  s tim u la ted -echo  pu lsed -fie ld -g rad ien t sequence fo r  a 26% (w/v) d rug  
so lu tion  a cqu ired  a t tw o d iffe ren t g rad ien t s treng th  g=2 and 22G /cm , show ing  the w a te r 
and p ro ton  peaks o f  the d ru g  m olecu le .
The self-diffusivities of water and drug peaks were determined based on the Stejskal-Tanner 
equation [Stejskal and Tanner, 1965]
su)/si0) = exp [- r 2 g'2 S 2 D  {A -  3)] 4-5
where yis the ]H gyromagnetic ratio, g  is the gradient amplitude, D is the diffusion coefficient, 8 
is the duration of the gradient pulses, A is the separation of the gradient pulses and S is the signal 
amplitude.
Semilog plots of S against 47fq2(A-S/?>) = f g 2<?(A-S/3) were used to determine D. The intensity 
can be determined either from the amplitude or the area of the peaks. Figure 4-16 shows example 
plots derived the water and drag peak areas in the spectrum for different drag concentrated 
solutions. The resulting plots for the all the water peak areas showed strong evidence of two 
component decay whereas the drug peak areas were much closer to single component.
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20% (w/v) D rug Solution 
W ate r peak area
(a)
0.04+00 8.0E+05 1.6E+06 2.4E+06 ^ E + #  4.0E+06 4.84+06
• •
47i 2q2(A-5 /3) (s/cm2)
F ig u re  4-16: N a tu ra l log  p lo t o f  the peak  area against 4rc2q2(A -8 /3 ) fo r  (a) 20%  (w/v) 
d ru g  so lu tion  in  9 5% D 20 /5 % H 20 ,  A=120ms, W a te r  peak  area, (b) 26%  
(w/v) d rug  so lu tion  in  9 5% D 20 /5 % H 20 ,  A=120ms, D ru g  peak  area o f 
H 3(16) and (c) 13%  (w/v) d ru g  so lu tion  in  9 5% D 20 /5 % H 20 ,  A=30ms, 
D ru g  peak area o f  H 3(10).
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The self-diffusion coefficient of the drug in each solution was detemiined from the gradient of the 
linear fitting of the data whereas for the water from the bi-exponential fit. All the results are 
summarised in Table 4-5 for data obtained at A=30ms and Table 4-6 for A= 120ms. The 
percentage amplitudes of the bi-exponential fits for all the water peak areas are also included.
T ab le  4-5: S e lf-d iffu s iv it ie s  o f  w a te r and  d ru g  estim ated fro m  the pea k  areas o f  spectra  ob ta ined  fro m  
d ru g  concen tra ted  so lu tion s a t A=30ms. T he  percen tage am p litudes  o f  the w a te r peaks a re  
shown.
% D ru g A n o f x lO - 6) ( c m V 1) . n  / v i n-6\ D c (20)-H3(10) (X10 6)
( c m V 1) (±4%)
-??C(18)-H3(9) (X lO  6)
( c m V 1) (±4%)
C o n cen tra tio n
(w/v)
Fa s t
(±5%)
S low
(±4%)
(cm 2®1) (±4%)
5 2796%
3.9
4% 4.3 4.4 4.1
13 17
83%
2.5
17%
3.3 3.3 3.4
20 19
78%
1.6
22% 1.5 1.4 1.6
26 11
63%
1.1
37% 0.9 1.2 1.0
29 187%
0.1
13% 0.1 0.1 0.1
T ab le  4-6: S e lf-d iffu s iv it ie s  o f  w a te r and d ru g  estim ated  fro m  the p e a k  areas o f  spectra  ob ta ined  fro m  
d ru g  concen tra ted  so lu tion s a t A=120ms. T he  percentage am p litudes  o f  the w a te r peaks 
a re  shown.
% D ru g  ■ 
L o a d
7>H20 (x lO '6) (cm 2®1) _ n  / v i a-® D c (20)-H3(10) (X lO  6)
(cm 2®1) (±4%)
A:(18)-H3<9)(x 10 6)
( c m V 1) (±4%)Fa s t
(±5%)
S low
(±4%)
J-'C(23)-H3(16) (. -*•" J
(cm 2®1) (±4%)
5 2698%
4.1
2% 4.3 4.6 4.2
13 1580%
1.8
10% 2.4 2.6 2.4
20 2281%
1.5
19% 1.5 1.5 1.5
26 1384%
1.0
16% 1.0 1.1 1.0
29 1475%
1.3
25% 1.4 1.3 1.3
Consider first the water peak and in particular the 20% (w/v) drug solution at A= 120ms as an 
example. This can be reasonably fitted to two exponentials as shown in Figure 4-16(a):
S = AX exp(-Djq2) + A2 exp(~D2q2) 4-6
with rt]=1985 D 1=2.2xl0'5cm2s'1 and A2=49, D2=T.5xlO‘6cm V1. In particular note that Dx was just 
a little less than the normal self-diffusivity of bulk water (2.5x10'5cm2s'!) and that the ratio Ax to
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A2 was approximately 4:1. From Table 4-5 and Table 4-6 it was observed that for all the drug 
samples Dx was closer to Auik water and was therefore judged to reflect the water diffusion.
The sample (2ml of 95%D20  / 5%H20; 0.5gr drag, Chapter 3, Section 3.2.2.3) contained 
approximately
2 x 2x 0.05 x .A.
 — —— — hydrogen nuclei where Aw is Avogadro’s number (6.02214199xl023mol"1) and
18.015 was the water molecular weight and 
3 x 0 . 5 x Aw
— ^ —  hydrogen nuclei m any particular -CH3 group where 450.98 was the drug molecular
weight. Hence, the water to any given -CH3 group intensity in the spectrum was expected to be in 
the ratio 3.3:1 before spin relaxation and H-D exchange were taken into account.
Careful analysis of the NMR spectra previously presented in the CYCLCROP experiments 
(Figure 4-10(b)) suggested that a drug CH3 line lie close to / underneath the water line. It seemed 
reasonable to assume that this peak contributed to the water peak, and manifested itself as the 
slow diffusing component within the water. It was however drug.
The diffusion coefficient for the three directly measured drag lines, C(23)-H3(16), C(20)-H3(10) 
and C(18)-H3(9), in the same sample were 1.50x1 O^cmV1,1.5x 10"6cm2s'1, and 1.5xl0"6cm2s'!, 
respectively (see Table 4-6 for 20% (w/v) sample) with a mean value of 1.5x10'6cm2s'1. This was 
similar to the slow “water” component (1.46xl0’6cm2s_1), supporting the argument that the bi­
exponential water decay contained a hidden drug line. Moreover, the definite drag lines had a 
sensible average relative intensity compared to the slow component of the water line -the hidden 
drug line- of 1.2:1.
Given the need to incorporate relaxation, the ratios of 4:1 (derived from a water peak area 
calculation, equation 4-6) and 3.3:1 (from nuclei counting of the drug) compared well indicating 
the experiment agreed with theory. Moreover, the ratio of 1.2:1, from comparison of drug and 
water line-hidden drug line- was close to 1 so the analysis was supportive of the general argument 
of a methyl group -CH3 underlying the water peak.
The self-diffusivities of the drug and water were also estimated from the decay of the amplitude 
of the peaks in the spectrum. Although the intensities derived from the amplitudes was a more 
rigorous procedure as the interference of overlaying peaks was less the resulting plots showed 
similar behaviour as the before. Figure 4-17 shows examples of a water peak with two component 
decay and drag peaks with a single component decay taken from different drug solutions.
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26% (w/v) Drug Solution 
D rug peak intensity o f H 3(16)
47t 2q2(A -S /3) (s/cm2)
F ig u re  4-17: N a tu ra l log  p lo t o f  the peak  am p litu de  against 47i 2q 2(A -S /3) fo r  (a) 20%  
(w/v) d ru g  so lu tion  in  9 5% D 20 /5 % H 20 ,  A=120ms, W a te r  peak 
in tens ity , (b) 26%  (w/v) d ru g  so lu tion  in  9 5% D 20 /5 % H 20 ,  A=120ms, 
D ru g  peak  in ten s ity  o f  H 3(16) and (c) 13%  (w/v) d rug  so lu tion  in  
9 5% D 20 /5 % H 20 ,  A=30ms, D ru g  peak in tens ity  o f H 3(10).
79
Chapter 4: NMR Characterisation o f Raw Materials
The estimated diffusion coefficients of the water and drug are listed in Table 4-7and Table 4-8.
T ab le  4-7: S e lf-d iffu s iv it ie s  o f  w a te r and  d ru g  estim ated  fro m  the p ea k  am p litudes  o f  spectra  
ob ta ined  fro m  d ru g  concen tra ted  so lu tion s at A=30ms. T he  percen tage am p litudes o f  
w a te r peaks a re  shown.
%Drug
Concentration
(w/v)
■»H2o(*10‘6) (cmV1)
.D rm vm n irfx lO  Dronvmnm ( x 10 Drnm-Hvm (*10
Fast
(±5%)
Slow
(±4%)
(cmV1) (±4%) (cmV1) (±4%) (cmV1) (±4%)
5% 2998%
4.5
2% 4.1 4.1 3.8
13% 2996%
2.4
4% 3.1 3.1 3.1
20% 2392%
1.9
8% 2.2 1.8 1.9
26% 1889%
3.0
1 1 % 1.5 1.5 1.4
29% 299%
0.2
1 % 0.1 0.1 0.1
Table 4-8: Self-diffusivities of water and drug estimated from the peak amplitudes of spectra
obtained from drug concentrated solutions at A=120ms. The percentage amplitudes of
water peaks are shown.
%Drug i»i,2o(x l0") (cmV)
D r m i - m n 10 6) (x 10 I*C(18)-H3(9) (*10 6)
(cmV1) (±4%)Concentration(w/v) Fast(±5%)
Slow
(±4%)
(cmV1) (±4%) ( c m V 1) (±4%)
5% 2899%
3.8
1% 4.1 3.9 3.6
13% 2498%
1.8
2% 2.5 2.4 2.4
20% 17
86%
1.2
4% 1.7 1.6 1.5
26% 1887%
0.9
13% 1.2 1.1 1.1
29% 1685%
1.4
15% 1.5 1.5 1.5
The tables showed that results obtained from the amplitudes were in good agreement with those 
obtained from the peak areas. The diffusion coefficient of the slow “water” component was again 
in good comparison to the drug lines in each sample and the calculated ratio of the water peak 
amplitude to the drug amplitude was 1.01:1 confirming that the second water diffusing component 
was actually a hidden drug line as previously suspected.
The average diffusivity data for all results in the above tables for the peak areas and amplitudes is 
shown in Figure 4-18.
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F ig u re  4-18: A ve rage  (a) Z>se|f as a fun c tion  o f  concen tra tion , peak area, and (b) Dsei{ as a fun ction  o f 
concen tra tion , peak  in ten s ity
Data confirmed again the good agreement of the results and show that -Dsei^ dmg) and Aeiftmo) were 
concentration dependant.
4 . 4  D i s c u s s i o n
The optimum Ti and T2 relaxation times of water swollen, spatially and temporally equilibrated 
Eudragit samples were determined at two different NMR frequencies, 20MHz and 400MHz. The 
spatial equilibration of the samples took a long time, approximately seven week and it was 
observed that the weight of each sample remained stable throughout the experimental period. For 
both frequencies, the spin-lattice relaxation, T u was a single component relaxation process along 
the whole range of the equilibrated samples. The experimental data were fitted to a single 
exponential recovery with a constant offset to account for the imperfect inversion. The low 
frequency Ti times were sensitive to water content compared to the high frequency and they 
increased as the water fraction of the sample was increased. It was suggested that the T] results for 
the high frequency measurements gave a weighted average of polymer with a small water fraction 
(likely <1%) and the bulk water between the grains. The purpose for obtaining the Tj values of 
water swollen, spatially and temporally equilibrated Eudragit samples was to use this data to 
interpret subsequent spatial resolved MRI data by determining water concentrations in the tablets.
The results obtained for spin-spin relaxation time were also affected by the above observations. 
The T2 relaxation time required a double exponential decay fits with a short and long component 
broadly assigned to polymer and water respectively. The combination of the FID and CPMG 
results led to the final interpretation of the T2 relaxation time for the Eudragit equilibrated 
samples. For both frequencies, experimental evidence showed that the T2 times of the short 
component was low in the order of ps indicating a solid (polymer) and they remained 
approximately constant along the whole range of samples. The T2 of the long component (in ms) 
was consistent with the water mass fraction of the sample as it was increasing with the water
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content. Finally, component amplitudes correlate with water mass fraction indicating a linear 
trend and corresponded particularly well at low frequency. The Tx and T2 relaxation times for both 
water and polymer were highly frequency dependent as the values obtained at 20 and 400MHZ 
were relatively different.
CYCLCROP 13C-edited spectroscopy was applied on a Diltiazem HCl solution in order to select a 
specific 13CH3 group in the molecule while suppressing all proton resonances, which did not arise 
from the desired molecular groups. This technique can reveal the amount of drug in solution and 
therefore it could enable drag concentration mapping in partially swollen matrices in imaging 
studies.
In order to obtain a strong drug signal a highly concentrated drug solution was required. The 
maximum concentration of drag in solution was 29% (w/v) (Chapter 3, Section 3.2.2.2). The 'H 
and 13C spectra of such solution were obtained and it was possible to assign specific methyl 
groups in the molecule; C(20)-H3(10) and C(23)-H3(16) as shown in Figure 4-10. The 'H 
spectrum (see Figure 4-10(b)) of the drag showed that the water peak had a very high resonance 
line compared to both H(10) and H(16) protons of the carbohydrate group, which suggested that it 
would be difficult to perform imaging on such sample. The CYCLCROP spectrum was acquired 
showing that it was a chemically specific method as it was possible to obtain signal for both the 
selected groups in the Diltiazem HCl molecule (Figure 4-11 and Figure 4-14). The spectrum 
showed that the H20  was clearly suppressed and only the peak of the methyl group was acquired. 
Therefore, the technique works at fixed carbon and proton frequencies. The CYCLCROP 
spectrum of Diltiazem HCl gave a 10 times better signal-to-noise compared to the 13C spectrum in 
significantly shorter acquisition time. The 13C NMR detection showed that the NMR sensitivity of 
13C nucleus was relatively weak and it required either a large number of 13C nuclei within the 
sample or very long experimental times in order to improve the sensitivity. Consequently, for 
imaging studies only 13C enriched material should be used to give 100 times better signal-to- 
noise. The validity of the results were confirmed by turning off the amplitude of 13C cross 
polarisation. So the magnetisation transfer did occur and no signal was obtained.
The self-diffusion coefficient of water and drug was estimated from solutions of drag as a 
function of concentration, with maximum drug concentration of 29% (w/v), using 
spectroscopically resolved stimulated-echo pulsed-field-gradient method. The drag peaks on the 
spectra were assigned according to information obtained from the CYCLCROP experiments.
The self-diffusivities of water and drug in each sample were estimated from either the amplitude 
or the areas of the peaks in the spectrum. For both cases evidence showed two component decay 
for the water peak, fast and slow, and a single component for the drug as shown in Figure 4-16 
and Figure 4-17. The fast component in the water was assigned to “water” as the Aeif[H2o-fast)
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compared well to bulk water and reduced as drug concentration increased as seen in Table 4-5 to 
Table 4-8. On the other hand, the slow component in water was assigned to a “hidden drag line” 
since its Aeif(H20-siow) anc* the intensity of the peak were similar to the principal drug lines. This 
was also confirmed by careful analysis of the !H NMR spectrum of the drug based on 
Ananthanarayanan et al. [Ananthanarayanan et al., 1993]. Finally, Figure 4-18 revealed that both 
the AeiKdrug) and Aeif(H20) were much concentration dependant.
Attempts were made to measure the pore size distribution of the drug/polymer matrix using NMR 
Cryoporometry [Valckenborg et a l, 2002]. This technique provides determination for pores in the 
range of a few nanometers to around 1-10/mi. However, the particle size of the components were 
big and so cryoporometry was not used to determine the porosity of the system.
4 . 5  C o n c l u s i o n s
In this chapter spectroscopic characterisation of the raw materials was conducted that will help the 
subsequent interpretation of spatially resolved MR data. The Ti and T2 relaxation times of water 
swollen, equilibrated Eudragit samples were determined at two different NMR frequencies. The 
Ti was measured using the inversion recovery pulse sequence, whereas T2 was determined by 
recording the FID and CPMG of each sample. For both frequencies showed a single 
component fit whereas T2 a double which corresponded to a short and a long component, water 
and polymer respectively. For the high frequency measurements it was suggested that an effective 
Ti of polymer and water was determined for the high concentration samples. CYCLCROP 
experiment on a 29%(w/v) solution of Diltiazem HCl was completed successfully as it was 
possible to obtain a signal for the selected methyl group in the molecule while totally suppressing 
the water signal and all the uncoupled or unselected *H resonances. This technique allows the 
indirect detection of 13C nuclei coupled to *H nuclei with the high NMR sensitivity of protons and 
therefore considerably better signal-to-noise compared to direct I3C NMR. However, it was 
concluded that I3C enriched material was necessary to use as the natural abundance of 13C gave a 
very low signal-to-noise. The technique is highly frequency selective and the magnetisation 
transfer is a relatively time consuming process.
Finally, the water and drug self-diffusivities in drag solutions were obtained. This is important 
information for modelling the drug egress.
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Chapter 5
5 Imaging studies of drug release from a solid 
polymer matrix
In this chapter, results from parameters affecting the release of the soluble drug from a non­
swelling polymer matrix are presented. MRI experiments on Eudragit tablets with different levels 
of compression, drug loading and particle size exposed to water were made in order to observe the 
ingress of water in to the tablet. In addition, samples were exposed to different dissolution 
environments. NMR spectroscopy was used to assess the amount of drug released. The MRI 
technique was complemented by other chemical and physical structural methods, such as X-ray 
//CT, UV spectroscopy, optical microscopy to characterise the matrix microstructure. The data 
obtained provided the means to understand the swelling and dissolution mechanism of the sample 
matrix.
5 . 1  W a t e r  i n g r e s s  i n t o  S t a n d a r d  S y s t e m
The release of the soluble drug was studied on a system containing Eudragit RSPO loaded with 
45% (w/w) Diltiazem HCl prepared according to the method in Chapter 3, Section 3.2.3.1 and 
compressed at 2tons (0.303GPa). For the rest of the study this is considered as the standard 
system. The tablet was exposed to water under static dissolution conditions (Chapter 3, Section 
3.2.3.1). Figure 5-1 shows exemplar LH 2D MRI images of a standard system acquired on the 400 
]H MHz superconducting magnet (9.4T) using the parameter sets listed in Chapter 3, Section
3.2.3.1. These are vertical slices (1mm thickness) taken from the centre of the sample and each 
took approximately 9mins to acquire.
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F ig u re  5-1: *H M R I  2D  im ages o f  45%  (w/w) d ru g  loaded E u d ra g it  tab le t exposed to w ater.
The bright areas corresponded to water above and below the tablet and the dark central band was 
the tablet. The spin-spin relaxation time (T2) of the tablet was less than the echo time (4ms) and so 
the tablet was invisible. As time passed the colour of the dark band changed to light grey 
indicating that water was starting to penetrate the system and the T2 of the tablet lengthened. The 
full penetration occurred after approximately 7.5hrs. Two observations can be made from this 
experiment. The first is that the water ingressed into the system with a sharp front and the second 
is that during the ingress of water the tablet was beginning to swell. The total change of tablet 
height over time was measured as shown in Figure 5-2. The height was determined by taking an 
average value of the increased height across the length of the tablet at each time point measured 
from the top surface of the tablet.
45%  (w/w) d rug  lo aded  E u d rag it tab le t
.OX)
'3x
XiCQ
T im e  (m ins)
F ig u re  5-2: Increase o f tab le t size w ith  tim e fo r 45%  (w/w) d rug  loaded tab let.
The data analysis revealed that by the end of the experiment the tablet of 0.3cm in thickness 
swelled by about 20%. In order to understand the origin of the swelling similar MRI further 
experiments on 100% Eudragit and 100% Diltiazem HCl compressed tablets (prepared as 
described in Chapter 3, Section 3.2.3.2) were conducted.
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5.1.1 MRI studies of water ingress into 100% Eudragit and 100% Diltiazem 
HCl compressed tablets
Figure 5-3 shows exemplar of *H 2D MRI images of 100% Eudragit RSPO tablet exposed to 
water. Each image took approximately 17mins to acquire.
F ig u re  5 -3 : 'H  M R I  2D  im ages o f  100%  E u d ra g it  tab le t exposed to w ate r.
Similar to Figure 5-1, the bright areas corresponded to water underneath and over the tablet 
whereas the dark band in between was the tablet itself. Figure 5-4 shows the vertical profiles 
extracted from the central region of the MRI images.
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F ig u re  5-4: 'H  M R I  one-d im ensiona l p ro f ile s  extracted  from  the im ages show n in  F ig u re  5-3 fo r  the 
100%  E u d ra g it  tab le t (a) fu ll p ro f ile  and (b) en la rge in  the low e r d iag ram .
The vertical profiles show the top of the tube on the left (water/tablet interface is at 0.02cm), the 
bottom on the right and the tablet in the middle (between 0.02 to 0.3cm). The signal intensity 
declines towards the sides of the profiles as only the central 10mm of the sample resides in the 
MRI coil. The substantial difference in the signal intensity between the dry tablet (black solid 
line) and the tablet exposed to water for 17mins (blue solid line) suggested that initially water 
diffused into the system quite rapidly. The subsequent gentle build up of the signal in the tablet 
with time as observed from the images in Figure 5-3 was indicated by the rising intensity in the 
central band. There was a slight increase in width, more evident in the enlarge profile, that 
suggested the tablet of initial thickness 0.28cm had swelled at most 4%, which was not significant 
compared to the 20% observed for the standard system.
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The 'H MRI 2D images of 100% drug compressed tablets were obtained for tablets exposed to 
different amounts of water ranging from 0.1ml to 2ml. An example is shown in Figure 5-5 where 
only the top of a 100% drug tablet was exposed to 2ml of water. The tablet was made up of two 
layers. A 100% drug layer sitting above a 100% Eudragit layer, which provided structural 
integrity during the experiment.
F ig u re  5-5: ’ H  M R I  2D  im ages o f  100%  Diltiazem HCl tab le t exposed to 2m l o f  w a te r on ly  fro m  the 
top surface.
The 2D images showed that water penetrated the system and by the end of the experiment, at 
1 lhrs, the length of the tablet had been reduced compared to the initial time as seen from Figure 
5-5-1 lhrs image. This suggested that water had started slowly to dissolve the material. The 
vertical profiles extracted from the MRI images are shown in Figure 5-6.
(a) 100%  Diltiazem HCl Tablet 
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end of 
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J  dry end
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(b) 100% Diltiazem HCl Tablet 
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F ig u re  5-6: ’ H  M R I  one-d im ensiona l p ro file s  extracted  fro m  the images show n in  F ig u re  5-5 fo r  the 
100%  Diltiazem HCl tab le t (a) fu ll p ro f ile  and (b) p ro f ile  w itho u t the 100% E u d ra g it  
laye r.
The vertical profiles show the tablet exposed to water only from one side, the left side, which 
corresponded to the top surface in the MRI image. The water /tablet interface is at -0.02cm. The 
end of the drug tablet is at 0.22cm and the end of the polymer layer is at 0.3cm. The increase in 
the intensity signal within the drug layer indicates the water ingress into the system. It was 
observed that as water invaded into the drug tablet there was an increase in the width of the tablet 
as seen in Figure 5-6(b) at 24mins (red solid line) and 85mins (green solid line). This suggested
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that the tablet had swelled at most 6% at 85mins. After that the width of the tablet decreased, 
Figure 5-6(b) 4.2hrs and 1 lhrs, suggesting that the material was stalling to dissolve. Especially in 
the 1 lhrs profile where it was clear that the width of the tablet had significantly changed due to 
the dissolution of the tablet. The decrease in the intensity values of bulk water, taken from the top 
of the tablet, was probably due to the dissolved drug in water.
Therefore, MRI experiments suggested that virtually nothing happened when a 100% Eudragit 
tablet was exposed to water and a small percentage of swelling followed by dissolution proceeded 
for a 100% Diltiazem HCl tablet. On the other hand when a compressed polymer/drug tablet was 
exposed to water a swelling of the matrix was observed.
5 , 1 . 2  P o r o s i t y  o f  d r u g  l o a d e d  E u d r a g i t  a n d  1 0 0 %  E u d r a g i t  t a b l e t
A vital parameter that affects the release of the drug is the porosity of the matrix. Initially, a 
standard system and a 100% Eudragit tablet were examined under the microscope to observe any 
pores on the surface. The tablets were examined dry and after they were exposed to water for Ihr 
for the standard system and 1 lhrs for the polymer tablet. The polymer and drug powders were 
also observed to estimate their particle size. An example of the optical micrographs obtained at 
different magnifications under reflected and transmitted illumination is shown in Figure 5-7.
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F ig u re  5-7: O p t ic a l m ic ro g rap h  o f  (a) po lym e r loose pow der and (b) d rug  loose pow der at d iffe ren t 
m agn ifica tion  u nde r tran sm itted  il lu m in a t io n , (c)-(d) d ry  and wet 100%  E u d ra g it  tab le t 
and (e)-(f) d ry  and wet 45%  d ru g  loaded tab le t unde r re flected  il lu m in a t io n .
Figure 5-7(a)-(b) suggest that the particle size of the polymer and drug loose powders varied from 
small particles, less than 50/mi, to larger ones, greater than 100/zm. The surface of the dry tablets 
was highly compacted. Large polymer particles can be distinguished in both 100% Eudragit and 
45% (w/w) drug loaded tablet as shown in Figure 5-7(c)-(e). In the latter the white powder spread 
between the larger polymer particles, as seen in Figure 5-7(e), can be assumed to be the drug 
powder. The optical micrographs of the wet samples indicated that the morphology of the tablets 
had changed. However, at this magnification no clear evidence of the porosity of the system was 
obtained.
Therefore, the porosity of the sample matrix was estimated gravimetrically based on the density of 
the two components. The density of the drug was calculated with respect to water. As the polymer 
is insoluble in water its density was estimated with respect to acetone [Sigma-Aldrich Chemicals]. 
For each component a known volume of liquid was placed in a glass vial. Then, powder was
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added into the vial and dissolved. The difference of mass uptake and liquid volume was used to 
calculate the density, p. The results gave
Ppolymer = 1.10 ±0.01 gr/cC 
pdrug = 1.24 ± 0.03 gr/cc
The porosity of the compact tablet was determined from the volume of system and components 
and for a 45% (w/w) drug loaded tablet was estimated to be (-2.0 ± 4)%. The percentage error was 
derived from the measurement of the polymer and drug density. The w/w drug percentage 
required to yield 0% porosity for the measured parameters was 65% (w/w).
The porosity of the matrix was also estimated from MRI. The *H MRI 2D images of a completely 
dry 45% (w/w) drug loaded Eudragit and 100% Eudragit tablets were acquired. Then water was
added on the top of the tablets and another 2D image was obtained (9mins acquisition time). The
45% (w/w) drug loaded tablet consisted of two layers, a drug loaded Eudragit and a pure Eudragit 
layer (see Chapter 3, Section 3.2.4.1, Dynamic dissolution section for sample structure).
(a) 3 nun
dry 9nnns
(b) 3mm
dry 9m ins
F ig u re  5-8: D ry  and wet *H M R I  2D  im ages o f  (a) 45%  (w/w) d rug  loaded E u d ra g it  and (b) 100%  
E u d ra g it  tab lets.
An average signal intensity value was taken from the images of the dry and wet tablets. Intensities 
were extracted from an area within the water, the tablet and from an area below the tablet, where 
the teflon sleeve supported the tablet (see Chapter 3, Section 3.2.3.1, Figure 3-8 for experimental 
set up). The intensity values for both the tablets are listed in Table 5-1 and Table 5-2.
Tab le  5-1: A ve rage  s igna l in tens ities taken  fro m  ‘H  M R I  2D  im ages o f  a d ry  and
ju s t wet 45%  (w/w) d ru g  loaded E u d ra g it  tab let.
Avg. Water Avg. Tablet Avg. Teflon
Intensity(a.u) Intensity(a.u) Intensity(a.u)
Dry Tablet 0.0086 0.0078 0.0068
Just Wet Tablet 0.1028 0.0108 0.0076
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T ab le  5-2: A ve rag e  s igna l in tens it ie s  taken  fro m  1H  M R I  2D  im ages o f a d ry  and 
ju s t  w et 100%  E u d ra g it  tab le t.
Avg. Water Avg. Tablet Avg. Teflon
Intensity(a.u) Intensity(a.u) Intensity(a.u)
Dry Tablet 0.0084 0.0087 0.0092
Just Wet Tablet 0.1048 0.0129 0.0086
Table 5-1 suggested that the mean signal intensity due to background noise (the data were 
modulus) was 0.0077 and so the tablet and water signal intensities were 0.0031 and 0.0951, 
respectively. Hence, the porosity of the 45% (w/w) drug loaded Eudragit tablet was 3.2%
Similarly the porosity of the 100% Eudragit tablet was 4.4%. This percentage corresponds to the 
air space between the compressed polymer particles in the tablet. It does not take account of the 
nano-porosity of the loose polymer grains, which is not measured here. The analysis suggested 
that the porosity of the drug loaded matrix was much less than that o f the pure polymer 
presumably as the drug powder was soft and filled the pores between the polymer grains under 
compaction. This was also observed from the optical micrographs in Figure 5-7(e) where the drug 
was spread between larger polymer particles. The result obtained is comparable to that calculated 
from the gravimetric analysis.
5 . 1 . 3  A n a l y s i s  o f  M R  i m a g e s  o f  s t a n d a r d  s y s t e m
5.1.3.1 Initial capillary uptake to porosity
One conclusion that can be drawn from the estimation of the porosity of the standard system was 
that the initial ingress of water across the whole tablet occurred very fast. That was supported 
from vertical profiles extracted from the 2D MRI images shown in Figure 5-8(a). The profiles 
are shown in Figure 5-9.
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F ig u re  5-9: (a) 'H  M R I  one-d im ens iona l p ro f ile  extracted fro m  a cen tra l reg ion  o f 
the im age data  ob ta ined  fo r  a d ry  and wet 45%  (w/w) d ru g  loaded tab le t 
and (b) en la rged  reg ion  o f  the tab let.
The tablet was exposed to water only from the top surface, which is the left side on the diagram. 
The water/tablet interface is at 0cm and the tablet is between 0 and 0.3cm. The upper layer (up to 
0.2cm) is the drug loaded Eudragit and the lower layer (0.2 to 0.3cm) is 100% Eudragit. The 
profile of the wet tablet indicated an increase in the intensity values across the whole tablet 
(Figure 5-9(b)) with more water present in the lower layer of the matrix. This suggested that there 
was a rapid capillary uptake of water into the porosity of the tablets ahead of the primary 
dissolution. Rapid uptake was also observed in the profiles for the 100% Eudragit tablet in Figure 
5-4(b).
5.1.3.2 Diffusion coefficient of water in the tablet
MRI experiments on water exposed drug loaded Eudragit tablets showed that initially the water 
rushed in across the whole tablet very quickly. The ‘H 2D images in Figure 5-1 revealed that 
water ingressed into the matrix with a sharp diffusion front that advanced in a much slower rate.
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Figure 5-10 shows exemplar intensity profiles extracted from the !H 2D MRI images of the 
standard system at two different time points.
F ig u re  5-10: ’ H  M R I  one-d im ensiona l p ro file s  extracted  fro m  the cen tra l reg ion  o f 
im ages ob ta ined  fo r  a 45% (w/w ) d rug  loaded E u d ra g it  tab le t exposed 
to w a te r fo r  9m ins (b lue  so lid  line) and 90m ins (red so lid  line).
The vertical profiles showed the tablet exposed to water from both surfaces, as labelled on the 
graph, with the upper water/tablet interface at 0cm. The 90mins profile indicated that water 
ingressed into the system as there was an increase in intensity in the central band, which is the 
tablet (red solid line between 0 and 0.3cm). The water ingress proceeded into the system with a 
sharp diffusion front. There was also an increase in the width of the tablet suggesting the swelling 
of the system. Measuring the distance of water ingressed as a function of time led to an estimate 
of the transport diffusion coefficient of water, Z),(H20). Figure 5-11 shows plots of the distance of 
water ingress against time and square root of time.
(a) Distance of water ingress against Time
Time (s)
(b) Distance of water ingress against Time
n r' 1/Z / 1 H \Time (s )
F ig u re  5-11: P lo t o f the d istance o f  w a te r ingress against (a) T im e  and (b) T im e 12.
The data revealed that water ingress proceeded linearly with the square root of time, t,/2. Hence, it 
was suggested to characterise the advance of the water sharp front as a “Fickian like” diffusion 
[Chapter 2, Section 2.4 for Fickian diffusion]. An indicative estimate of the diffusion coefficient,
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D,(H20), was made by calculating the [gradient]2 of the fitted line (solid line) in Figure 5-11(b). It 
was approximately 1.8x 10'6cm2/s ±3%.
• The Boltzmann’s Transformation
Figure 5-11(b) suggested that the ingress of the primary dissolution front -  as opposed to any 
initially capillary uptake into the tablet pore space -  was governed by Fickian diffusion [Chapter 
2, Section 2.4]. The data obtained from the self diffusion measurements (see Chapter 4 Section
4.3) revealed that the self-diffusivities of water and drug were concentration dependant (Chapter 
4, Figure 4-18). Fields second law for one-dimensional diffusion when the diffusion coefficient, 
D, depends on the concentration, c, is
d c  _  d  
d t d x
D{c)
dc
d x
5-1
It was advantageous to transform the data according to Boltzmann’s transformation [Crank, 1975] 
in order that the curves lie on a master profile. Boltzmann demonstrated that for semi-infinite 
boundary conditions when the diffusion coefficient, D, is a function of concentration, c, then the 
diffusion can be expressed in terms of a new variable
77=
x
211/2
5-2
Equation 5-2 can be reduced to an ordinary differential equation in c and rj as shown below.
dc2 r)^°  -  ^  
di} dr)
D(c)
dr]
5-3
Integrating equation 5-3 it is possible to estimate the diffusion coefficient as a function of 
concentration [Crank, 1975]:
D,{c)=
- 2 j \°Tjdc
5-4
di]
The transformation was applied to all the intensity profiles extracted from the 3H 2D images of the 
standard system obtained in Section 5.1. The results shown in Figure 5-12 are from profiles taken 
after 43mins of initial water exposure until it was fully invaded the tablet.
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A  ►
B ----- ►
C  ►
F ig u re  5-12: B o ltzm a n n ’ s tra n s fo rm a tio n  o f  the in ten s ity  p ro file s  o f  45%  (w/w) d rug  
loaded E u d ra g it  tab let.
The water/tablet interface is at p = Ocm/s12. The graph shows clearly three distinct regions: region 
A is the bulk water; region B is the dissolution region (water in the tablet) and region C is the 
water in the capillaries between the particles in the tablet (the initial capillary uptake of water). 
From Figure 5-12 the drug fraction was estimated from the intensity values of the three regions 
according to:
B — C
 100 = percentage drug fraction. If values from the 43mins run were taken then the drug
A
fraction was equal to 46%. This was in good agreement with the expected percentage of drug in 
the tablet which was 45%. So it was suggested that in region B there was 46% of drug. As solid 
drug did not give any signal and if the 'H concentration in drug was similar to water, then it could 
be assumed that the solution in region B was saturated and that drug was dissolved.
However, the estimation of the drug fraction has some limitations. There is a difference in the 
intensity values through out the sample. For instance in regions A and B this difference is due to 
difference in relaxation times. It can be assumed that the initial signal intensity in region A is 
proportional to 100% water. However, Ti and T2 relaxation times are different for the bulk water 
and the adsorbed water in the tablet (region B) resulting in different signal intensity values, which 
makes calibration difficult. The Bolzmann’s transformation considers semi-infinite boundary 
conditions. However, here water is also ingresses into the system from the back end of the tablet, 
as both surfaces were exposed to water, illustrated in Figure 5-12 as the rear front. Finally, it is 
observed that the intensity values of the bulk water (region A) throughout the run are varying 
probably due to the presence of dissolved drug in the water with time.
0.25
Boltzmann's transformation 
45%(w/w) drug loaded Eudragit tablet
Sharp
i ► • |  Dissolution region front
-5.00E-04 0.00E+00 5.00E-04 
77 (cm/s12)
1.00E-03 1.50E-03
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Figure 5-12 showed evidence that dissolution proceeded slowly (>5hrs until the two fronts met) 
presumably due to water saturation in the tablet by the liquid drug given that up to 29% of drug 
could be dissolved in water as discussed in Chapter 3 Section 3.2.2.2. The water diffused into the 
tablet forming a sharp diffusion front, which is suggested to comply with Fickian diffusion. 
Boltzmann’s transformation analysis was applied to the data with the assumption that the surface 
was well defined and not moving. So the transform was applied in a frame of reference fixed to 
the “sample surface”. Hence, the profiles in Figure 5-12 were integrated to yield the diffusivity as 
a function of concentration based on equations 5-4. This was a more rigorous procedure than the 
simple position, x, against square root of time plot previously used (Figure 5-11(b)).
The concentration of water within the sample was calculated and plotted against the variable 77. 
Figure 5-13(a) shows the transformed and smoothed data of Figure 5-12 and Figure 5-13(b) the 
transport diffusion coefficient of water as a function of concentration.
(a) % Concetration o f water against 77
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F ig u re  5-13: (a) % C o n cen tra t io n  o f  w a te r against 77, (b) d iffu s io n  coe ffic ien t o f 
w a te r in  tab le t as fun c tio n  o f  concen tra tion .
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Figure 5-13(a) shows that approximately 53% of water had gone into the tablet. It was observed 
that there was a minor surface resolution problem as the boundary surface (bulk water and tablet) 
at tj= Ocm/s12 was not completely well defined. That was partly due to (i) the dissolution and 
swelling of the tablet, that caused problems to the Boltzmann analysis, (ii) to the actual imaging 
experiments and (iii) to the roughness of the tablet surface. Finally, Figure 5-13(b) revealed the 
A(H20 )  to be in the order of 10‘6-l0"7cm2/s. Similar to value obtained from Figure 5-11(b).
5 . 1 . 4  A i r  v o i d s  i n  t h e  s t a n d a r d  s y s t e m
MRI experiments were conducted on a standard system exposed to water for longer times. Figure
5-14 shows exemplar ’H 2D images of a bi-layer constructed tablet (see Chapter 3 Section 3.2.4.1 
for sample structure) exposed to water for 4 days. Each image took approximately 34mins to 
acquire. The last picture is a diagram of the image illustrated the different characteristics of the 
images after 4 days of water exposure.
F ig u re  5-14: *H M R I  2D  im ages o f  45% (w/w) d ru g  loaded E u d ra g it  tab le t exposed to w a te r fo r  4 
days. (Im age p ixe l size 2 9 x l8 8 //m 2)
The image after one hour of water exposure showed the ingress of water into the system followed 
by swelling of the sample matrix. As before there was evidence that water was present at the back 
end of the tablet (above the Eudragit layer) corresponding to the rapid capillary uptake of water 
into the porosity of the tablet ahead the primary dissolution. The new observation from these 
experiments was that after water fully invaded into the tablet there was accumulation of air voids 
in the system with time. The observation of air voids in the system from the MRI experiments led 
to the microstructural analysis of the matrix using high resolution X-ray pCT.
5.1.4.1 X-ray //C T  of drug loaded Eudragit tablets exposed to water
The purpose of the X-ray //CT experiments was twofold: firstly, to obtain 10//m high spatial 
resolution visualisation of drug loaded Eudragit tablets in order to gain information on the 
microstructure of the sample; the overall porosity of the system and the drug distribution and 
secondly, to confirm the MRI results obtained from experiments discussed in Section 5.4.1.
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microstructure of the sample; the overall porosity of the system and the drug distribution and 
secondly, to confirm the MRI results obtained from experiments discussed in Section 5.4.1.
X-ray //CT differed from MRI, as a single slice was not acquired independently of the other 
slices. Instead a large number of X-ray radiograph projections were acquired whilst rotating the 
sample through 360 degrees. The X-ray projections contained superimposed images of the entire 
sample which were recovered into three-dimensional data as described in Chapter 3 Section 3.2.5. 
Figure 5-15 shows exemplar of 2D reconstructed X-ray //CT images of a dry and wet 25% (w/w) 
drug loaded Eudragit tablet prepared according to the method in Chapter 3 Section 3.2.5.1 and 
acquired using a third-generation cone-beam X-ray //CT scanner with parameters listed in Chapter 
3, Section 3.2.5. The process of acquiring projections and mechanically moving the sample was 
inherently slow and the scan time for each sample was 8hrs. The experiment was conducted under 
static dissolution conditions where the sample was exposed to water for 2 days prior to imaging as 
described in Chapter 3, Section 3.2.5.1. The images were central slices extracted from the three- 
dimensional data set. The vertical slice was taken along the axis of the sample cell and included 
one diagonal whereas the horizontal slice was orthogonal to that plane.
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F ig u re  5-15: X - ra y  /X2T im ages o f  a 25% (w/w) d rug  loaded E u d ra g it  tab le t (a) d ry , 
h o r izo n ta l s lice, (b) d ry , ve rt ic a l slice, (c) in  w a te r fo r 2 days, h o r izo n ta l 
slice, (d) in  w a te r fo r  2 days, v e rt ic a l slice. L in e a r  d im ens ion  o f  each 
voxe l was 10//m over a f ie ld -o f -v iew  o f 5.12 x 5.12m m 2.
Figure 5-15(a) shows the sample cell (grey outer circle), the tablet (inside circle) and the air 
(circle between container and tablet). The reconstructed X-ray //CT data were essentially a set of 
consistent but un-calibrated grey-scale values. The dry tablet has clearly two different grey-levels.
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A bright (white) corresponding to drug and a darker (grey) corresponding to the polymer, which 
has similar grey scale to the teflon container. On the other hand, from the image of the wet 
system, Figure 5-15(c) and (d), it was really difficult to distinguish the actual tablet. The electron 
density of the whole matrix had changed radically after leaving the sample in water for two days 
and it seemed that the entire sample had a single grey scale intensity similar to that of the 
polymer. The wet images showed evidence that there was accumulation of air voids in the sample 
after two days exposure to water as seen in MRI experiments (Figure 5-14). There was a faint 
white circle around the tablet, which was probably a mixture of water and drug.
Histograms of the above data were obtained so as to assign the grey scales of the components in 
the heterogeneous system. The histograms of the data did not separately resolve each of the 
components polymer, drug, water and air in the partially swollen system. So, calibration scans of 
just water, 100% drug and 100% polymer powders compressed at 0.1 tons (0.137GPa) were 
obtained under the same acquisition parameters in order to allow the grey-scales associated with 
the individual components to be attributed to grey-scales in the heterogeneous system. The 
histograms of the materials provided information on the component fraction in the sample. The air 
was calibrated from an area above the tablet. The resulting histograms of the components are 
shown in Figure 5-16.
F ig u re  5-16: H is tog ram s o f  a ir , po lym er, w a te r and d rug .
It was observed that the histograms of air, polymer and drug were well separated from each other. 
So in a dry system it would be easy to assign the grey scales of the components. On the other 
hand, in a wet system, water dramatically complicated the matrix as it had a very similar density 
and composition to polymer and the grey-scale values in the histogram overlapped. This can be 
seen in Figure 5-15(c) and (d) where it is difficult to distinguish the polymer and water in the wet 
samples. There was also the problem of partial filling of voxels by more than one medium (air / 
drug / polymer / water). The tablet swelled as water ingressed into the system and the voxels were
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filled with a mixture of dissolved drug and a fraction of polymer, water and air. The mixture of 
drug/water outside the tablet as shown in Figure 5-15(c) was again difficult to define. 
Consequently, it was possible to assign the grey scales of each individual component in the 
heterogeneous system only for a dry tablet using the values obtained from the calibration data. 
Figure 5-17 shows the colour coded images of the dry tablet obtained in Figure 5-15 (a) and (b).
(a) 1 m in
—  drug 
“““ polymer
F ig u re  5-17: C o lo u r  coded im ages o f (a) h o r izo n ta l s lice and (b) v e rt ic a l s lice  o f the 
d ry  25% (w/w) d rug  loaded E u d ra g it  tab lets show n in  F ig u re  5-15(a) 
and (b).
The components in the dry tablet were successfully assigned giving black for air, red for drug and 
green for polymer. The colour coded images revealed that (25 ± 0.5)% of the system was drug, 
which was a reasonable approximation, uniform distributed within the tablet and that the porosity 
of the system was very low as not much air was present in the sample.
Another set of static dissolution experiments were conducted according to the method in Chapter 
3 Section 3.2.5.1 where the wet sample was exposed to water for 60mins. The excess reservoir of 
water was removed and scans were acquired immediately using the same parameters in order to 
observe any effect in the morphology of the matrix. Figure 5-18 shows exemplar 2D colour coded 
images of dry and wet tablets. The wet sample were left to dry for 2.2 days. During that time the 
images were recorded. The acquisition time of each scan was approximately 8hrs and the 2D 
images were central slices extracted from a three-dimensional data set during that time. The 
images in Figure 5-18 are labelled with the acquisition time of each scan.
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D ry:8hrs D r y : l6hrs ^
D ry:39hrs Dry:54hn> /n
1m m
F ig u re  5-18: X - ra y  //C T  im ages o f  a 25%  (w/w) d rug  loaded E u d ra g it  tab le t. V e r t ic a l 2D  
slices (10//m) o f a (a) d ry , and wet tab le t le ft to d ry  fo r (b) 8hrs, (c) 16hrs, (d)
31hrs, (e) 39hrs and (f) 54hrs. Im age area 5.12 x 5.12m m 2.
The dry colour coded image shows that the drug was uniformly distributed throughout the tablet. 
The images obtained for the wet tablet left to dry revealed two distinct regions in the sample. One 
outer region showed where the water had ingressed into the tablet and an inner second region, 
where it had not and the morphology of the tablet remained unaltered. It can be inferred that the 
ingress of water into the system proceeded with a sharp diffusion as seen from the separation of 
the two regions which was well defined. This agrees with the results obtained from the MRI 
imaging experiments (see Figure 5-1). The colour coded images suggested that water had fully 
penetrated into the system with undissolved drug left in the tablet, which can be seen from the 
early drying stages (image (b)) where water (blue) and drug (red) dominated the inner region of 
the tablet. It can be assumed that water had gone into the system but there was not sufficient time 
and amount of water, in the whole system, to allow the full dissolution of the drug to take place. 
This compares well to the observation made in the MRI experiments that initially water rushed in 
across the whole tablet very quickly followed by slower dissolution of the tablet. The histograms 
(Figure 5-16) obtained for each component showed that the polymer and water grey scales 
overlapped and hence at these values it was difficult to identify accurately the specific 
components. This interfering region corresponded to the light blue colour in the colour coded 
images that dominated both regions in the beginning of the experiment as seen in image(b).
It can be observed that the morphology of the sample changed completely with time. The outer 
region became very porous presumably due to evaporation of water. In the inner region there was
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accumulation of drug at the edges with time. It can be assumed that initially water dissolved some 
of the drug. The drug was then carried to the surface by water. However, there was not sufficient 
time to continue the release of the drug out of the system as by the end of the experiment most 
water evaporated leaving the drug at the edges. Similar effect was observed at the top surface of 
the tablet where image(f) showed evidence that the drug had moved at the surface possibly 
attempting to egress out of the system. The deformation of the top left surface of the wet tablet 
was caused by the needle used to remove the excess reservoir of water from the top.
5 . 2  M o d i f y  S t a n d a r d  S y s t e m
The dissolution mechanism of the drug was studied as a function of manufacturing parameters. 
These parameters included, the drug loading, polymer and drug particle size, the degree of 
compression of the tablet, and at the last stages, the incorporation of a third highly soluble 
component in the matrix and the use of a different type of polymer. All the experiments were 
conducted on tablets compressed at 2tons (0.303GPa) under static dissolution conditions.
5 . 2 . 1  W a t e r  i n g r e s s  i n t o  t a b l e t s  c o n t a i n i n g  d i f f e r e n t  d r u g  l o a d i n g s
Tablets containing different amounts of drug loading were examined in order to observe the effect 
on water diffusion in the system. Figure 5-19 shows exemplar 'H 2D MRI images of tablets 
containing 15% (w/w), 35% (w/w), 55% (w/w) and 75% (w/w) drug load prepared according to 
the method in Chapter 3, Section 3.2.3.2 and acquired with parameter sets listed Section 3.2.3.1. 
Each image took approximately 9mins to acquire.
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3mm
F ig u re  5-19: ’ H  M R I  2D  im ages o f  E u d ra g it  tab le t con ta in ing  (a) 15%  (w/w) so lub le  d rug , (b) 
35%  (w/w) so lub le  d rug , (c) 55%  (w/w) so lub le  d rug  and (d) 75%  (w/w) so lub le  
d rug , com pressed at 2tons.
The images are presented and understood in a manner analogous to that discussed for the standard 
system in Figure 5-1. The 2D images of all the samples showed that water ingressed into the 
system with a sharp diffusion front. For the high drug content tablets (> 45% (w/w) drug load) the 
ingress of water appeared to be very fast, sometimes resulting in the destruction of the tablet, that 
fell to the bottom of the NMR tube. This can be seen in Figure 5-19(c) and (d) where by the end 
of the run a uniform bright area is observed throughout the sample indicating only the presence of 
water. On the other hand, the ingress of water in the low drug content tablets (< 45% (w/w) drug 
load) proceeded in a much slower rate and without any immediate effect on the structure. The 
images showed evidence that the swelling of the sample matrix was more dominant for tablets 
with high drug content (> 45% (w/w) drug load). These have a dome like shape also observed in 
the standard system in Figure 5-1. The experimental data suggested that the 55% (w/w) drug 
loaded tablet swelled approximately 31%, obtained similarly to Figure 5-2, compared to 14% for 
the 35% (w/w) drug loaded tablet, derived from the intensity profiles.
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The transport diffusion coefficient of water, £>,(H20), in each sample was estimated from the plot 
of the distance of water ingress into the tablet against square root of time, as discussed in Section
5.1.3.2. The results are summarised in Table 5-3 and presented in Figure 5-20.
T ab le  5-3: D ,(H 20 )  o f  the d iffe ren t d ru g  loaded E u d ra g it  tab lets.
% Drug load (w/w) A (H 20 )  x10‘6 (cm2/s)
15 0.9 ± 2%
35 1.2 ±3%
45 1.8 ±3%
55 9.6 ± 3%
75 23.0 ±4%
(a) Distance o f water ingress against Time
0.20
0.15
0.10
0.05
0.00
• 15% Drug
• 35% Drug
• 45% Drug
• 55% Drug
• 75% Drug
(b)
25
~£ 20 o
U  15 o
JL io o
£  5
TO
D, (H20 )  vs. % Drug load (w/w)
10 20 30 40 50
% Drug load (w/w)
60 70
F ig u re  5-20: P lo t o f (a) d istance o f  w a te r ingress aga inst T im e 12 fo r  ca lcu la t in g  the Z>,(H20 )  o f  the 
d iffe ren t d rug  loaded E u d ra g it  tab le ts and (b) Z>XH20 )  against %  D ru g  load (w/w).
The data revealed that the diffusion of water correlated with the drug loading in the tablet as the 
higher the drug load the faster it diffused. For the 75% (w/w) drug load the diffusion of water was 
very fast (as seen from the images) with an estimated Z),(H20 ) value close to that of the bulk water 
(2.5xl0 '5 cm2/s).
As the front advanced according to “Fickian like” diffusion the Boltzmann’s transformation 
analysis was applied to all the intensity profiles obtained from the images in Figure 5-19 and an 
example of a low and a high drug loaded tablets is shown in Figure 5-21.
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(a) 35% drug loaded Eudragit Tablet 
Profde
• 18mins
• lOSmins
• 150mins
• 204mins
• 252mins
• 306mins
• 354mins
-5.00E-04 -2.50&04 O.OOE+OO 2S0&04 5.00E-04 7.50E-04 1.00E-03 
rj (cm/sm)
(a) 55% drug loaded Eudragit Tablet 
Profile
• 9mins
• 18mins
• 27mins
• 36mins
• 45mins
• 54mins
• 63mms
-1.00E-03 O.OOE+OO 100E-03 2.00E-03 3.00E-03 400E-03
T) (cm/sia)
35% Drug loaded Eudragit tablet
O.OOE+OO 250E-04 5.00E-04
T) ( c m /s ‘ a )
(b) 55% Drug loaded Eudragit tablet
-1.00E-03 -5.00E-W O.OOE+OO 5 00E-04 1.00E-03 1 50E-03 2.00E-03 2.50E-03 
rj (cm/s,a)
(c) 35% Drug loaded Eudragit tablet
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10+
10‘
10+
10+
10+
(C) 55% Drug loaded Eudragit tablet
C
=
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% Concetration of water
20 30 40 50 60
% Concetration of water
F ig u re  5-21: B o ltzm a n n ’ s tra n s fo rm a tio n  ana lys is  fo r  the 35%  (w/w) and 55%  (w/w) d rug  loaded 
tab lets; (a) in ten s ity  p ro f ile s  data, (b) %  C o ncen tra tio n  o f  w a te r vs. p and, (c) d iffu s ion  
coe ffic ien t o f w a te r in  tab lets as fun c tion  o f concen tra tion .
The data were interpreted similarly to the standard system discussed in Section 5.1.3.2. For both 
examples the estimation of the drug fraction in the tablets was subject to the limitations discussed 
for the Boltzmann’s transformation (Section 5.1.3.2). For the 35% (w/w) drug loaded tablet the 
results suggested that the drug fraction was roughly 33% with approximately 40% of water in the 
tablet and a Z)f(H20 ) in the order of 10‘6-10~7cm2/s. For the high drug content tablet problems in 
the Boltzmann’s transformation analysis were encountered, as shown from the shape of the data in 
Figure 5-21(b) due to the fast penetration of water into the system and to the higher degree of the 
swelling in the tablet. Careful analysis suggested that the drug fraction was 54% and 
approximately 66% of water had gone into the system. The £>,(H20 )  is in the order of 
10° -10'6cm2/s, faster than the lower content tablet.
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The experiments showed that changing the amount of drug in the system had an immediate effect 
to the diffusion of water into the sample. The higher the amount of drug (> 45%) the greater the 
A(H 20 ) and also the bigger the swelling of the tablet compared to the low drug content tablets.
5 . 2 . 2  W a t e r  i n g r e s s  i n t o  d r u g  l o a d e d  E u d r a g i t  t a b l e t s  w i t h  d i f f e r e n t  p a r t i c l e  
s i z e  c o m p o n e n t s
‘H MRI experiments were carried out on drug loaded tablet having different particle size 
components for both polymer and drug in order to observe the effect of particle size on 
dissolution. The experimental parameters and samples studied are listed in Chapter 3 Table 3-4. 
The 'H 2D images revealed that in all the samples water ingressed into the system with a sharp 
diffusion front followed by a swelling of the matrix. The D,(H20 )  of each sample was again 
estimated from the plot of the distance of water ingress to the square root of time as shown in 
Figure 5-22 and the results are summarised in Table 5-4.
D ,(H 20 )  fo r tablets with different particle sizes
•  45% drug load:
Drug = small
•  45% drug load:
Drug = medium
•  45% drug load:
Drug = large
•  25% drug load:
..............................
Drug = mediurr
0 50 100 150 200 250 300 350™ 1/2 f 1/2.Time (s )
F ig u re  5-22: Z),(H20 )  o f  d ru g  loaded E u d ra g it  tab le ts w ith  d iffe ren t p a rt ic le  size com ponents.
T ab le  5-4: Z),(H20 )  o f tab lets w ith  d iffe ren t p a rt ic le  size com ponents.
P a rt ic le  size: S m a ll (<45/xm), M e d iu m  (45-180//m) and L a rg e  (>180//m).
Particle size
D,(H20 )  xlO'6 (cm2/s)
Drug Polymer
/o urug (w/w)
Small Large 45 1.9 ±4%
Medium Large 45 0.8 ± 4%
Large Small 45 0.3 ± 3%
Medium Medium 25 0.6 ± 3%
The data obtained showed that there was an apparent effect of the particle size on dissolution as 
small drug particles allowed water to ingress diffused faster as indicated by the higher diffusion 
constant. This was also confirmed from the Boltzmann’s transformation analysis of all the
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intensity profiles of the samples. Figure 5-23 shows exemplar data sets of tablets with of small 
and large drug particle size.
(a)
£ 0.04
45% drug loaded Eudragit tablet 
small drug - large polymer particle size 
Profile
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(a) 45% drug loaded Eudragit tablet
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(b) 45% drug loaded Eudragit tablet 
small drug - large polymer particle size
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45% Drug loaded Eudragit tablet 
large drug - small polymer particle size
20 30 40 50 60
% Concetration of water
F ig u re  5-23: B o ltzm a n n ’ s tra n s fo rm a tio n  ana lys is  fo r  45%  (w/w) loaded tab lets cons isting  o f 
d iffe ren t p a rt ic le  size com ponents; (a) in tens ity  p ro file s  data, (b) %  C o n cen tra tio n  o f 
w a te r vs. 77 and, (c) d iffu s io n  coe ffic ien t o f  w a te r in  tab lets as fun c tion  o f concen tra tion .
Figure 5-23 (a) shows that water fully invaded the tablet with smaller drug particles in less than 
half the time compared to the larger drug particle. The two samples had similar drug fractions but 
the transformed and smoothed data (Figure 5-23(b)) suggested that in the tablet with the smaller 
drug particles more water had gone into the system, approximately 47% as opposed to 40% for 
the larger drug particle size tablet. The estimations were subject to the limitations discussed for 
the Boltzmann’s Transformation in Section 5.1.3.2. Finally, the A(H 20 )  of the two sample 
demonstrated that the smaller the drug particles the faster the water diffusion as for small drug
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was in the order of 10'6-10'7cm2/s whereas for large drug particles was 10‘7-10'8cm2/s. This 
seemed sensible as large particles with less surface area per unit volume takes longer to dissolve.
It was possible to measure the time required for a single drug particle to dissolve and so to 
determine the dissolution constant of the drug. The dissolution constant of drug particles with size 
>180//m was estimated using optical microscopy. A single drug particle was placed under the 
microscope. The particle was exposed to water and snapshots of the particles dissolving with time 
were recorded. The decreasing size of the particle was measured from the snapshots for each time 
and the change of its size was plotted against that time to estimate the dissolution constant. An 
example is shown Figure 5-24 with the corresponding graph of size against time.
Time required for a single drug particle 
to dissolve in water
60 80 
Time (sec)
F ig u re  5-24: (a) O p t ic a l m ic rog rap h  o f d ru g  p a rt ic le  w ith  size over 180/xm, (b) tim e requ ired  fo r  a 
s ing le  d ru g  p a rt ic le  to d isso lve  in  w ater.
The graph showed that the total time for the particle to dissolve was approximately 2mins. The 
dissolution constant was estimated from the gradient of the dotted line and found to be equal to 
5xl0'3cm/s ± 3%. This information was subsequently used for modelling the dissolution 
mechanism.
5 . 2 . 3  W a t e r  i n g r e s s  i n t o  p o l y m e r  t a b l e t s  w i t h  d i f f e r e n t  c o m p a c t i o n  l e v e l s
The effect of the pressure in the ingress of water into the system was also examined by conducting 
experiments on tablets prepared with different compression levels. These experiments were 
completed on polymer tablets prepared according to the method in Chapter 3 Section 3.2.3.2. 
Figure 5-25 and Figure 5-26 show exemplar 'H 2D MRI images of 100% Eudragit tablets 
compressed at O.ltons (0.015GPa) and 3tons (0.455GPa) respectively with the intensity profiles. 
Data for each sample were acquired for four consecutive days and here images recorded after 
17mins and 3days for Eudragit tablet at O.ltons and after 17mins and 3.8days for Eudragit tablet 
at 3tons are presented. Each image took 17mins to acquire.
108
Chapter 5: Imaging studies o f drug release from a solid polymer matrix
3 m in
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F ig u re  5-25: ‘H  M R I  2D  im ages o f  100%  E u d ra g it  tab le t com pressed at O .lton s and exposed to w a te r 
at 17m ins and 3days. In tens ity  p ro file s  show  an en la rge  reg ion  o f  the tab le t extracted  
fro m  the 2D  images.
0 0.1 0.2 0.3
Position (cm)
F ig u re  5-26: *H M R I  2D  im ages o f  100%  E u d ra g it  tab le t com pressed at 3tons and exposed to w a te r 
at 17m ins and 3.8 days. In tens ity  p ro f ile s  show an en large reg ion  o f  the tab le t extracted  
fro m  the 2D  images.
The images show the tablet (dark band) exposed to water (bright region) from both surfaces. The 
intensity profiles extracted from the images suggested that after 17mins of exposure the intensity 
of water in the low compressed tablet was significantly higher compared to the high compressed 
tablet, which reached that level after more that 3days. The intensity of the water signal of Eudragit 
tablet at 3tons compares well with that obtained for Eudragit tablet at 2tons in Figure 5-4. Hence, 
Eudragit tablet at O.ltons was more permeable to water as there was more air space between the 
grains to absorb the water due to lower compaction. This adds to the first observation that initially 
water rushed in across the whole tablet very quickly (Figure 5-9) but the rate and amount is 
presumably affected by the degree of compaction. In both experiments no significant swelling 
was observed.
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The T] weighed images of the Eudragit tablets were acquired for an array of saturation delay 
times according to the method in Chapter 3, Section 3.2.3.2. Intensity profiles were extracted from 
the resultant magnitude Fourier transformed images at different locations in the image. The 
intensity of bulk water and polymer were recorded at these specific locations and plotted against 
the saturation delay time (Chapter 3, Section 3.2.3.2). An example is shown in Figure 5-27.
Intensity of water and polymer for Eudragit tablet 
compressed at O.ltons and 3tons after 2 days in water
x (ms)
Figure 5-27: Plot of intensity of water and polymer extracted from specific location in the 
image (raw 276) for Eudragit O.ltons and 3tons exposed to water after 2 days.
The graph shows that after 2 days of water exposure the intensity of water in the polymer for the 
Eudragit tablet at 3tons was less compared to Eudragit tablet at O.ltons suggesting higher fraction 
of water present in the second. Similar observation to that made from the intensity profiles in 
Figure 5-25 and Figure 5-26.
Similar plots to Figure 5-27 were obtained for all the images recorded for the Eudragit tablet 
compressed at 3tons. The data were fitted to an exponential recovery in order to determine the Tj 
relaxation time of the polymer.
M{r)=Com„+M 1 -e x p
\ \r
Tx
5-5
J)
Matching the Ti values of the polymer tablet with the values obtained from the spatially 
equilibrated samples could lead to the estimation of the water fraction in the tablet. However, this 
estimation was not possible, as there was a noticeable difference between the Ti values of the 
compressed tablet and the equilibrated samples (Chapter 4, Section 4.1.1.3). The fraction of water 
in the tablet was determined from the amplitudes of water and tablet obtained from the 
exponential fit used to extract the Ti of the tablet. The amplitude of the water data fit 
corresponded to just bulk water. On the other hand the amplitude of the tablet data fit 
corresponded both to a fraction of water and a fraction of polymer, with the latter showing no 
signal. So the fraction of water in the tablet was estimated from Amplitude1 Iablet] / Amplitude[Water].
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A summary of the water and tablet amplitudes from each fit, the H20  fraction and the Ti of the 
polymer obtained from a location near the centre of the tablet are listed in Table 5-5 .
Table 5-5: Amplitude of water and polymer from exponential fit, H20  fraction of the 
polymer and T3 relaxation time of polymer.
Amplitude1'™611 Amplitude|Tabletl Mass Fraction of H20 Ti (+2ms) of polymer
2.54 0.06 0.02 1750 (@ 17mins)
2.54 0.08 0.03 880 (@ lday)
2.55 0.12 0.04 1020 (@ 2days)
2.59 0.20 0.07 1460 (@ 3 days)
2.54 0.23 0.09 1498 (@ 4days)
Figure 5-28 shows the plot of Tj and fraction of water in the polymer, over the whole period of 
measurements.
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Figure 5-28: T! of polymer for 100% Eudragit tablet compressed at 3tons vs. H20  
mass fraction.
Figure 5-28 shows similar behaviour with that discussed for the equilibrated sample in Chapter 4 
Figure 4-7 but with different Tj values. The Ti relaxation time obtained for the equilibrated 
samples corresponded to an effective Ti value of polymer and water as discussed in Chapter 4 
Section 4.1.1.3. The difference of the Ti values between the equilibrated samples and the tablet 
may be due to various reasons. A plausible suggestion would be that the values here were 
obtained from non-equilibrated compressed tablets where the water was probably spread between 
the grains of the powder giving average longer Ti values.
The surface of dry Eudragit tablets compressed at O.ltons and 3tons were examined under the 
microscope. An example of the optical micrographs obtained under reflected illumination is 
shown Figure 5-29.
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Figure 5-29: Optical micrograph of the surface of a (a) Eudragit tablet compressed at O.ltons and (b) 
Eudragit tablet compressed at 3tons, under reflected illumination
The surface of the Eudragit O.ltons tablet appeared have small cavities whereas the polymer 
particles on the surface of the Eudragit 3tons tablet seemed to be more close together with a better 
defined surface due to higher pressure. The surface of both tablets seemed to be rough.
5.2.4 W ater ingress into drug loaded Eudragit tablets incorporating a third 
component in the sample matrix
A highly soluble component was added to the standard system in order to observe the effect on 
the dissolution of the drug. The third component in the matrix was Sucrose and the 
Sucrose/Eudragit/Dz'/riazew HCl tablets prepared according to method in Chapter 3 Section
3.2.3.4 were exposed to water. Figure 5-30 shows exemplar ‘H 2D MRI images of a tablet 
containing 10%(w/w) Sucrose / 45% (w/w) Drug / 55% (w/w) Polymer, acquired with the 
parameter sets listed in the same section, exposed to water. The acquisition time of each image 
was approximately 9mins. The tablet was made up of two layers according to the method in 
Chapter 3 Section 3.2.4.1.
3mm
'ySr ■* * a
9nnns 4.5hrs 9.41ns 14hrs lS.Shrs
Figure 5-30: 'H MRI 2D images of 10% (w/w) Sucrose / 45% (w/w) Drug / 55% (w/w) Polymer 
loaded tablet exposed to water.
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The 2D images show the water ingressed into the system with a sharp diffusion front. Images 
suggested that there was no apparent effect on the shape of the matrix as observed for the high 
drug loaded tablet (> 45% (w/w) drug load) in Figure 5-1 and Figure 5-19(c) and (d). There was 
evidence of water signal at the back end of the tablet (above the 100% Eudragit layer) after 9mins 
of water exposure indicating the rapid capillary uptake of water to the porosity of the matrix. This 
can also be observed from the 9mins intensity profile in Figure 5-31, where there is an increase in 
the intensity value in the lower layer of the matrix (the tablet is between 0 and 0.32cm). The dry 
intensity profile was taken from the 100% Drug tablet intensity profile in Figure 5-6. The swelling 
of the matrix was estimated from the intensity profile extracted from the images
10%(w/w) Sucrose/45%(w/w) Drug/55%(w/w) Polymer 
tablet
Position (cm)
Figure 5-31: AH MRI one-dimensional profiles extracted from the central region of images 
obtained for the 10%(w/w) Sucrose / 45% (w/w) Drug / 55% (w/w) Polymer 
tablet in Figure 5-30 exposed to water for 9inins and 18.8hrs.
The vertical profiles showed the tablet exposed to water from both surfaces with the upper 
water/tablet interface at 0cm and the lower interface at 0.32cm. The 18.8hrs profile indicated that 
water ingressed into the system as there was an increase in intensity in the central band. The 
increase in the width of the tablet after 18.8hrs of water exposure was measured suggesting that 
the tablet swelled at most 6%. Similarly, for a-30% (w/w) sucrose load the tablet swelled about 
12% which compares with low drug content (35% (w/w)) results in Section 5.2.1. The water 
ingressed with a sharp diffusion front which proceeded as a square root of time leading to the 
estimation of the transport diffusion coefficient of water, D,(H20 ) as in Figure 5-11(b). A 
summary of the values are in Table 5-6 with the corresponding graph in Figure 5-32.
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Table 5-6: Z>,(H20) of Sucrose / 45% (w/w) Drug / 55% (w/w) Polymer loaded tablets.
% Sucrose load (w/w) A(H20) xlO'6 (cm2/s)
5 0.69 ± 2%
10 0.7 ± 2%
20 0.7 ± 4%
30 1.2 ±4%
Three component matrix 
Sucros e-D rug-Poly me r
rr. 1/2 , 1/2.Time (s )
Figure 5-32: Z)^ H20) of tablets containing three components: Sucrose-Drug-Polymer.
The diffusion coefficient of water suggested that the higher the percentage of sucrose in the 
sample matrix, with constant drug/polymer ratio, the faster the ingress of water into the matrix.
5.2.5 W ater ingress into drug loaded Eudragit tablets exposed to water using 
Eudragit RLPO as polymer
MRI experiments, under static conditions, were conducted on tablets containing Eudragit RLPO 
as a solid polymer matrix instead of Eudragit RSPO. Both polymers are permeable in aqueous 
media due to the presence of quaternary ammonium groups in their structure as discussed in 
Chapter 3, Section 3.2.3.5. Eudragit RLPO has a greater proportion of these groups and so is more 
permeable than Eudragit RSPO. Figure 5-33 shows exemplar 'H MRI 2D images of a 55% (w/w) 
drug loaded Eudragit RLPO tablet prepared according to the method in Chapter 3 Section 3.2.3.5 
and acquired with parameters listed in Section 3.2.3.1. Each image took approximately 9mins to 
acquire. The tablet was exposed to water only from the top surface.
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Figure 5-33: 'H MRI 2D images of 55% (w/w) drug loaded Eudragit RLPO above 100% Eudragit 
layer exposed to water only from the top and compressed at 2tons.
The MR images showed the ingress of water followed by the swelling of the sample matrix. The 
distance of water ingressed was measured as a function of time (ti/2) to estimate the diffusion 
coefficient of water, Z),(H20). It was found to be approximately 10.2xl0'6cm2s'1 ± 2%. The 
diffusion coefficient of water obtained for an equivalent drug loaded Eudragit RSPO tablet was 
9.6xl0'6cm2/s ± 3% (see Table 5-3), suggesting faster diffusion of water into RLPO systems. Oth 
and Moes [Oth and Moes, 1989] studied the sustained release of solid dispersions of indomethacin 
from Eudragit RS and RL in buffer solutions where the release profiles of the drug were fitted to 
the square root of time. They observed that solid dispersions prepared with Eudragit RS gave 
slower release rates than those with Eudragit RL. This seemed reasonable due to the structure of 
the polymer as it was more permeable to water. The total change of tablet height over time was 
measured and compared with the equivalent drug loaded Eudragit RSPO tablet from Figure
5-19(c). Figure 5-34 shows the resulting graphs where the height in both tablets was determined 
by taking an average value of the increased height across the length of the tablet at each time 
point measured from the top surface of the tablet.
55% drug loaded Eudragit RLPO and RSPO tablet
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Figure 5-34: Increase of tablet size with time for 55% (w/w) drug loaded Eudragit 
RLPO and RSPO tablets.
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The difference in the experimental times was due to Eudragit RSPO tablet being exposed to water 
from both surfaces as seen in Figure 5-19(c). The data analysis revealed that by the end of the 
experiment the Eudragit RLPO tablet swelled about 38% compared to the 31% of Eudragit RSPO 
tablet. This was probably related to the different type of polymer.
In order to validate this assumption the 'H MRI 2D images of a 100% Eudragit RLPO tablet 
exposed to water were obtained as shown in Figure 5-35. Each image took 17mins to acquire.
12hrs 24hrs 1 .Nilas s 2.6days
3mm
Figure 5-35: ’H MRI 2D images of 100% Eudragit RLPO tablet exposed to water and compressed at 
2tons.
Figure 5-36 shows the vertical profiles at 17mins and 2.6 days extracted from the central region of 
the MRI images. The dry profile was taken from the 100% Eudragit RSPO tablet in Figure 5-4.
-0.1 0 0.1 0.2 0.3 0.4
Position (cm)
Figure 5-36: 'H MRI one-dimensional profiles extracted from images in Figure 5-35 for 
17mins and 2.6 days.
Figure 5-36 suggests that after 17mins of water exposure there is a substantial increase in the 
signal intensity within the tablet (between 0.01 and 0.31cm) compared to the dry tablet indicating 
that water diffused into the system quite rapidly. There is a further increase in the intensity until 
the end of the experiment, which is not significant suggesting that most of the water invaded the 
matrix in 17mins. The width of the tablet had changed indicating that it had swelled at most 6% 
compared to the 4% of Eudragit RSPO. So data suggested that there was an increase in the length 
of the 100% Eudragit RLPO but the percentage was small compared to the drug/polymer matrix.
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5.3 Modification to the environment of the standard system
The previous experiments identified the effect on the dissolution mechanism of the drug as a 
function of the manufacturing parameter of the standard system when the sample was exposed to 
water. The effect on dissolution mechanism was also examined by changing the environment to 
which the tablet was exposed to. In the subsequent experiments the samples were made up of a 
layer of drug loaded Eudragit RSPO above a 100% Eudragit RSPO, which provided structural 
integrity as the experiment proceeds, and compressed at 2tons (0.303GPa).
5.3.1 Drug loaded Eudragit tablets exposed to water under dynamic 
dissolution conditions
MRI experiments revealed that the dissolution of the drug from a sample matrix exposed to water 
under static dissolution conditions was a slow process. In order to initiate the faster drug egress 
the sample was exposed to a continuous flow of tap water over its surface. The dynamic 
dissolution experiments enabled the determination of the amount of drug in solution and the rate 
at which the drug diffused out of the system. Figure 5-37 shows exemplar 'H 2D MRI of 55% 
(w/w) drug loaded tablet prepared according to the method in Chapter 3, Section 3.2.4.1 exposed 
to a slow, but continuous flow, in the order of 4.6ml/min, of tap water. Each image took 
approximately lOmins to acquire, with parameters listed in Chapter 3, Section 3.2.3.1. The first 
image was recorded 1 Omins after the water started flowing over the sample.
Figure 5-37: 'H MRI 2D images of a 55% (w/w) drug loaded Eudragit tablet exposed to water under 
dynamic dissolution conditions.
The 2D images show that the ingress of water proceeded with a sharp diffusion front with no 
evidence of image distortion from the continuous flow of water. After two hours most of the water 
had penetrated the tablet followed by swelling of the system. The images recorded at 56mins and 
2.2hrs indicated two regions in the tablet. One region at the top of the sample shows clearly the 
water in the tablet. The second in the middle of the tablet just above the Eudragit layer shows the 
rapid capillary uptake of water to the open porosity of the tablet ahead of the primary dissolution.
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The diffusion coefficient of water, Z)f(H20), was estimated as in Figure 5-11 and was 
approximately 2.3x 10 ' W s '1 ± 2%. Similarly, the diffusion coefficient of water obtained for an 
equivalent drug loaded Eudragit tablet under static condition (see Section 5.2.1) was estimated to 
be 9.6xl0'6cm2s'1 ± 3%. This difference may be due to the slow flow rate of water above the 
surface of the tablet. The FID of the water samples collected every hour was recorded but did not 
show evidence of the drug. Thus, similar dynamic experiments were conducted using a greater 
water flow rate so as to achieve detecting drug in water. Figure 5-38 shows exemplar ]H 2D 
images of such experiment with flow rate of 32ml/min.
Figure 5-38: 'H MRI 2D images of a 55% (w/w) drug loaded Eudragit tablet exposed to water under 
dynamic dissolution conditions with high flow rate.
Figure 5-38 shows that the imaging experiments were affected by the high flow rate but still the 
water region remained visible. There are flow artefacts as flow corrupts the phase encoding of the 
MR signal. The FID of the collected samples was recorded but again it was not possible to 
determine the drug content in the solution. Probably the concentration was too small and as the 
water signal dominated the 'H spectrum of the drug solution as seen also in Chapter 4 Figure 4- 
10(b), it was difficult to obtain a signal for the drug. For this purpose, UV spectroscopy was used 
as an alternative technique.
5.3.1.1 Determination of drug content in solution using UV spectroscopy
The UV absorbance of the samples collected from the MRI dynamic dissolution experiments at 
different time points was measured in order to estimate the drug concentration in solutions. 
Calibration measurements were conducted on solutions of known drug concentrations according 
to the method in Chapter 3 Section 3.2.6 as shown in Figure 5-39.
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Figure 5-39: (a) Absorbance of standard drug solution vs. wavenumber, (b) absorbance of standard 
drug solution vs. standard concentration.
Calibration showed that standards were in a very good agreement. The absorbance values of the 
standards were used to normalise the data obtained from the collected samples and estimate the 
drug content in solution. Figure 5-40 shows the results of three distinct experiments of 55% (w/w) 
drug loaded tablets with different water flow rates.
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(c) Exp. 3: 55% (w/w) drug loaded tablet 
(wavenumber 273nm)
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Figure 5-40: %Drug concentration in the sample solution over time for three different experiments 
with flow rates of (a) 17.6ml/min, (b) 32ml/min and (c) 8ml/min.
The volume of the drug was estimated by integrating the area under the curve and multiplying by 
the flow rate. From Figure 5-40 the total volume of drug released was; (a) 0.02cc, (b) 0.08cc and 
(c) 0.07cc. The actual volume of drug in the 55% (w/w) tablet was 0.08cc. Experimental results 
compared well with the expected volume apart from the first experiment (Figure 5-40(a)) the run 
time of the experiment was short compared to the Exp. 2 and Exp. 3 in Figure 5-40. The results
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indicated that the drug was released and it was a process that took approximately 24hrs. Figure
5-40 illustrates that the shape of the line demonstrating the drug release is a ‘noisy’ line, 
especially in Exp.l and Exp.2. This might be due to flow rate fluctuations during the experiment. 
Controlling the flow rate and keeping it completely constant was a difficult process as there was 
no actual visibility of the sample cell since it was inside the magnet as shown in Chapter 3, Figure 
3-10. The water travelled in and out of the system using long rubber tubing, more than a meter in 
both directions, due to the size of the magnet. Given that the water had to travel such long 
distances before it was collected it can be assumed that some of the drug particles were released, 
dissolved and finally diluted by the high amount of water. The experimental results showed that it 
was feasible to detect the drug in solution. However, it was deemed necessary to improve the 
experiment setup so that it would be possible to perform the analysis in a more controlled 
environment. The drug content in the solution surrounding the tablet was also determined by 
NMR spectroscopy.
5.3.1.2 Determination of drug content in solution using NMR spectroscopy
The UV spectroscopy results were correlated with NMR spectroscopy experiments. A static 
dissolution experiment was set up according to the method in Chapter 3, Section 3.2.6 by 
exposing the top surface of a 55% (w/w) drug loaded Eudragit tablet to water. The 'H NMR 
spectrum of the solution above the tablet was recorded periodically, in order to determine the 
amount of drug released over that period. The proton spectrum of a 29% (w/v) drug solution, as 
shown in Chapter 4, Figure 4-10(b), was used to normalise the data. The -CH3 groups of the drug 
molecule in the spectrum have already been assigned from the CYCLCROP experiments 
discussed in Chapter 4, Section 4.2. The intensity of each drug peak was determined from the 
peak areas in the ‘H spectrum. Figure 5-41 shows the results of two different experiments.
For both experiments the final percentage concentration of drug in solution was approximately 
1.6%. The volume of the liquid above the tablet was 6mls resulting in the total volume of drug 
released to be approximately 0.09cc. This was again in reasonable agreement with expectation, 
which was 0.08cc. Figure 5-41(a) shows that the drug was released giving two distinct gradients
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whereas in the second experiment the release was initially slow but then it advanced with a 
straight line until it finished. For both experiments the area of the water peak remained reasonably 
constant.
Based on the above analysis it was possible to determine the transport diffusion coefficient of the 
drug. A standard system was assumed, with the tablet exposed to water from one side. A simple 
diagram showing the water going into the system is presented in Figure 5-42.
0% drug end of tablet29% drug
Saturated
solution
Figure 5-42: Simple diagram of sample matrix exposed to water from one side.
The rate of transfer of drug diffusing out of the system is proportional to the concentration 
gradient and so the flux of drug is
F = D 8A
dr
where c corresponds to the maximum concentration of the drug in solution, which was 29% (w/v) 
already determined in Chapter 3, Section 3.2.2.2, r is the distance of water front ingress into the
system, which evidence showed that advanced as square root of time. So r= a t1/2, where a  is the
gradient of the line obtained in Figure 5-11(b). If it is assumed that D was constant and no air 
voids were present in the system then the volume of the drug, Vdrug, was proportional to the 
integral of the flux in equation 5-6:
v^=\Fdt=iDS»dt s-7
According to data in Figure 5-41 and by differentiate equation 5-7 the transport diffusion 
coefficient of drug was estimated to be in the order of 10'7cm2/s.
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5.3.2 X-ray //CT dynamic dissolution experiments
The ingress of water into the system was also visualised using X-ray //CT. In the high resolution 
dynamic dissolution experiments the tablet was exposed to water and images were recorded in 
real-time. Figure 5-43 shows exemplar of 2D reconstructed X-ray //CT images of a 25% (w/w) 
drug loaded Eudragit tablet prepared according to the method in Chapter 3 Section 3.2.5.1 and 
exposed to water. The acquisition parameters are listed in the same section. The scan time of each 
image was 47mins with total experimental run time of approximately 6hrs. Images presented here 
were taken during the time of each sample acquisition. The 2D vertical slices were extracted from 
the middle of a 3D data set.
Figure 5-43: X-ray //CT images of a 25% (w/w) drug loaded Eudragit tablet under dynamic 
dissolution (a) dry and wet (b) 47mins (c) 94mins (d) 141mins (e) 3hrs lOmins (f) 4hrs (g) 
4hrs 47mins (h) 5hrs 34mins. (slice thickness of 10//m). The image area is 5.12mm by 
5.12mm.
Similarly to Figure 5-15 the bright white areas in the dry image(a) corresponded to drug whereas 
the darker grey corresponded to polymer. As water was introduced into the system the density of 
the whole sample changed and it became difficult to distinguish the edges of the tablet due to the 
overlapping grey scales of polymer and water shown in the histograms (Figure 5-16). However, 
the penetration of water into the system was still visible as the region of the bright white drug 
became smaller over time. It was observed that dissolution proceeded slowly with a sharp 
diffusion front, which was consistent with the MRI experiments. Image(h) suggested that full 
dissolution of the drug had not occurred as there was still bright white region left in the bottom of 
the sample by the end of the run.
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The important observation of these dynamic dissolution experiments was the high accumulation 
and growth of air voids in the wet sample with exposure time. The high spatial resolution of the 
X-ray juCT system assessed the feasibility for determining the air void size distribution of the 
samples as it changed with time. As images were extracted from a three-dimensional data set all 
subsequent analysis was carried out in respect to volume so as to obtain data characteristic for the 
whole sample. A subset of the three-dimensional data for each sample was extracted using the dry 
system data set (Figure 5-43(a)) to determine the boundaries over which the analysis was to be 
conducted. The binary threshold of the data was obtained based on the grey-scale values of air 
previously determined from Figure 5-16. The data set was then labelled, assigning each discrete 
volume a unique range of values. The number of voids and their size was determined with a three- 
dimensional void labelling algorithm written in IDL version 6.0 [Jenneson et al, 2004]. The air 
void distribution within the samples was determined by the histograms of the above analysis. The 
resulting graphs of the frequency against the air-void volume size distribution for each exposure 
time are shown in Figure 5-44. The raw data were plotted on a normal and natural logarithmic 
scale for the volume axis.
The experimental data showed that the histogram of the air voids distribution plotted on a natural 
logarithm scale as seen in Figure 5-44 gave a characteristic bell shaped form. It was decided to fit 
the data to a log-normal size distribution as discussed later in Chapter 6 Section 6.1. The log­
normal distribution is a common particle size distribution. A random variance x has a log-normal 
distribution if  its natural logarithm, y = log(x), has a normal distribution (or Gaussian distribution) 
[O’Grady and Bradbury, 1983]. The experimental data shown in Figure 5-44 for the natural 
logarithm plots were fitted to a Gaussian function according to:
where p(lnV) was the probability distribution function of ln(F), with V was the air void volume
shown in Figure 5-44, InF and s were the mean and standard deviation of ln(F). An example 
graph of the lognormal distribution of air voids from a single data set is shown in Figure 5-45.
5-8
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Figure 5-44: Histograms of air void distribution from data in Figure 5-43. Frequency of air void 
against the normal and natural logarithm scale of the air void volume.
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Figure 5-45: Lognormal distribution of air voids of a single experimental data 
(black line) fitted to a Gaussian curve (red line).
It was more convenient to work in terms of just air void volume, V, so as to obtain the actual 
mean and standard deviation of the distribution. The probability distribution function of the 
lognormal distribution of V is given by
f { v )  =
1
V s j l n
exp
(ln F -  ln F j2
2s 2
for V)0 5-9
The mean, F , and standard deviation, a, of F distribution given in terms of mean, ln F , and 
standard deviation, s, of ln(F) are shown below.
F=exp((2 ln F + s 2)/ 2) 
cr = -y/exp(21nF + 2 s 2 )-exp(21nF + s 2)
5-10
5-11
Subsequently, the mean volume of each air void distribution data set was calculated using 
equation 5-10 and plotted against time as shown in Figure 5-46.
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Mean volume of air voids against time
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Figure 5-46: Mean volume of air voids in the sample for the whole experiment against time.
Data showed that the mean volume followed a linear trend with time suggesting that the size of 
the air voids increased over time which seemed reasonable to occur. Data at early time points 
could not be obtained due to resolution limitations as shown also in Figure 5-44.
In order to detect if the voids in the wet tablet were moving the distance of several air-voids 
relative to each other were calculated from their centres of gravity. The distances were measured 
for each image of the dynamic experiment (see Figure 5-43). Figure 5-47 shows the distance 
between two different pairs of air-voids in the tablet and an example of an X-ray pCT image 
labelling the voids used for the calculations.
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Figure 5-47: X-ray //CT vertical slice showing the air voids used to estimate the distance between two 
different pairs of voids over time and the associated graph.
The graph showed that there was only a small, but not zero, motion of voids at the late times in 
the experiment. The model of the air voids formation is discussed in more detail in Chapter 6 
Section 6.1.
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5.3.3 Drug loaded Eudragit tablets exposed to phosphate buffer pH 7.4
‘H MRI 2D images of drug loaded Eudragit samples exposed to phosphate buffer solution pH 7.4 
under static dissolution conditions were conducted according to the method in Chapter 3, Section
3.2.4.2 in order to observe the behaviour of the system in the different dissolution medium. Figure
5-48 shows exemplar 2D images of a 55% (w/w) drug loaded tablet. Each image took 
approximately 9mins to acquire.
V m m s  I 4  5 nuns, I 2.5lirs 7hrs I I l.4lms
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Figure 5-48: ‘H MRI 2D images a 55% (w/w) drug loaded Eudragit tablet exposed to phosphate 
buffer pH 7.4 compressed at 2tons.
The images revealed that the buffer solution ingressed into the system with a sharp diffusion front 
followed by the swelling of the system. The diffusion coefficient of the phosphate buffer solution, 
A(Phos) was estimated with the similar method used to estimate that of the water in Figure 5-11. 
The swelling of the tablet was also determined from the change of tablet height over time (as in 
Figure 5-2)
Figure 5-49: Plot of (a) distance of phosphate buffer ingress against Time12 for calculating the 
D/Phos) and (b) increase of tablet size with time for the 55% (w/w) drug loaded 
Eudragit tablet exposed to phosphate buffer.
The Dt(Phos) was found approximately 9.9x10'6cm2s'1 ± 3% and the tablet swelled at most 29%. 
The analysis suggested that the results were not very different from those obtained for a 55%
127
Chapter 5: Imaging studies o f drug release from a solid polymer matrix
(w/w) drag loaded tablet exposed to water, which had Z),(H20 ) of 9.6x 10'6cm2/s ± 3% and swelled 
at most 31%.
MRI experiments on 55% (w/w) drug loaded tablets were conducted on tablets exposed to 
electrolyte solution. The chosen electrolyte solution in this study was aqueous sodium chloride 
solution (NaCl). The matrix was exposed to two different concentrations: 0.2M and 2M. The 
samples were prepared according to method in Chapter 3 Section 3.2.4.2. Figure 5-50 shows 
exemplar 'H MRI 2D images of 55% (w/w) drug loaded tablets exposed to 0.2M and 2M salt 
solution. The acquisition parameters are listed in Section 3.2.3.1. Each image took approximately 
lOmins to acquire.
3mm
Figure 5-50: MRI 2D images of 55% (w/w) drug loaded tablet exposed to (a) 0.2M and (b) 2M NaCl 
solution.
The images revealed that at low salt concentration the matrix swelled whereas at high salt 
concentration it did not. This was probably due to the charge-screening effect caused by the 
presence salt which is discussed in Chapter 6 Section 6.5.
5.3.4 100% Eudragit tablets exposed to concentrated drug solution
Thus far it was observed that the release of the drug from the high loaded Eudragit tablets (> 45%) 
was associated with the swelling of the sample matrix. Experimental evidence in Section 5.1.1 
confirmed that the neither of the two components, polymer or drug compacts, significantly 
swelled when exposed to water. A 100% Eudragit RSPO tablet was exposed to concentrated drug 
solution prepared in order to rule out the possibility that the swelling was not due to the dissolved 
drug present in the tablet. Figure 5-51 shows exemplar *H 2D MRI images of a 100% Eudragit 
tablet exposed to 29% (w/v) drug solution prepared according to the method in Chapter 3, Section
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3.2.4.3 under static dissolution conditions. The drug was dissolved in copper sulphate solution in 
order to reduce the nuclear spin lattice relaxation time of pure water as described in method in 
Chapter 3 Section 3.2.3.1. Each image took 21 mins to acquire.
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Figure 5-51: *H MRI 2D images of 100% Eudragit RSPO tablet (2tons) exposed to 29% (w/v) drug 
solution under static dissolution conditions.
Figure 5-52 shows the vertical profiles at 21mins and 2.1 days extracted from the central region of 
the MRI images. The dry profile was taken from the 100% Eudragit RSPO tablet in Figure 5-4.
100% Eudragit RSPO tablet
Position (cm)
Figure 5-52: 'H MRI one-dimensional profiles extracted from images in Figure 5-51 
for 21 mins and 2.1 days.
The intensity profiles revealed that the tablet had swelled at most 4% after 2 days of exposure to 
concentrated drug solution. Hence, it can be concluded that the concentrated drug solution had 
virtually no effect on the sample matrix.
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5.4 Discussion
In this chapter manufacturing parameters affecting the release of Diltiazem HCl from solid 
Eudragit matrix were determined in order to understand the dissolution mechanism of the sample. 
It is believed that the total porosity of the highly compressed tablets (2tons) was very low. 
Evidence showed that the porosity of the compact Eudragit was less than 5% and for the drug 
loaded Eudragit matrix was even less in the order of 3%, presumably as the drug is soft and fill 
the pores under compaction. MRI experiments on water exposed drug loaded Eudragit tablets 
showed the uniform ingress of water into the system. The intensity profiles extracted from the 
images revealed that initially the water rushed in across the whole tablet very quickly, in the order 
of less than 10 minutes. This rapid capillary uptake of water into the pore space of the tablets, 
ahead of the primary dissolution, was affected by the compaction level of the tablet as low 
compressed 100% polymer systems absorbed greater amount of water compared to higher ones in 
same exposure times. Subsequently, dissolution process was at a much slower rate accompanied 
by swelling of the sample matrix. The swelling was observed only for the drug/polymer matrix 
with a characteristic dome like shape for the higher drug loaded system (>45% (w/w) drug load) 
and found to be approximately 20%. Virtually no swelling for the 100% Eudragit tablet (about 
4%) and simple dissolution for the 100% ding tablet was observed with a swelling of the matrix in 
order of 6%.
The dissolution proceeded with a sharp diffusion front, which advanced according to “Fickian 
like” diffusion. Therefore, the transport diffusion coefficient of water in the tablet was estimated 
as a function of concentration. This was limited by the dissolution of the drug and saturation of 
the pore space solution. Experimental evidence showed that the rate of water ingress into the 
system was directly related to the amount of drug in the tablet and the particle size of the 
components. The water diffused faster in higher drug loaded tablets (> 55% (w/w drug load) with 
a transport diffusion coefficient in the order of 10‘5cm2/s. Similarly, the MRI experiments 
conducted on tablets prepared with carefully characterised and varied polymer and drug particle 
sizes revealed that water ingressed faster into tablets with small drug particles. This was 
consistent with optical microscopy observations. The effect on water diffusion in systems with 
three components (Sucrose/Eudragit/DzYtinze/M HCl) was also determined. The amount of the third 
highly soluble component (Sucrose) in the system changed the rate at which the water ingress. 
However, in these samples the swelling of the matrix was not visual. Different polymer matrix 
was used, Eudragit RLPO, to observe any effect on dissolution. This type of Eudragit is more 
permeable to water due to its molecular structure. It is more porous and thus allows faster ingress 
of water into the system. Although the imaging experiments suggested higher degree of swelling
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of such matrix, the 100% polymer tablet did not show evidence of any significant swelling in 
water, in the order of 6%.
The egress of drug was followed both by UV and NMR spectroscopy. The UV absoiption of 
samples collected from MRI dynamic dissolution experiments showed that most of the drug was 
accounted for in approximately 24hrs. The resulting curve demonstrating the drug release 
suggested that further experimental development was needed to perform more accurate 
measurements. Thus the data obtained from the static NMR spectroscopy measurements were 
used to interpret the drug egress, which took approximately 5 days. An estimation of the transport 
diffusion coefficient of drug was made and found to be in the order of 10'7cm2/s.
MRI experiments revealed accumulation of air voids in the matrix exposed to water for five days. 
Consequently, high spatial resolution X-ray //CT experiments were conducted to observe the 
microstructure of the system. The experiments revealed that water ingresses into the system with a 
sharp diffusion front and air voids started to accumulate and grow in the sample which agreed 
with findings already seen from MRI experiments. The observation of air-voids ripening within 
the matrix suggested that the accumulation of air voids is a significant process affecting the 
dissolution mechanism of the drug. The X-ray juCT system allowed the air-void size distribution 
to be quantified as it changes over time. The data showed that the mean volume of the air voids 
followed a linear trend with time.
Finally, the sample matrix was exposed to different dissolution environments, phosphate buffer 
pH 7.4 and drug concentrated solution. In the phosphate buffer the system had similar behaviour 
as in water whereas in the concentrated solution virtually no swelling was observed. This 
suggested that the swelling of the system was not due to the saturated drug solution present in the 
sample matrix during dissolution.
A simple schematic diagram of the dissolution model of the sample matrix as discussed above is 
shown in Figure 5-53.
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Figure 5-53: A simple schematic diagram illustrating the dissolution model of the sample matrix.
All the above observations were used to construct theoretical models able to describe the air voids 
formation and the swelling and dissolution mechanism as discussed in Chapter 6.
5.5 Conclusion
In this chapter non-destructive imaging techniques were used to observe the dissolution of drug 
from a solid polymer matrix and the evolving micro-structure of the system during dissolution. 
Different manufacturing parameters were studied such as different drug loading, levels of 
compaction, particle size, matrix type and dissolution environments, which will enable to 
understand the dissolution mechanism of the sample matrix. It is suggested that initially water 
rushed in across the whole tablet very quickly and then dissolution proceeded in a much slower 
rate with a sharp diffusion front that advanced according to “Fickian” diffusion. Subsequently, the 
swelling of the sample matrix was observed only for the drug/polymer matrix since virtually no 
swelling for the 100% Eudragit tablet and simple dissolution for the 100% drug tablet was 
observed. The drug egress was followed both by UV and NMR spectroscopy. The imaging 
techniques of MRI and X-ray //CT have both been used to independently image the ingress of 
water into the system and observe the formation of air-voids in drug loaded Eudragit matrices 
exposed to water. The high spatial resolution of the X-ray //CT system allowed the air-void size 
distribution to be quantified as it changes over time. The mean-volume of the air-voids was 
observed to increase linearly with time.
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C h a p t e r  6
6  T h e o r e t i c a l  m o d e l s  o f  a i r  v o i d s  f o r m a t i o n  
a n d  d i s s o l u t i o n  m e c h a n i s m
In this chapter models are presented to describe the accumulation and ripening of air voids, 
swelling and dissolution mechanism of the sample matrix. The models were developed based on 
the experimental results found in Chapters 4 and 5.
6.1 Model of air voids formation
MRI and X-ray //CT showed evidence that as water ingressed into the tablet there was 
accumulation of air voids in the system. The high spatial resolution of the X-ray //CT experiments 
revealed that these small air voids were ripening to form bigger voids with smaller total surface 
area with time. The results obtained showed three main features; (i) the probability distribution 
function of air voids was broad and well fitted by a log-normal distribution function, (ii) the mean 
volume increased linearly with time and (iii) the voids moved only small distances relative to their 
size at late times.
Attempts to understand the ripening or coarsening of droplets, particles or voids have a long 
histoiy. Many systems have a final equilibrium that has two separate bulk phases but start out 
with the two phases mixed on a small or even microscopic scale. This length scale then increases: 
this process is called Ostwald ripening, it is also referred to as ripening or coarsening. In Ostwald 
ripening, large molecules or clusters of atoms grow in size at the expense of smaller ones, a 
process that continually decreases the total interfacial area of the system [Che and Houyt, 1995]. 
Two main mechanisms have been studied extensively over the years that cause the increase in 
length scale. These include the diffusion of individual molecules or atoms and coalescence.
The theory for the ripening occurring not via coalescence but via diffusion of molecules is well 
developed. It was initially introduced by Lifsbitz, Slyozov [Lifshitz and Slyozov, 1961] and 
Wagner [Wagner, 1961] (LSW) and much work has been done since [Voorhees and Glicksman, 
1984] [Yao et al., 1993], The LSW theory describes a model where the growth of particles or 
voids occurred via continuous diffusion driven by chemical potential gradients. The size
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distribution predicted by the LSW theoiy was a rather narrow distribution with quite sharp decline 
at large sizes as seen in Figure 6-1. The graph was redrawn from [Lifshitz and Slyozov, 1961].
z m
Figure 6-1: The LSW probability distribution. Redrawn from [Lifshitz and Slyozov, 1961].
Figure 6-1 shows the probability distribution of a particle or void in the sample that would have a 
reduced volume Z as a function of Z1/3. The volume was reduced such that particles or voids with 
Z1/3 of 1 neither grew or shrank, while diffusion made the larger particles or voids to grow at the 
expense of the voids with Z1/3 less than 1. The LSW theory also yielded the well known result that 
the cube of the average particle radius (or the volume) increased linearly with time [Che and 
Houyt, 1995].
The second mechanism that causes the increase in length scale is coalescence occurring via 
conventional diffusion of particles or voids into contact by migrating particles or voids in the 
matrix as observed in emulsions. The droplet size distribution in emulsions has been studied by 
different groups and has been well described by log-normal size distribution [Lonnqvist et al., 
1997, McDonald et al., 1999]. Dickinson et al. [Dickinson et al., 1999] studied the Ostwald 
ripening kinetics in «-alkane oil-in-water emulsion stabilised by sodium caseinate to monitor the 
time-dependent changes in the average droplet diameter and droplet size distribution. They 
showed the linear increase of droplet size with time stored.
However, coalescence can be considered as an episodic process where the particles or voids are 
not continuously growing or shrinking by difference in radii but they grow via discrete events, as 
shown in Figure 6-2.
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Figure 6-2: Diagram of coalescence as an episodic process. Increase of droplet or void size by discrete 
events.
This episodic process of coalescence can lead to a log-normal size distribution as the log-normal 
distribution is a generic property and does not necessarily require that particle size distribution is 
due to diffusion of voids into contact.
According to the experimental observations the data were well fitted to log-normal size 
distribution and there was a linear growth of the mean volume with time. The linear growth is 
consistent with the LSW theory. However, the particle size distribution did not have the shape 
predicted by the LSW theory that of an asymptotic narrow distribution, but more closely matched 
the much broader log-normal distribution. Moreover, it was shown that there was only small, but 
not zero, translational motion of voids at the late times in the experiments. This observation ruled 
out the mechanism of coalescence via migration as seen in emulsions. According to Figure 6-2 it 
can be suggested that the increase of the void size within the matrix was via coalescence in a 
sense that pairs of nearby voids were becoming bigger by combining suddenly in discrete events. 
As the experiments only yielded data on length scales of micrometres and upwards, and the 
acquisition times were long, it was not feasible to either directly observe coalescence or to follow 
the diffusion of individual air molecules. Therefore, this combining of the air voids could possibly 
involve little motion or some local diffusion.
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Figure 6-3: Void ripening mechanisms of: LSW theory; Emulsion moving; and predicted theory.
The experimental data in Chapter 5 Section 5.3.2 showed the log-normal distribution of air voids 
at a given time. It was suggested that the ripening of the air voids in the sample matrix was via a 
sudden combining, which could lead to a log-normal size distribution. A simple model based on 
this combining process of the air voids with voids all initially of the same size, V0, can be built as 
follows. It can be assumed that at any time, t, the size of the void i, which was directly related to 
the volume was V(t). At t=0, the volume of the void was V0. After one collision with a void of the 
same volume the volume changed to 2V0 and after a second collision per void it changed to 4V0 
and so on. Therefore, after n = number of collisions per void the volume became
V = 2 nK JL = 2n 6-1
assuming at each step that the combining voids have equal volumes. Alternatively, this could be 
written as
In —  = «(ln2) 6-2
where n was an independent random variable with its probability distribution, p(n), a Gaussian 
distribution. Granqvist and Buhrman [Granqvist and Buhrman, 1976] showed that coalescence 
naturally leads to a volume that can be expressed according to equation-6-2 which is Gaussian 
distribution. Hence, at any time t the volume of a void i, could be expressed as
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Vt[f) = 2“W 6-3
where n(t) was the number of combining events for void i which has occurred at time t.
According to the assumption that the driving mechanism of the growth of the air voids was the 
sudden combining of the air voids discussed above, a simple differential equation was considered 
able to describe the rate of change of total number of air voids per unit volume p(t) as function of 
time t
— -^ = - / c(f ) //2 6-4
d t K ^
where k(V) was the rate coefficient for the combining of a pair of air voids with volume V. This 
simple equation neglected the spread in void volumes at a given time, and also neglected any 
variation in space, i.e., any heterogeneities. The number of voids per unit volume p and the 
volume of a void V must be inversely proportional to one other as the product pV  equalled the 
fraction of air in the sample, which was assumed to be constant. The experimental data yielded a 
volume per void that increased linearly with time, Foe t, and so pec f 1. If in equation 6-4, the rate 
coefficient for the combining of the air voids was set constant, k(V) = constant then p  oc f 1 is 
indeed a solution to this equation. Thus if  the air voids combined at a rate proportional to the 
square of the number of air voids per unit volume, then the time dependence of the void volume 
found in experiment was obtained. This was very reasonable, since if  the voids were distributed at 
random in the sample then the number of pairs of voids close to each other would scale as the 
square of their number density.
It has been observed that the combining of the air voids can genetically lead to a log-normal 
distribution after times such that each void has combined with many other voids. A simple 
physically reasonable model of this combining thus agreed with the experimental observations 
that of the log-normal distribution of air voids at a given time and of the linear relationship of the 
mean volume with time. Finally, coalescence of voids did not necessarily require large-scale 
motion within the sample. It can be considered as an episodic process and thus agreed with the 
final experimental observation that there was a small but not zero motion of voids within the 
sample at late times.
6.2 Development of a model of dissolution mechanism
In Chapter 5 experimental evidence showed that changing certain parameters in the 
manufacturing process of the drug/polymer matrix had an effect in the release of the drug from 
the system. The next step was to get insight into the process of dissolution by developing a 
mathematical model able to describe all the experimental facts.
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The quantitative description of the experimental results developed in this chapter was based on 
key observations made from the experimental analysis. The observations included the porosity of 
the drug/polymer matrix, the ingress of water that was characterised by a sharp diffusion front 
advancing as a square root of time, the swelling of the polymer/drug matrix, the effect particle 
size and drug loading and the Aeif measurements of water and drug
In Chapter 1, experimental and theoretical work of several different research groups have been 
discussed that have elucidated the dissolution mechanism of polymeric drug delivery systems. 
Here, the theoretical description of drug release from the sample matrix was a combination of 
diffusion and dissolution processes.
Diffusion is the most important mechanism used to control drug release. The transport of water, 
into a matrix where diffusion is concentration gradient driven can be described by Fick’s second
where cw is the concentration of water, D(cw)  is the concentration dependent diffusion coefficient 
of water, x  the position, and t time. The ingress proceeds at a square root of time. However, this
is to be preserved. Nor does it permit the back flow of a third component such as drug. For 
systems with more than one component the process is more complicated and involves the 
interdiffusion of components. The general equation that describes the Fick’s first law for 
multicomponent system diffusion is [Wallin et a l, 2000] [Bird et a l, 2002]
where Ft is the flux of component z, cj is the concentration of component j,  and D fj  is a 
multicomponent coefficient. Generally, D*,j + D*J$i and not all the D*y are mutually independent. 
For example, a ternary system has four independent coefficients. If D*;j = D*jti then this reduced to 
three. Different authors have tried to rewrite this equation in terms of binary mixture diffusion 
coefficients. For the heterogeneous system studied in this thesis the diffusion model chosen was 
based on that described by Wallin et a l [Wallin et a l, 2000]. These authors studied polymer 
mobility as a function of depth in cross-linking latex coatings during their film formation. They 
adopted a model of diffusion that occurred by pairwise exchange of components using an 
“atomistic” approach on a discretised lattice. So the diffusion coefficient of component z in 
component j  can be expressed as A /- In such circumstances the flux of component z with respect 
to component j  is given by
law [Crank, 1975]
6-5
simple law does not account for swelling and the back flow of the matrix material if total volume
6-6
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D u
dc, dc, \.    c . — -
dx J dx
6-7
where Dp = Dp, so that the effective diffusion equation relating to component i is
82c, 82c,
C ;  p  —C,
J d x2 ' d x2 v y
6-8
For a system of n components, this expression requires definition of (1 + 2  + 3 ... + («-l)) 
diffusion coefficients.
The second process described in the model was dissolution. The rate at which the solid drug 
particles dissolve was proportional to the total solid drug particle surface area and the difference 
in concentration of surrounding solution from equilibrium. According to the Noyes-Whitney 
equation [Noyes and Whitney, 1897].
where csoudj ritg was the concentration of solid drug, which was related to the volume of drug per 
unit volume, (dimensionless), dcsoiidj nig/dt was the rate of dissolution, A, was the area of the drug 
particles per unit volume of tablet (cm"1), k was the dissolution constant (cm/s) and f eq) and f () 
were the fractions that corresponded to the saturation concentration of drug in solution and the 
concentration of drug at time t, respectively. In particular/^) was 29% (w/v). One way to increase 
dissolution rate of a drug was to increase the surface available for dissolution. This can be done 
by reducing particle size of the component as a few large particles would dissolve at a much 
slower rate than lots of smaller size. According to Equation 6-9 it was essential to consider how 
the surface area of the drug particles changed with time. It was assumed that all the drug particles 
were spherical and had the same initial size. For a uniform drug particle distribution in the solid 
matrix the surface area was dependent on the size of the particles and was expressed as
^  ^ so lid  _drug ( 7) j  ]
il/3
6-10
where c°solid dnig was the initial concentration of ding in the matrix, csolid dntg (/) was the 
concentration at time t, and r0 was the initial drug particle radius.
Noyes-Whitney equation has been used by different groups to describe the drug dissolution. 
Frenning and Stromme [Frenning and Stromme, 2003] presented a model combining dissolution, 
diffusion, and immobilization caused by adsoiption of the drug to the tablet constituents. They 
studied the drug release using alternating ionic current method [Frenning et al., 2002]. Their
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model was formulated in terms of a pair of coupled nonlinear partial differential equations, based 
on Fick’s law, Noyes-Whitney equation and Langmuir-Freundlich adsoiption isotherm, which 
were solved numerically by using finite differences. Schreiner et al. [Schreiner et al., 2005] 
measured the wettability, porosity, water uptake, and drug release rates of several ketoprofen- 
excipient preparations (powder blends, granulations, tablets). The drug release was determined via 
dissolution measurements. They showed that the time-dependent change of the effective 
dissolution surface in all preparations followed stochastic models where the dissolution equation 
was based on the differential Noyes-Whitney equation combined with a distribution function the 
e.g. the lognormal distribution, and numerically solved using a specialised software system. The 
model adopted here followed many of these ideas. However, the model constructed in this thesis 
was based on observation obtained from MRI experiments, which has the ability to provide 
internal images of the matrix under study in real-time conditions, non-destructively and non 
invasively with high spatial resolution.
The model equations were solved numerically using standard finite differences techniques by 
writing codes in IDL version 5.5 (Research Systems Inc., Colorado, USA). The model considered 
four components: water, polymer, solid drug and liquid drug. The initial concentration of the solid 
drug was set uniform throughout the sample. Time and space steps, St and Sx were defined and 
the step-sizes used in the calculations were set small to 0.2sec and 0.014cm respectively. The 
numbers were kept small so as to achieve small increments. The calculations proceeded in a series 
of time loops. Within each loop there were basic steps: (i) updated concentrations for dissolution 
and (ii) updated concentrations for diffusion. The steps were repeated for each loop. It was 
sensible to suggest that the amount of solid drug decreased at the same rate as the total drug in 
solution increased in the absence of diffusion.
iiquiddrug _  solid drug —  6-11
d t  d t
The model was constructed in a series of steps, which systematically included different processes 
as shown in Figure 6-4.
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Figure 6-4: Model constructed in a series of Diffusion and Dissolution step in loop.
The diffusion step was performed in which the concentration of each component in the sample 
was updated according to Equation 6-8 in order to reduce any spatial concentration gradient The 
dissolution step was performed to calculate the decrease in the concentration of the solid drug and 
the increase of the concentration of liquid drug.
The model was tested for a non-swelling system and a swelling system as discussed in the 
following sections.
6.3 Model for a non-swelling system
For the non-swelling system the model was effectively simplified to just two components: water 
and liquid drug. The diffusion mechanism involved two processes. The water penetrated the 
drug/polymer matrix and the liquid drug diffused out of the system as shown in Figure 6-5
141
Chapter 6: Theoretical models o f air voids formulation and dissolution mechanism
t
Figure 6-5: Water ingress into the system of length, L, and liquid drug diffuse out. The green block 
denote the polymer particles and the red blocks the drug particles of size r0.
There was an exchange of water and drug within the system with a constant mutual diffusion 
coefficient for drug in solution in which the flux of drug balanced the flux of water the other way. 
From equations 6-8
dc
— -  = D w,liquid _ drug nliquid drug dx2
d2c
— c. liquid _ drug
dx2
6-12
dcliquid _  drug
dt XX liquid _ drug.w
d2ci;liquid _ drug
dx2
~  C,:liquid _  drug
8 \
dx2
6-13
In first approximation the diffusion coefficient of polymer (Dp anythin?) and solid drug 
(Tsolid drug,, anything) were assumed zero.
A system was constructed consisting of a tablet of solid drug and polymer and a small fraction 
(3%) void filled with water in contact with a reservoir of water at time zero. The initial conditions 
were obtained from the assumption that all the drug was undissolved in the initial state and for a 
45% drug loaded tablet
X<0 Cw 1, Cliquid_drug (-solid drug 0 and Cp  0
X —0 cw 0.03, Ciiquid^dryg 0, csond drug 0.45 and cp 0.55
where cw was set to cw = 0.03 for x>0 to allow the initial capillary uptake of water. No flux 
boundary conditions were assumed at the lower tablet surface and at the upper water surface.
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Figure 6-6: Initial condition of the model of the two component system.
The model inherently conserved volume and there was therefore no swelling. It was assumed that 
locally solid drug dissolved to liquid drug according to equation 6-9 and that water and drug 
diffused according to equations 6-12 and 6-13. Simulations were conducted to observe what 
happened. They did predict the sharp diffusion front of water and the drug egress. These 
simulations were meant to compare to the experiment results in Chapter 5 and the initial 
parameters were set based on the experimental formulations. Figure 6-7 and Figure 6-8 show a 
typical result for a 45% drug loaded tablet, 0.3cm in length, dissolution constant, k, of 
2.5x 10'6cm/s, Dw = 1.82xl0'6cm7s and drug particle radius, r0 = 0.0045cm. The water-tablet 
interface was at x = 0cm; water to the left (x<0) and tablet to the right (x>0). The water reservoir 
extended to -0.6cm. Profiles are shown at selected times.
Water profile model data (45% drug load)
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Figure 6-7: Water profiles of model data (45%w/w), k = 2.5xl0'6cm/s, Dw= 1.82xl06cm2/s.
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Liquid drug profile model data (45% drug load)
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Figure 6-8: Liquid drug profiles of model data (45%w/w), £=2.5xl0'6cm/s, Z)^=1.82xl0"6cm2/s.
Figure 6-7 shows the water penetrating into the system with a sharp diffusion front until it reaches 
the end of the tablet, at x = 0.3cm. Until the water reached the far end of the sample, it was 
essentially a semi-infinite system to which the Boltzmann transform could be applied. Figure 6-9 
shows the Boltzmann transform of the data in Figure 6-7. It is seen that, with the exception of the 
very early time profiles, all the profiles lie on master curve.
Boltzmann's transform of model data (45% drug load)
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Figure 6-9: Boltzmann’s transform of modelled (45% drug load). Data of Figure 6-7.
The Boltzmann transform of the data (Figure 6-9) is very similar to the curve obtained from the 
experimental data (Chapter 5, Figure 5-12). The data show the sharp diffusion front which 
advances according to the square root of time. This was also confirmed from the plot of the 
distance of water ingress from the initial time until it was fully invaded the tablet against time172 
which gave a straight line.
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Model data (45% drug load)
Time1/2 (sec1/2)
Figure 6-10: Plot of the distance of water moved into the tablet against Time172 for 
model data of 45% drug load.
Figure 6-11 shows calculated profiles and the corresponding Boltzmann’s transform for a 
different set of parameters: 45% drug loaded tablet, 0.3cm in length, k -  2.5xl0'8cm/s, 
Dw-  1.82xl0~6cm2/s and drug particle radius, i*o= 0.0045cm. These parameters were the same as 
in Figure 6-7 except for the dissolution constant, k, which was 100 times smaller than before. It 
can be observed that the shape of the profiles is completely different and the Boltzmann’s 
transform did not yield a master curve.
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(a)
Water profile of modelled data (45% drug load)
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Figure 6-11: (a) Water profile of modelled data (45% (w/w) drug load) 
A^2.5xl0'8cm/s, Z>=1.82xl0'6cm2/s and (b) Boltzmann’s transform of 
modelled data (45% (w/w) drug load).
The difference in shape between Figure 6-7 and Figure 6-11(a) is due to the change in balance 
between diffusion and dissolution between the two parameters set. In the former the process is 
diffusion limited whereas in the latter is dissolution limited.
The values for the Dw used for the simulations were similar to the corresponding transport 
diffusion coefficient of a 45% (w/w) drug loaded Eudragit tablet obtained from the experiments 
(Chapter 5, Section 5.1.3.2). It was anticipated that the self-diffusion coefficients of the drug and 
water obtained in Chapter 4 would be helpful. In this event transport diffusion coefficients were 
used. Although the two are of comparable magnitude, currently no satisfactory link between the 
two has been identified. Although some authors have tried [Ciampi and McDonald, 2003, Liu and 
Gao, 2003].
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6.3.1 Dimensionless analysis
A dimensionless parameter was introduced to best reflect the competition between dissolution and 
diffusion. This parameter was defined as the ratio of the time required for water to diffuse across 
the tablet and the time for the drug to dissolve. The characteristic timescale o f diffusion, tDIFj for 
water diffusion across the tablet was defined as
where L was the length (thickness) of the tablet in cm and Dw the diffusion coefficient of water in
where r0 was the drug particle radius in cm and k  is the dissolution constant in cm/s.
A dimensionless “time” parameter was defined as the ratio of the timescale of diffusion and the 
timescale of dissolution
A relevant model to this study was the one developed by Harland et a l [Harland et a l, 1988b] as
mechanism by one single equation. In this thesis, two coupled equations are used to describe the 
diffusion and dissolution mechanisms. Moreover, Harland et al also introduced a dimensionless 
parameter to classify different dissolution regime limits. As already discussed in Chapter 1 their 
parameter was defined as
However, Dt implicitly only included a single length scale R, which is equivalent to the tablet size 
L defined in equation 6-16. It did not include the size of the drug particle r, which in this analysis 
would require the typical dimension of a pore within the microstructure and, due to the different 
definition of k, also the total internal surface area of porous microstructure. Therefore, Harland 
cannot discuss the time for dissolution as effectively as in the current work.
6-14
cm2/s. The corresponding characteristic timescale for dissolution of a drug particle tdis was 
defined as
Y
Timescale o f  Dissolution, rDIS = —
k
6-15
6-16
already discussed in Chapter 1 Section 1.4. They described the ding dissolution and diffusion
6-17
where k have units of s'1, different to the k  parameter defined here which has units of cm/s.
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In this thesis model profiles were calculated for different dimensionless numbers, t, by varying 
the dissolution rate, tablet length, drug load and diffusion constant. It was observed that when 
t » 1 there is a rapid dissolution at the front that saturates the solution and prevents front 
advancing. It is the subsequent egress by diffusion of drug which limits the progress and we call 
this drug-diffusion limited. When z«  1, the reverse is true. The water at the front is not saturated 
so readily and therefore a normal water diffusion front occurs. The egress rate is thus limited by 
the dissolution rate and we term this drag-dissolution limited. This basic idea is analogous to 
Harland except of course his Di involves the single length scale and looses inherent information 
about microstructure.
The effect of the particle size on the theoretical model data was also investigated. Figure 6-12 and 
Figure 6-13 show calculated water profiles and their corresponding Boltzmann’s transforms for 
particle sizes of 0.0045cm (dimensionless number: 14) and 0.45 (dimensionless number:0.14) 
respectively. The other parameters were: 45% drug load, 0.3cm length, k = 2.5><10"6cm/s and 
Dw= 3.5xl0'6cm2/s.
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Water profile of model data (x = 14)
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Figure 6-12: (a) Water profile (b) Boltzmann’s transform (c) Solid drug profile and (d) Liquid drug 
profile of model data for 45% drug load, ro=0.0045cm and Dimensionless number 14.
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Figure 6-13: (a) Water profile (b) Boltzmann’s transform (c) Solid drug profile and (d) Liquid drug 
profile of model data for 45% drug load, ro=0.45cm and Dimensionless number 0.14.
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It can be observed that for big drag particle size, giving small dimensionless number (0.14), the 
process was drug-dissolution limited and for small particle sizes, with large dimensionless number 
(14), was drug-diffusion limited.
The model was tested for similar parameters as the experiments (e.g. dissolution constant, particle 
size, porosity, ding load) and the resulting profiles were shown to yield release characteristics in 
good agreement with those observed experimentally (drug-diffusion limited). However, this 
version of the model did not take into account at all the swelling of the sample matrix and so that 
led to the second approach of the modelling, the incorporation of the swelling effect.
6.4 Model of a swelling system
Experimental evidence showed that the swelling of the tablet was only observed for a 
polymer/drag matrix. In this part of the model it was considered that the drug and water diffuse 
independently so that swelling was possible. At this stage, no mechanism for the independent 
diffusion is yet discussed. In order to achieve swelling it was allowed that
C\v + C liquidating + £solidjirug + Cp + 1
in a unit length of sample. Thus, to accumulate cw + Ciiqu iddru g  + csoUd drug + cp = 1, the length scale 
was renormalised by considering the amount of the components at location x fixed but Sx was 
changed to allow swelling. Hence, the length of the zfll element
S x z = S x  {cw + cliquid drug + csolid dnig + cp )) 
so that the position of the zdl element was
xz = S x  j ^ ( c w + cUquid drug + csolid 
v«=o
on the assumption that cw + Cuqilid_drug + csolid_drug + cp -  1 at t  = 0.
The results presented are for constant values for the water and drug diffusion coefficient. So for a 
45% drug loaded matrix of 0.3cm in length and r0 = 0.0045cm the selection of the water and 
liquid drug diffusion coefficients were obtained according to experimental findings in Chapter 5. 
So a 45% drag loaded tablets had a Dw in the order of 1.82xl0"6cm2/s and the Dtiquid dnig was 
approximately 10 times smaller in the order of 1.82x10'7cm2/s. The dissolution constant was set at 
k = 2.5xl0'6cm/s as previously done. Figure 6-14 shows the resulting profiles at selected times 
with water-tablet interface set at x = 0cm; water to the left and tablet to the right. The water 
reservoir extended to - 0.6cm.
_  drug + <))
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Figure 6-14: (a) Water profile modelled data, (b) liquid profile modelled data and 
(c) polymer profile modelled data.
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From Figure 6-14(a) and (b) it can be seen that as the water was going into the system the 
boundary of the water and the tablet was shifted to left indicating the swelling. In the water 
profile, it is observed that the water has reached the end of the tablet whereas from the liquid drug 
profile it can be seen that there was not sufficient time for the drug to come out with that 
simulation length. Only a very small amount did. Figure 6-14(c) shows the polymer profile. As 
the water was going into the tablet the polymer expanded. The polymer stopped expanding after 
101.3hrs (solid orange line). After that it started slowly to recover back to its initial position. The 
black solid line at 176hrs implies that the length of polymer has just started to return back to its 
initial position. The above profiles showed that swelling of the matrix was observed if 
independent drug and water diffusivities were assumed. The total change of tablet height over 
time was measured for the model data and compared with one obtained from experiment. The 
model data were obtained with similar parameters as for the experimental data for a 55% drug 
loaded matrix with Dw= 10'3cm2/s, Diiquiddrug = 10'6cm2/s, k = 2.5><10'6cm/s, matrix length 0.3cm 
and r0 = 0.0045cm.
55% (w/w) drug loaded Eudragit tablet
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Figure 6-15: Increase of tablet size with time for 55% (w/w) drug loaded tablet (a) experimental data 
and (b) model data.
Thus far simulations did not consider the origin of the swelling. One plausible suggestion was to 
assume that the swelling of the sample matrix was due to double layer repulsion inherit in the 
system as discussed in the following section.
6.5 Swelling of the sample matrix due to osmotic pressure
It was assumed that the driving force for the swelling of the sample matrix was double layer 
repulsion. In literature, work can be found on clay swelling systems [Madsen and Muller- 
Vonmoos, 1989] and polyelectrolyde polymer gel swelling systems [Elliott and Hodson, 1998] in 
which models were based on electric double layers.
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In general when ionised surfaces are in a medium that contains counter-ions, they interact with 
each other by electrostatic forces. The simple charged interactions are moderated by two effects: 
the first one is that the counter-ions will tend to weakly interact with opposite charges and the 
second is that there is a screening of these electrostatic forces by the bulk concentration of ions in 
solution. So when the two charged surfaces approach each other the ion concentration between the 
surfaces increases due to the requirement to maintain electrical neutrality and so a greater osmotic 
pressure is generated that leads to a repulsive force. This can be applied to the system studied here 
as it contains Eudragit polymer and Diltiazem HCl drug, which were both positively charged 
molecules (cationic) as shown from their structure in Chapter 3, Figure 3-1 and 3-2 respectively. 
As water enters the system there is a local increase in the concentration of counter-ions, leading to 
an increase in the local osmotic pressure, which results in a repulsion between the particles. 
Therefore, it can be assumed that the osmotic pressure in the system led to repulsive forces that 
resulted in the swelling of the sample matrix. A schematic diagram of the double layer repulsion 
is shown in Figure 6-16.
H20
Repulsive force Repulsive force
Figure 6-16: Double layer repulsion within the sample matrix leading to swelling.
Such a process is effectively a pressure acting on the water forcing it to ingress the tablet and 
cause swelling. Whilst it is likely that it can be dressed mathematically to look like diffusion, it 
need not strictly be diffusion and hence one should not be surprised if the effective diffusion 
coefficients for the water and drug are independent.
In a medium that contains free charges such as an electrolyte solution, these interactions become 
screened [Israelachvili, 1991]. This charge-screening effect occurs as a result of the presence of a 
large number of free ions in solution that are able to cluster around surface charges. This has the 
effect of shielding these surface charges from participating in their normal electrostatic 
interactions and so weakens the repulsive forces that presumably drive the swelling of the matrix. 
A very common electrolyte solution is aqueous sodium chloride solution (NaCl). Hence when two
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surfaces are exposed to NaCl solution the repulsive pressure, which is the force per unit area, 
between the two surfaces at a constant surface potential, y/0, is [Israelachvili, 1991]
P  =  ( l.5 9 x l0 8)[W aC/]/2e'*° 6-18
where y=tanh(zey/0 / 4/c7), where 2 is the valency, e is the electronic charge, k  is the Boltzmann’s 
constant and T is the absolute temperature, [NaCl] is the concentration of NaCl (mol/dm'3) and 
e~KD is the screening effect with D  being the distance between two surfaces (m). So the double­
layer interaction between two surfaces decays exponential with distance according to e KD where 
the characteristic decay length, k 1 (m), is known as the Debye screening length [Israelachvili, 
1991]. When e_KD is very small then the pressure is very small as well and so no swelling is 
occurring. More salt in solution increases the value of k leading to a more dominant screening 
effect as
1 0.304
6-19
where k 1 is in nm [Israelachvili, 1991]. The chosen electrolyte solution for this study was NaCl 
solution. The polymer/drug matrix was exposed to two different concentrations of salt solution: 
0.2M and 2M. The results presented in Chapter 5 Section 5.3.3 showed that when the tablet was 
exposed to 0.2M solution the matrix swelled whereas when it was exposed to 2M it did not. As 
the particles were compressed in a tablet it can be suggested that the distances between them in 
the compact sample were very small. Hence from the experimental results it can be assumed that 
small distances of particles can swell in concentration of 0.2M with k = 1.5nm'\ Above this 
concentration, at 2M NaCl, the particles cannot see each other in the presence of salt due to 
screening effect as at has higher value, k = 4.7nm"1, and so the matrix did not swell.
Another plausible suggestion for the swelling of the matrix is the solvation of drug particles. As 
water diffuses into the system it can be assumed that the drug particles attract more water 
molecules than the polymer particles due to their chemical structure (more polar groups). So as 
drug particles start to dissolve there is an increase in the area around them because it dissolves 
which possibly leads to the swelling of the matrix.
k  f [ m e t ]
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Solvation
Figure 6-17: Solvation of drug particles.
6.6 Conclusions
In this chapter models were adopted to explain the accumulation and ripening of air voids in the 
sample matrix observed during the ingress of water into the sample matrix, and the dissolution 
and swelling mechanisms.
The predicted model for the air voids distribution enabled to make an educated suggestion about 
how the ripening proceeded. It seemed likely that the increase of the void size within the matrix 
was due to a sudden combining of voids in discrete events which possibly involved little motion 
or some local diffusion. The rate of combining per unit volume was proportional to the square of 
the number density of voids. The predicted model was compared with existing models in literature 
which also shown the linear relationship of particle size (or volume) with time. However, it can be 
suggested that measuring just the mean size as a function of time is not sufficient to distinguish 
between the two mechanisms of ripening, diffusion and coalescence by migrating particles. An 
imaging technique, such as the MRI and X-ray //CT, that enables the distribution function to be 
obtained is required. The techniques and system studied here was actually one of the few systems 
by which the probability distribution function can be measured in situ and non-destructively.
It was possible to develop a model to describe the release of the drug from the matrix by 
combining diffusion and dissolution processes based on Fick’s law and Noyes-Whitney equation 
respectively. The initial stage of the model described a non-swelling matrix where a mutual 
diffusion coefficient of the water and liquid drug was assumed. The next stage involved a 
swelling matrix where it was necessary to decouple the mutual diffusion coefficient to separate Dw 
and Diiguidjrug to achieve swelling. The model was tested for different parameter sets and was able 
to reproduce the characteristic trends of the experiments reported in Chapter 5. The important 
outcome of this model was the introduction of a dimensionless parameter able to reflect the
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competition between dissolution and diffusion. The parameter was the ratio of the time of 
diffusion and the time for dissolution. When the parameter was greater than one the process was 
drug-diffusion limited. When it was less than one it was drug-dissolution limited.
Finally, it was suggested that the driving force of the swelling of the drug/polymer matrix 
observed in the experiments was due to osmotic pressure. An assumption based on the double 
layer repulsion as the two components in the sample matrix were cationic molecules.
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C h a p t e r  7
7  C o n c l u s i o n s  a n d  F u t u r e  w o r k
7.1 Conclusions
In this thesis the principal factors affecting the release of a soluble drug from a non-swelling 
polymer matrix are studied so as to understand better the dissolution mechanism. The release of 
the drug is examined using a variety of non-destructive and non-invasive imaging methods 
including MRI, X-ray /CT, UV spectroscopy and optical microscopy. The tablets are prepared 
with different drag loadings, level of compaction, particle size, matrix type and exposed primarily 
to water and other dissolution environments. MRI experiments on drug loaded tablets exposed to 
water suggest that there is a rapid capillary uptake (< lOmins) of water into the initial pore space 
the tablet ahead the primary dissolution. This porosity is determined to be very small, less than 
4% for 100% Eudragit tablet and even less for drug loaded tablet. Slow subsequent dissolution 
characterised by a sharp diffusion front is observed, which separates the invaded and un-invaded 
regions. It is shown that water ingresses linear with the square root of time and the transport 
diffusion coefficient of water in the tablet is estimated as a function of concentration. The rate of 
water ingress is affected by the drug load and the drug particle size. Swelling of the whole tablet 
at intermediate drug loading (>45%) is detected but no comparable swelling for either 100% 
polymer or 100% drag tablets. NMR and UV spectroscopy were used to assess the amount of 
drug released. An important observation made in this thesis, is the accumulation and ripening of 
air voids within the sample matrix as water ingresses into the tablet. This is important as it 
possibly affects the release rate of the drug. This phenomenon was both observed by MRI and X- 
ray //CT. The high spatial resolution of the X-ray //CT system allowed the air-void size 
distribution to be quantified as it changes over time. A simple model is proposed predicting that 
the ripening of the air-voids occurred via a combining process of air voids, which possibly 
involves little motion or some local diffusion. A mathematical model is developed able to 
describe the dissolution mechanism of the sample matrix based on the observations made from the 
experimental analysis. The theoretical description of ding release from the sample matrix is a 
combination of diffusion and dissolution processes. A dimensionless time is introduced to best 
reflect the competition between dissolution and diffusion. This parameter is defined as the ratio of
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the time required for water to diffuse across the tablet and the time for the drug to dissolve. This 
parameter helped describe the effect of particle size on dissolution. Finally, it is assumed that the 
driving force for the swelling of the drug loaded polymer matrix observed in the experiments is 
the osmotic pressure. This assumption is based on the double layer repulsion as the two materials 
in the system were cationic molecules.
7.2 Future work
In this thesis it was possible to understand in great extent the dissolution mechanism of a soluble 
drug from a non-swelling polymer matrix by vaiying principal manufacture parameters. However, 
there is still potential for further work by changing more parameters and observe the effect on the 
dissolution mechanism.
In Chapter 5, the effect of pressure in the ingress of water into the system was examined by 
conducting experiments on tablets prepared with different compression levels. These experiments 
were completed only on 100% Eudragit tablets compressed at 0.1 and 3tons (0.015 and 
0.455GPa). The data obtained suggested that tablets with low compression were more permeable 
to water as there was more air space between the grains to absorb the water due to lower 
compaction. The drug loaded matrices were only studied on tablets compressed at 2tons 
(0.303GPa). Therefore, similar experiments could be conducted on drug/polymer matrices 
prepared with different compression levels, ranging from 0.1 up to 3tons (0.015 and 0.455GPa) to 
observe the effect of pressure on drug release and diffusion of water. The different compression 
level could also affect the initial pore space of the dry matrix. This could be determined as 
discussed in Chapter 5 Section 5.1.2 and observe any changes. All the experiments presented in 
this thesis were conducted at room temperature. Increasing the temperate, for example to 37°C, 
would help observe any effect on the dissolution mechanism.
MRI and X-ray pCT experiments showed evidence that as water ingressed into the polymer/drug 
matrix there was accumulation of air voids in the system. The X-ray pCT system allowed the air- 
void size distribution to be quantified as it changes over time. Vaiying the experimental 
parameters in the X-ray pCT experiment such as, drug loading, compression level, polymer type 
(Eudragit RLPO), different dissolution environment (phosphate buffer) could enable to check if  
there is any affect in the degree of coalescence. One more suggestion would be to try 
incorporating the air voids formulation into the mathematical model developed to describe the 
dissolution mechanism.
The theoretical explanation of the swelling of sample matrix observed in the experiments was 
based on the assumption that there was a built of osmotic pressure within the system. It would be
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useful though to demonstrate this experimentally. A possible suggestion could be to take two 
glass tubes and fill one with concentrated drug solution (29% w/v) and the other with just water. 
Then connect the two tubes with a membrane that is permeable to water but not to drug. This 
could be a thin layer of Eudragit compressed tablet. Epoxy adhesive can be used around the 
Eudragit layer so as to hold the system together. Water should then permeate to the tube 
containing the drug/water solution and the difference in height would help determine the osmotic 
pressure.
The egress of drug from the system was followed both by UV and NMR spectroscopy. The UV 
experiments showed a ‘noisy’ line representing the drug release. This led to the assumption that it 
was necessary to perform the experiment in a more controlled environment. The water travelled in 
and out of the system using long rubber tubing so one suggestion could be to try to use shorter 
tubing. However, this could be still difficult due to the size of the magnet.
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